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ABSTRACT 
 
Brian W. Jarecki 
 
 
Gating of the sensory neuronal voltage-gated sodium channel Nav1.7:  Analysis 
of role of D3 and D4 / S4-S5 linkers in transition to an inactivated state 
 
 
Voltage-gated sodium channels (VGSCs) are dynamic membrane-
spanning proteins crucial for determining the electrical excitability in nerve and 
muscle.  VGSCs transition, or gate, between opened, closed, and inactivated 
states, in response to changes in transmembrane potential.  Altered VGSC 
gating can affect electrical communication and is implicated in numerous 
channelopathies.  Nav1.7, a VGSC isoform highly expressed in the peripheral 
nervous system, plays a unique role in pain perception as evidenced by single 
point missense mutations causing a spectrum of pain syndromes (inherited 
erythromelalgia; IEM and paroxysmal extreme pain disorder; PEPD) and 
nonsense mutations resulting in human insensitivity to pain (CIP).  These studies 
indicate Nav1.7 is critical in pain transduction and, as such, structural 
perturbations to Nav1.7 affecting conformational stability and response to 
changes in transmembrane potential have the potential to cause pain.  
Therefore, the aims of this dissertation were to (1) examine the effects of PEPD 
mutations on the voltage-dependent properties Nav1.7; (2) investigate the effects 
Nav1.7 alternative splicing has on the impact of IEM and PEPD mutations; (3) 
evaluate the effects channelopathies, resulting from slowed inactivation, have on 
modulating an unusual type of sodium current that flows during membrane 
repolarization; and (4) determine the structural components involved in stabilizing 
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Nav1.7 inactivation.  Standard patch-clamp electrophysiology was used to study 
changes in channel properties.  Results from this dissertation demonstrate that 
(1) PEPD mutations significantly shift the voltage-dependent properties of Nav1.7 
channels, destabilize an inactivated state in a residue specific manner, and 
render nociceptive neurons hyperexcitable; (2) alternative splicing can 
functionally impact PEPD; (3) channelopathies, resulting from slowed inactivation 
in neuronal and muscle VGSC isoforms, increase an unusual sodium 
conductance that flows during repolarization; and (4) specific residues located in 
distinct regions of Nav1.7 serve as docking sites to stabilize inactivation at 
different membrane potentials.  Overall, this dissertation answers key questions 
regarding the molecular mechanics required during inactivation and the 
biophysical consequences of Nav1.7 mutations implicated in painful disorders.  
The results of this dissertation are important for a more detailed understanding of 
pain perception and validate the applicability of studying Nav1.7 for discovery of 
therapeutic targets for treatment of pain. 
 
Theodore R. Cummins, Ph.D., Chair 
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“And instead of saying all of your goodbyes, let them know you realize that life 
goes fast, it's hard to make the good things last, you realize the sun doesn't go 
down, it's just an illusion caused by the world spinning round.” 
 
       Do You Realize?? 
       The Flaming Lips 
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I. INTRODUCTION 
A. Overview 
Pain is a widespread medical epidemic.  Defined by The American 
Academy of Pain Management (AAPM), pain is “a complex mélange of emotions, 
culture, experience, spirit and sensation resulting from an unpleasant sensation 
and emotional response to that sensation”.  Approximately 90 million people live 
with the devastating neurological disorder of chronic pain (“the disease of pain”) 
and of these, 45% will seek care at some point during their life, thus, accounting 
for about 20% of physician’s visits and 10% of drug sales.  Unfortunately, 
treatment for such pain represents a major issue confronting our culture where 
many of the people suffering from pain are unable to find adequate pain relief.  
Furthermore, pain therapeutics to date, although initially effective, have the 
potential to produce addiction, physical dependence, tolerance, as well as 
unwanted side effects due, in part, to lack of target specificity.  With remarkable 
advances in molecular biology, the scientific community is able to better 
understand the mechanisms involved in the generation of pain, which will allow 
for discovery of more unique therapeutic targets and appropriate drug design. 
Pain transduction and perception involve complex biological events, 
utilizing several levels of the nervous system that originate from the periphery.  
Nociceptors, which are a subpopulation of primary sensory neurons activated by 
noxious, or painful, stimuli, are the primary afferent neurons where a component 
of chronic pain arising from pathology in the peripheral nervous system, termed 
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peripheral neuropathic pain, can be initiated.  Compelling evidence suggests that 
this type of complex pain, is, at least in part, a result of changes in ion channels 
(transduction proteins) and additional key proteins (Woolf and Salter, 2000; 
Campbell and Meyer, 2006).  In particular, neuronal voltage-gated sodium 
channels (VGSCs or Nav) expressed in nociceptive dorsal root ganglia (DRG) 
neurons have been hypothesized to play a critical role in peripheral sensitization 
(Amir et al., 2006).  VGSCs play a crucial role in generating action potentials 
(APs), which can transmit and relay information from the periphery to the high 
order neurons in the central nervous system (CNS) for interpretation. 
Because a constellation of VGSCs are expressed in “pain sensing” 
neurons within the peripheral nervous system (PNS) a substantial amount of pain 
research has resourcefully exploited this relationship.  Changes in neuronal 
VGSC expression and functional properties can contribute to increased 
excitability (hyperexcitability) in sensory neurons and increased pain sensation 
(Matzner and Devor, 1994; Waxman et al., 1994; Akopian et al., 1999).  Thus, 
expression of specific VGSC isoforms in sensory neurons contributes to fine 
tuning the neuronal firing properties.  However, because of the complexity of the 
VGSC subtype expression in DRG and lingering questions related to how 
structural changes in these channels affect gating, it has been difficult to 
determine the precise role of individual isoforms in neuronal hyperexcitability.  
Additionally, a lack of information regarding the tertiary structure of VGSC 
subtypes has complicated drug development targeting specific VGSCs.  
Therefore, a better understanding of the intramolecular interactions during 
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transitions between gating states will help determine (1) the contribution of 
specific isoforms during hyperexcitability of sensory neurons leading to peripheral 
sensitization and (2) potential target sites for therapeutic agents. 
The central focus of this dissertation revolves around the structural and 
biophysical properties of the VGSC isoform Nav1.7.  Nav1.7 channels, highly 
expressed peripheral and sympathetic nervous systems, are essential in 
nociception as evidenced by single point missense mutations causing a spectrum 
of pain syndromes (Drenth et al., 2001; Fertleman et al., 2006; Dib-Hajj et al., 
2007), and nonsense mutations resulting in human insensitivity to pain (Cox et 
al., 2006).  These studies indicate that Nav1.7 is a critical component in the pain 
transduction pathway and, as such, structural perturbations to Nav1.7 that affect 
conformational stability and response to changes in transmembrane voltage have 
the potential to cause extreme pain.  Therefore, channelopathies, or inherited 
diseases caused by defects in ion channel proteins, associated with Nav1.7 
provide useful insight into structural mechanisms involved in channel gating and 
associated conformations which may aid in a more complete understanding of 
pain perception and development of novel channel-targeted therapeutic 
strategies to treat various painful disorders. 
B. Brief history and background of voltage-gated sodium channels 
Cells are enveloped by a highly lipophilic membrane which serves as a 
barrier to non-permeable solutes (Singer and Nicolson, 1972).  This lipid barrier 
creates a charge separation across the membrane based on the intracellular and 
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extracellular charged ionic species composition yielding an electrochemical 
gradient / transmembrane potential (Cole, 1949a).  However, specific modes of 
transport of these ionic species across the membrane and the importance of this 
process in communication between nerve and cells were a topic of great debate 
(Hille, 2001).  A series of elegant experiments defining the period of classical 
biophysics (1935-1952), further established the ionic theory of membrane 
excitation.  It was during this time that Nobel-prize winning (1963) pioneers Sir 
Alan L. Hodgkin and Sir Andrew F. Huxley published their work detailing the ionic 
components carrying transmembrane current and the application to conduction 
and excitation in nerve (Hodgkin and Huxley, 1952).  Measuring changes in 
membrane current across the squid giant axon, Hodgkin and Huxley were able to 
accurately describe how kinetic changes in ion (Na+ and K+) permeability 
contribute to action potential (AP) generation by clamping the cellular membrane 
voltage (Cole, 1949b; Marmont, 1949; Hodgkin et al., 1952). 
Clamping the membrane voltage enabled Hodgkin and Huxley to measure 
changes in ionic current, at fixed command membrane potentials, and allowed for 
a current-voltage relationship to be determined for particular ionic species.  This 
technique differs from current-clamp, which records the variable membrane 
potential, determined by several ionic species, by injecting current into a cell 
through a recording electrode.  Current-clamp is particularly useful for 
determining the specific phases of an AP.  The voltage-dependent increase in 
Na+ or K+ permeability could be described by the changes in channel 
conductance for a particular ion species.  The direction of the current through a 
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channel is based on the driving force through an electrochemical gradient 
according to Ohm’s Law.  Thus, it was hypothesized that at particular depolarized 
voltages, relative to the resting potential, Na+ permeability increased.  This was 
postulated to be based on mobile “activating particles” whose movement through 
the membrane to occupancy sites is accelerated during depolarization, 
increasing Na+ conductance and allowing Na+ to flow inward down its 
electrochemical gradient, driving the membrane potential towards the Na+ 
reversal potential (~+40 mV).  Because the inward current of Na+ was transient, 
Hodgkin and Huxley theorized that separate mobile structures called “inactivating 
particles” could block the flow of Na+, thereby decreasing Na+ permeability and 
conductance.  The block or “inactivation” of Na+ current would therefore allow for 
membrane repolarization and return to a resting potential.  Thus, inactivation of 
Na+ currents plays an important role during the AP refractory period by 
decreasing the response probability to an additional stimulus until a large fraction 
of channels have recovered from inactivation (reprimed or reset).  On the other 
hand, K+ currents are extremely important in determining resting membrane 
potential and firing frequency.  These K+ currents are also slowly activated during 
membrane depolarization, and therefore produce the outward current; flowing 
down its electrochemical gradient towards K+ reversal (~-70 mV), needed to 
repolarize the membrane potential in addition to Na+ channel inactivation. 
Together, the selective permeability and inward and outward flow of these 
ions, along with their unique voltage-dependent kinetics, predominantly account 
for the AP characteristics.  However, the currents carried by additional ionic 
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species such as calcium (Ca++) and chloride (Cl-) can also alter the shape of the 
AP.  Therefore, the AP represents a change in membrane potential caused by 
the flow of ions through selective pores in the membrane of excitable cells.  
Results from these experiments expanded on previous hypotheses (Hodgkin, 
1937b, a; Hodgkin and Katz, 1949; Hille, 2001) and verified that changes in the 
membrane permeability of Na+ and K+ are controlled, in part, by changes in 
membrane voltage (Figure 1A) and that these permeability changes determine 
the waveform of an AP (Figures 1C and D).  An AP waveform can be roughly 
broken down into three components: (1) a rising phase during membrane 
depolarization when Na+ current activation and conductance dominates; (2) 
falling phase, where K+ current activation and Na+ current inactivation take over 
to repolarize the membrane potential and (3) recovery phase where currents can 
reprime for rapid regeneration of AP. 
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Figure 1.  Representative traces illustrating voltage-dependent ionic 
conductance and simplified gating scheme contributing to action potential 
(AP) generation.  (A) Whole-cell voltage-clamp recording from a small-medium 
diameter (< 25 µm; 16.08 pF) excitable rat dorsal root ganglia (DRG) cell.  Inward 
sodium (Na+) and outward potassium (K+) current is noted.  The cell was held at -
100 mV and stepped from -80 mV to +60 mV in + 10 mV increments.  (B) 
Representative trace from a rat DRG cell transfected with Nav1.7r (see Methods).  
Highlighted traces represent changes in inward Na+ conductance in response to 
depolarizing steps (-80, -50, -10, +40 mV) in membrane potential towards Na+ 
reversal potential (+65 mV) passing through the various populations of voltage-
dependent configurations defined as closed (C), open (O), and inactivated (I).  
Inset shows a simplified state-occupancy gating scheme using the same 
abbreviations as above.  (C) Representative action potential (AP) recording from 
a rat DRG cell with a resting membrane potential of -55 mV and the response to 
injected steps (+25 pA) of current (pA) required to elicit an AP.  Dominant state 
occupancy of the population of VGSCs denoted with C, O, I along the AP shape.  
(D) Representative train of AP recordings in response to an injected ramp of 
current over a 500 ms duration. 
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Based on changes in membrane voltage, Hodgkin and Huxley 
hypothesized that ion permeability rapidly activates (rises) and inactivates 
(decays), a process governed, in part, by independent particles (m and h) or 
“gates” of conducting pores (Hodgkin and Huxley, 1952).  Movement of these 
activating (m) and inactivating (h) particles or gates were postulated to act as 
molecular gatekeepers to allow or restrict Na+ flow through the membrane.  For 
example, the rate, based on membrane potential and time, at which the 
activating (m) particle moves determines the rate of Na+ current and the rate at 
which Na+ current declines is based on the h particle rate of movement.  
However, further examination and manipulation of these processes required 
pharmacological intervention. 
Toxins isolated from puffer fish and marine dinoflagellates, tetrodotoxin 
(TTX) and saxitoxin (STX) respectively, revealed that Na+ and K+ permeation 
were determined by independent “ion canals / channels” (Narahashi et al., 1964; 
Nakamura et al., 1965; Narahashi et al., 1967; Hille, 1968).  These toxins 
selectively inhibited Na+ conductance, whereas the quaternary ammonium cation 
tetraethylammonium (TEA) selectively blocked K+ conductance (Tasaki and 
Hagiwar, 1957; Armstrong and Binstock, 1965).  Taken together, these seminal 
experiments added molecular details to the hypothesis that Na+ conductance can 
be modulated by channels that undergo voltage-dependent conformational 
changes that transition the channel between closed (C), open (O), and 
inactivated (I) configurations, or states, in response to time, temperature, and 
membrane voltage (Figure 1).  Transition through these states reveals specific 
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drug-receptor sites for molecules such as TEA.  The binding sites for ligands 
such as TEA, TTX, and STX were useful for shedding light on the intracellular 
and extracellular topology of these voltage-sensitive channels.  Further 
advancements (Hamill et al., 1981; Sakmann and Neher, 1984) to the voltage 
clamp technique allowed for increased resolution with recordings from patches of 
isolated cells expanding the understanding of voltage-dependent gating 
mechanisms.  Experiments outlined throughout this dissertation utilize these 
electrophysiological techniques to study to voltage-dependent properties of a 
particular VGSC isoform. 
C. Diversity of VGSC isoforms 
Voltage-sensitive Na+ conducting membrane canals, or VGSCs, are 
dynamic membrane-spanning proteins that play a crucial role in determining the 
electrical excitability in nerve and muscle (Hodgkin and Huxley, 1952).  These 
channels exist as multi-subunit complexes in the lipid membrane consisting of a 
highly processed α-subunit that, when expressed alone, can produce functional 
current, which can also associate with multiple auxiliary β-subunits (Catterall et 
al., 2005).  Nine isoforms of the highly homologous pore-forming α-subunit 
(Nav1.1-9, 220-260 kDa) have been identified, each with subtle differences in 
channel properties likely due to differences in amino acid sequence (Catterall et 
al., 2005).  The α-subunit is important for drug binding, ion selectivity, and pore 
formation (Catterall, 2000) whereas the auxiliary β-subunits (32-36 kDa) have 
been suggested to play a key role in channel modulation, adhesion, and 
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trafficking (Isom et al., 1992; Isom et al., 1995b; Isom et al., 1995a).  In addition 
to the β-subunits, several other proteins interact with VGSCs (Wood et al., 2004) 
such as calmodulin (Herzog et al., 2003a) and annexin II (Okuse et al., 2002) for 
example.  These interacting proteins have been found to modulate the functional 
properties of VGSCs. 
The sequence conservation and redundancy between each of the various 
VGSC isoforms likely contributes to their broad similarities (ion selectivity and 
voltage-dependence), whereas differences in channel coding sequence between 
isoforms may play a role in evolutionary adaptation, such as pharmacological 
sensitivities (TTX-sensitive; TTX-s vs. TTX-resistant; TTX-r), kinetic properties 
(fast vs. slow activating / inactivating channels), or transcriptional editing and 
tissue specific transcription factors may account for the variety of regional 
distributions for VGSCs.  For example, Nav1.4 is highly expressed in skeletal 
muscle (Trimmer et al., 1989), whereas Nav1.5 is predominantly located in 
cardiac tissue (Rogart et al., 1989).  Interestingly, mRNA and current expression 
for Nav1.5 is detectable in dorsal root ganglia (DRG) neurons (Renganathan et 
al., 2002).  Nav1.1, 1.2, and 1.6 channels are expressed in various combinations 
in adult CNS neurons (Trimmer and Rhodes, 2004).  Adult DRG sensory neurons 
express a myriad of Nav1.1, 1.6, 1.7, 1.8, and 1.9 VGSCs (Black et al., 1996; 
Dib-Hajj et al., 1998; Amaya et al., 2000).  It is worth noting that Nav1.3 is 
primarily expressed in immature neurons and can be upregulated to levels 
significantly above native levels under injurious conditions suggesting this 
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channel may be important in altered pain states (Beckh et al., 1989; Waxman et 
al., 1994; Boucher et al., 2000). 
As mentioned above, the VGSC isoforms can also be pharmacologically 
separated by their sensitivity to TTX (Baer et al., 1976; Ritchie and Rogart, 1977; 
Klugbauer et al., 1995; Akopian et al., 1996; Dietrich et al., 1998; Cummins et al., 
1999; Meadows et al., 2002), and classified as sensitive (TTX-s = 1-25 nM; 
Nav1.1, 1.2, 1.3, 1.4, 1.6, and 1.7) or resistant (TTX-r = 1-60 mM; Nav1.5, 1.8, 
and 1.9) to nanomolar (nM) or millimolar (mM) application of TTX.  Furthermore, 
several of the VGSC isoforms can be distinguished by their unique current 
kinetics and steady-state voltage-dependent properties.  For example, VGSC 
expressed in neurons of the central nervous system (CNS) produce rapidly 
activating and inactivating currents with a high degree of sensitivity to TTX 
(Ritchie and Rogart, 1977).  Conversely, the population of VGSCs found in dorsal 
root ganglia (DRG) neurons generates rapid activating and inactivating TTX-s as 
well as slowly activating / inactivating and persistent TTX-r currents that display 
more complex kinetics and steady-state properties (Kostyuk et al., 1981).  The 
diverse population of VGSCs and their unique voltage-dependent properties has 
been proposed to play a critical role in the fine-tuning of electrical 
communication, via AP generation and propagation in the tissues where they are 
expressed.  With this in mind, alterations to the voltage-sensitivity of these 
channels and / or their expression patterns can significantly impact the 
generation and perception of electrical signals in the body. 
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D. Structural components and gating characteristics of VGSCs 
1. Abbreviated introduction 
As previously mentioned, VGSCs are dynamic Na+ conducting proteins 
with the intrinsic ability to transition between distinct gating configurations based 
on their capacity to “sense” changes in transmembrane potential.  This is in 
contrast to transmembrane ion-permeable channels, such as nicotinic 
acetylcholine receptors (nAchR) and ionotropic gamma-aminobutyric acid 
(GABAA) receptors that change configuration upon binding their namesake 
ligand.  Several decades of research have shown that many of the characteristic 
features of VGSCs, such as pharmacological sensitivity and gating kinetics, are 
due to their unique structural properties, amino acid composition (primary 
structure) and signature motifs (secondary structure) in regions critical for gating, 
ion selectivity, and modulation which distinguish them from other ion permeable 
voltage-sensitive channels (Hille, 2001).  The well-conserved topology of the 
VGSC α-subunit (220-260 kDa) structure (Figure 2A and B) consists of four 
domains (D1-D4).  Biochemical and structural analyses, molecular cloning and 
hydropathy plots showed that each domain contains six transmembrane α-helical 
segments (S1-S6) that possess unique properties important for retaining a 
definitive channel structure (Levinson and Ellory, 1973; Beneski and Catterall, 
1980; Noda et al., 1984; Durell and Guy, 1992).  For example, evidence indicates 
the voltage-sensing components in voltage-dependent ion channels (i.e. Nav, Kv, 
Cav) are the S1-S4 segments in each domain, where the highly positively 
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charged S4 segments are the mobile charge “voltage sensors” (Armstrong and 
Bezanilla, 1973; Armstrong, 1981; Stuhmer et al., 1989; Papazian et al., 1991; 
Chahine et al., 1994; Starace et al., 1997).  Conversely, the S5-S6 segments and 
adjoining P-loops (S5-P-S6) form the aqueous ion-conducting channel pore and 
ion selectivity filter (Durell and Guy, 1992; Doyle et al., 1998; Yellen, 1998).  
Specifically, in response to changes in membrane potential, transitions between 
ion conducting (opened) and non-conducting (closed and inactivated) gating 
states (Figures 1B, 2B and C) have been linked to particular domains and 
segments of the channel that cooperatively result in changes to the channel 
configuration, thus allowing or restricting ion movement through the pore 
(Catterall, 2000).  A description of the molecular components and interactions 
required for gating are discussed below. 
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Figure 2.  Representative schematics of voltage-gated sodium channel 
(VGSC) topology.  (A) Linear representation of the VGSC topology including the 
four domains (D1-4) and plasma membrane-spanning intradomain segments 
(S1-S6).  Noted are important mobile motifs for activation (positively-charged S4 
“voltage sensors”, colored in yellow) and inactivation (D3-D4 inactivation gate 
motif; colored in pink) gating.  Pore forming regions are highlighted in blue.  
Critical D3-D4 inactivation gate tetrapeptide is labeled with one letter amino acid 
designations (IFMT) and channel terminal ends are abbreviated at the N and C-
termini.  (B) Top down extracellular view of the aqueous VGSC pore surrounded 
by the transmembrane segments.  (C) Cartoon image of the structural changes 
of the pore-surrounding S6 alpha helices in response to changes in membrane 
potential (Vm).  Upon membrane depolarization, residues near the hinge region 
(grayed half-circle) allow for conformational flexibility and distal S6 splaying 
conferring an open (ion-conducting) channel conformation.  These figures were 
created using CorelDraw version 9 and were adapted from several models in the 
literature (Noda et al., 1984; Guy and Seetharamulu, 1986; Stuhmer et al., 1989; 
Guy and Conti, 1990; Catterall, 2000; Long et al., 2005a). 
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2. Voltage-gated channel activation and associated gating charge 
movements 
Transition between gating states, in part, is determined by a focused 
electric field based on the ionic charge separation across a lipophilic membrane 
(capacitor), thus creating an electrical gradient (Asamoah et al., 2003; Sigg and 
Bezanilla, 2003).  The charge gradient supplies voltage-sensitive channels with 
the potential energy required to surmount conformation-dependent energy 
barriers (Seoh et al., 1996).  Hodgkin and Huxley originally postulated that 
“changes in ionic permeability depend on the movement of some component of 
the membrane which behaves as though it had a large charge or dipole moment” 
(Hodgkin and Huxley, 1952).  The structural basis of their theory was validated 
after the VGSC was cloned.  The S4 segments of the cloned VGSC were 
clustered with basic residues and were hypothesized to act as the voltage 
sensors (Noda et al., 1984).  Indeed, in several electrophysiological experiments 
the voltage-dependent rise of inward Na+ conductance described by Hodgkin and 
Huxley, was due to the mobile charge translocation through the electric field, thus 
activating the channel (Armstrong and Bezanilla, 1973; Keynes and Rojas, 1973; 
Armstrong and Bezanilla, 1974; Keynes and Rojas, 1974; Meves, 1974; Stuhmer 
et al., 1989) which precedes the channels adopting an open (ion-conducting) 
pore configuration.  Upon charge translocation, the channel activation / m gates 
(Hodgkin and Huxley, 1952) were hypothesized to open and allow ion 
conductance.  In contrast, deactivation, or transition from an open to a closed 
configuration, is thought to involve an integrated return of the S4 voltage-sensors 
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to a primed state, allowing the activation gates to close, and can, thus, be 
observed as a tail current of ionic current during membrane repolarization 
(Oxford, 1981; Kuo and Bean, 1994; Featherstone et al., 1998).  The charge 
movement of the S4 segments through the electric field carried what was defined 
as gating current from a position buried in the membrane to an accessible 
extracellular space outside the membrane yielding an outward current 
(Armstrong and Bezanilla, 1973) distinct from the ionic pore-conducting current 
(Armstrong and Bezanilla, 1974; Bezanilla and Armstrong, 1974).  The voltage-
dependent accessibility of these once buried charges was further tested in 
relation to holding potential using site directed mutagenesis and extracellular pH 
manipulation or chemical modifying techniques (Yang and Horn, 1995; Larsson 
et al., 1996; Starace and Bezanilla, 2001; Ruta et al., 2005).  These results 
suggest that the S4 segments donate a specific number of charged residues (per 
S4 segment) to the extracellular field during channel activation.  Recent studies 
of gating current using fluorescent probes to track the timecourse of gating 
charge movement demonstrated there are two components (early and late) to 
VGSC gating charge movement and activation (Chanda and Bezanilla, 2002) 
determined by a separate gating particle that immobilizes the S4 gating charges 
(Cha et al., 1999).  Thus, sequential S4 activation of all four VGSC S4 segments 
from membrane depolarization increases the probability, on a millisecond 
timescale, of channels transitioning to an open configuration.  However, several 
hypotheses with regard to how the S4 segments translocate their charges have 
been suggested and highly debated. 
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Theoretical molecular models such as the “stepping ratchet” and 
“transporter model” involve relatively short distance (2-3 Å) charge movement, 
whereas the “helical screw” and the “paddle” models involve larger charge 
movements of 5-13 Å and 15-20 Å, respectively.  Several techniques including 
electrophysiological recordings, scanning mutagenesis, site-directed accessibility 
studies, cross-linking, fluorometric techniques employing environment-sensitive 
dyes, and distance measurements using (fluorescence resonance energy 
transfer) FRET and (luminescence resonance energy transfer) LRET, have been 
used to track and characterize these movements (Hille, 2001; Tombola et al., 
2006).  Furthermore, site-directed mutagenesis studies based on inherited 
channelopathies, or diseases associated with ion channel dysfunction, have 
demonstrated that several VGSC mutations can alter the voltage-dependent 
properties of activation and ion conduction (Cannon, 2000; George, 2005; 
Meisler and Kearney, 2005; Koopmann et al., 2006; Catterall et al., 2008).  
Studies examining the underlying mechanisms involved in various ion channel 
disorders implicated in disease have been extremely useful in characterizing 
several ion channelopathies and the effects inherited mutations have on gating 
properties.  Furthermore, these types of studies have been useful in probing the 
channels to determine their tertiary structure and topology.  Together, these data 
suggest the movement of the S4 segments is a highly regulated process, 
determined in part by the primary and secondary structure. 
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3. Ionic current through a channel pore upon opening 
Since ionic (hydrophilic) species will not simply diffuse through a lipophilic 
barrier, the structural components tethering and translating the voltage-sensing 
gating charge movement to ion flux through the membrane, and theoretically 
channel opening, remained somewhat elusive.  Based on a model circuit 
analogy, existence of a conducting medium or pore would allow ion flux through 
a relatively low energy barrier or pathway.  In a series of elegant experiments 
examining ion permeability, Hodgkin, Huxley, and Keynes, it was hypothesized 
that the positively charged ionic species pass along several negative charges, as 
suggested by Hodgkin and Huxley (1952) or in a single file through narrow tubes 
or channels thus accounting for variations in calculated flux ratios (Hodgkin and 
Keynes, 1955).  Pharmacological experiments utilizing the membrane 
impermeable TEA+, suggested the presence of an aqueous K+ permeable pore 
(Armstrong and Binstock, 1965; Armstrong, 1966, 1969, 1971).  It was 
hypothesized that intracellular application of TEA+ could bind to a putative 
receptor site; distinct from a receptor site from extracellular TEA application, to 
block K+ channels only if a conducting pore was open and available.  
Furthermore, this theoretical block by TEA+ could be overcome by increasing 
extracellular K+ concentration, suggesting a distinct pore block.  This open 
channel block did not affect the inherent pore activation mechanism, however the 
blocking reaction did progress similarly to what Hodgkin and Huxley called 
inactivation based on increasing depolarization.  Thus, the process of activation 
in response to depolarization appeared to allow access to an intracellular 
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receptor site for TEA that could occlude K+ current (Armstrong, 1974).  For the 
first time, a kinetic scheme detailing a state-dependent blocking event, based on 
membrane potential, was described suggesting the channel state may allow or 
deny access to aqueous receptor sites within the channel pore.  Additional 
molecules, such the local anesthetic lidocaine, exhibited similar voltage-
dependent block of ionic current (Strichartz, 1973; Hille, 1977).  These models 
suggested that intracellular application of local anesthetics could reach an ion 
binding site within the pore if the gating apparatus was open.  Alternatively, local 
anesthetics could reach a binding site through the plasma membrane if one or 
both of the gates were closed.  Taken together, these experiments showed that 
intracellular application of “blocking” molecules can abolish ionic current in a 
voltage-dependent manner once a pore-binding site becomes available however; 
the structural components involved were not resolved. 
Structural predictions and analysis of the pore forming components of 
voltage-gated ion channels have been investigated by using site-directed 
scanning mutagenesis and cysteine accessibility, toxin binding, ion replacement, 
and computer modeling.  These studies demonstrated that the S5-S6 linker, or P-
loop, forms the outer vestibule and selectivity filter of voltage-gated ion channels 
and the membrane-spanning S6 segments align to form an pore (Hille, 2001).  
For VGSCs, the inner pore consists of the S6 segments from which the S5-P-S6 
“P-loop” extends extracellularly from each of the four domains that contribute 
residues (DEKA motif; net charge -1) critical for permeant ion selection 
(selectivity filter) as determined by ion size and radius (Fozzard and Hanck, 
 20 
1996; Marban et al., 1998).  Thus, it was hypothesized that the S6 segments 
altered their conformation to selectively allow or restrict Na+ passage through the 
aqueous pore in response to changes in transmembrane potential as sensed by 
the S4 gating charge movement (Yellen, 1998). 
Remarkable work from the MacKinnon laboratory finally shed light on the 
molecular details and components transmitting these gating movements to pore 
opening and ion selectivity by crystallizing several K+ channels in different 
conducting states (Doyle et al., 1998; Jiang et al., 2002; Jiang et al., 2003; Long 
et al., 2005b, a; Long et al., 2007).  Their results yielded great insight into the 
molecular details of the aqueous cavity and pore-forming components of ion-
selective channels and the way that certain ions are filtered.  Further details were 
noted regarding how the channels open and close.  The crystal structure of 
voltage-sensitive K+ channels showed critical motifs, such as (1) a well-
conserved glycine residue near the middle of the S6 segments provides flexibility 
for opening; (2) hydrophobic residues near the intracellular portion of the S6 
segments may interact with additional hydrophobic residues during opening; and 
(3) an S4-S5 linker appeared to come into close proximity of the distal portions of 
the S6 segments that may be critical for coupling gating charge movement to 
pore opening, (Long et al., 2005a).  Indeed, studies examining the importance of 
residues in the pore domain (Soler-Llavina et al., 2006), including the putative 
“glycine hinge” region (Zhao et al., 2004; O'Reilly et al., 2008), and the S4-S5 
and C-terminal portion of the S6 segments (Chen et al., 2001; Lu et al., 2001, 
2002; Long et al., 2005a; Ferrer et al., 2006; Prole and Yellen, 2006; Labro et al., 
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2008) demonstrated these regions of the channel are critical for voltage-sensitive 
channel opening.  However, scanning mutagenesis studies of voltage-gated 
channels indicate that these regions are important “docking” sites required for the 
transition to / and stability of an inactivated state (Isacoff et al., 1991; McPhee et 
al., 1994, 1995; Tang et al., 1996; Lerche et al., 1997; Smith and Goldin, 1997; 
Filatov et al., 1998; McPhee et al., 1998; Tang et al., 1998; Popa et al., 2004).  
Because crystal structures capture proteins in only one, static conformation, as 
opposed to multiple snapshots of several dynamic voltage-dependent transitions, 
the molecular significance of these regions is still debated and highly studied. 
4. The molecular mechanics of inactivation gating 
Hodgkin and Huxley originally hypothesized (1952) that the voltage-
dependent rate constants, over a millisecond (ms) timescale of the inactivation 
process did not intimately depend on the state of the rapid channel activation, 
and therefore were not coupled processes.  However, subsequent studies using 
mathematical modeling (Hoyt, 1963, 1968) suggested the rise and fall of Na+ 
conductance during depolarization depends on only one variable controlled by 
two or more coupled processes.  This observation suggested that the voltage-
dependence of inactivation (h) gating, proposed by Hodgkin and Huxley (1952), 
was derived from the more rapid voltage-dependent kinetics of activation gating.  
Evidence supporting these mathematical implications came from experiments 
measuring changes in gating currents in response to time and varied conditioning 
(pre) voltage pulses before a test pulse was implemented in a two-pulse protocol 
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(Goldman and Schauf, 1972).  With a two-pulse protocol the experimenter can 
determine the fraction of channels accumulating in an inactivated state at specific 
voltages with respect to time.  Results from this study demonstrated that 
inactivation depends on the Na+ conductance during a test pulse and the rate of 
development is a function of the rise of Na+ conductance during a conditioning 
pulse.  Thus, the inactivation process could modify activation and gating charge 
movement by charge immobilization, suggesting the gating mechanisms were 
coupled. 
Further studies investigating the mechanics of inactivation suggested a 
model for the transient, voltage-dependent current block which involved an 
intramolecular particle acting like a mobile ball tethered to a chain to plug the 
conducting channel pore (Armstrong and Bezanilla, 1977) and immobilize gating 
charge movement (Nonner, 1980).  This “ball-and-chain” / “foot-in-the-door” 
inactivation model for channels inactivating from an ion-conducting state, defined 
as open-state inactivation (OSI), was based on previous studies showing that it 
was possible to prolong the timecourse of an AP in the presence of proteolytic 
enzymes, called proteases, or cross-linking reagents (Tasaki and Takenaka, 
1964; Rojas and Atwater, 1967; Shrager et al., 1969; Takenaka and Yamagishi, 
1969) and voltage-clamp studies internally perfusing pronase (Rojas and 
Armstrong, 1971; Armstrong et al., 1973), N-bromoacetamide (Oxford et al., 
1978), or papain (Quandt, 1987).  Notably, VGSCs had also been hypothesized 
to transition to an inactivated state directly from a resting or closed state, defined 
as closed-state inactivation (CSI).  This idea was based on two key findings: (1) 
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macroscopic current results demonstrating that steady-state inactivation was 
accelerated at voltages more hyperpolarized than those required for full 
activation and Na+ conductance (Oxford and Pooler, 1975; Bean, 1981), and (2) 
single channel studies  indicating the probability of inactivation did not depend on 
that of activation (Horn et al., 1981).  Together, these studies suggested an 
inactivated state (fast inactivation; occurring rapidly on a millisecond timecourse) 
that precedes m gate opening, which may also confirm one mode of h gate 
stabilization in the presence of local anesthetics, such as lidocaine, prior to 
channel activation, from a membrane phase (Hille, 1977). 
Hypotheses for an additional inactivation gating mechanism were 
proposed based on several studies in nerve and muscle demonstrating that ionic 
conductance decreased during a prolonged depolarization of several seconds 
(Hille, 2001; Ulbricht, 2005).  This type of inactivating mechanism, where 
development and recovery occur over a second to minute timescale, was defined 
as slow inactivation.  Slow inactivation is distinct from the (fast) inactivation 
mechanism that rapidly occurs after activation and can be removed by 
intracellular proteolytic enzyme application (Rudy, 1978).  This mechanism of 
slow inactivation had been postulated to contribute to the repolarization phase of 
an AP even after removal of fast inactivation aiding in return of the membrane 
potential to voltages where VGSC activation gates start to close (Armstrong et 
al., 1973).  A more detailed examination of the voltage-dependent kinetics of 
slow inactivation in the presence of pronase was investigated in the squid giant 
axon (Rudy, 1978).  Results from this study suggest four gating states (c; closed, 
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o; open, h; fast-inactivated and s; slow-inactivated) for VGSCs where slow 
inactivation can be accelerated upon destruction of the h (fast) inactivation gate.  
Occupancy of channels from an open state to a slow-inactivated state may 
therefore explain AP firing adaptation.  However, upon removal of fast 
inactivation with enzymatic treatment that does not directly alter the slow 
inactivation gate, the development rate of slow inactivation is faster suggesting 
the fast and slow inactivation mechanisms may be modulated by one another 
based on the stability of their individual gates and / or channel occupancy in one 
of the inactivated states. However, the coupled nature of these two gating 
processes remains controversial because the structural components responsible 
for transition to a slow inactivated state have not been defined (Ruben et al., 
1992; Vedantham and Cannon, 1998). 
A suggestion for individual fast and slow inactivation gates came from 
studies demonstrating that trypsin, which is a serine protease with similar 
hydrolytic activity to a component in pronase (Rojas and Rudy, 1976), can 
differentially affect transition to a slow-inactivated state (Starkus and Shrager, 
1978).  A later kinetic analysis of the steady-state availability of VGSCs and 
potential interactions between activation and slow inactivation proposed that 
gating of slow inactivation is controlled by a separate, slow moving voltage 
sensor that may be electrostatically coupled to the activation voltage sensors 
(Ruben et al., 1992).  Comprehensive state-occupancy models based on 
cumulative data from single channel, macroscopic and gating current analyses, 
where forward and reverse rate constants can be calculated at particular 
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voltages, have been developed to better explain the multi-state paths VGSC can 
traverse in response to changes in transmembrane voltage with respect to time 
and temperature (Vandenberg and Bezanilla, 1991).  A critical feature that must 
be noted in the model is that channel recovery from an inactivated state does not 
traverse through an open state, implying that no ionic current can pass through 
the channel during recovery from an inactivated state when channels reprime to 
a closed state.  A caveat to this transition, and will be discussed in further detail 
below, is the probability that ionic currents, in fact, can pass during repriming.  
These unique types of currents, that “resurge” during membrane repolarization 
are thought to arise from a competing molecule whose binding affinity is similar 
to that of the inactivation gate but upon binding only transiently competes with 
the fast inactivation gate (Raman and Bean, 1997).  Thus, upon repolarization, 
channels that bind this competing particle allow a resurgence of current during a 
recovery protocol.  The components responsible for this current and importance 
on gating and AP properties will be discussed in more detail in the following 
sections.  Unfortunately, structural implications about the specific gating 
pathways in the absence of a crystal structure are complicated to validate.  
However, with the advent of molecular biology and studies utilizing scanning and 
site-directed mutagenesis, the molecular determinants governing transitions to 
and from the different inactivation mechanisms were able to be investigated 
further. 
As stated above, upon S4 charge translocation and activation gate / S6 
splaying open, Na+ conductance through VGSCs is rapidly occluded by a gating 
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mechanism called fast inactivation which appears to occur via pore blocking by 
an intracellular component of the channel.  Conclusions from studies using 
blocking agents with specific amino acid side chain moieties (Rojas and Rudy, 
1976; Eaton et al., 1978) and amino acid-specific proteolytic enzymes (Oxford et 
al., 1978) implied certain residues were critical for the binding affinity of the 
inactivation gate to the receptor site within the channel pore.  Several years later, 
advancements in the field allowed molecular biologists to identify a putative 
inactivation gate motif within the D3-D4 loop (Stuhmer et al., 1989) critical for fast 
inactivation utilizing site-directed antibodies (Vassilev et al., 1988; Vassilev et al., 
1989; Benz et al., 1997), a molecular scissor approach (Stuhmer et al., 1989), 
and scanning, deletion, and site-directed mutagenesis (Patton et al., 1992; West 
et al., 1992; Kellenberger et al., 1997).  Collectively, these studies identified an 
amino acid triad motif (isoleucine, Ile; phenylalanine, Phe; methionine Met), 
whose one-letter designations are IFM, within the D3-D4 cytosolic linker that 
serves as a hydrophobic latch for a hinged lid formed by the D3-D4 linker 
required for complete fast inactivation in VGSCs to occur.  Further mutagenic 
studies suggested that fast and slow inactivation gating mechanisms can be 
disrupted by mutating the Phe residue within the inactivation motif which was 
hypothesized to be important for coupling between the two inactivated states 
(Nuss et al., 1996).  However, the extent to which these inactivating mechanisms 
may be coupled is questionable because longer conditioning pulses (50 sec) 
used to transition channels to “steady-state” slow inactivation showed no 
difference in available current from wild-type or Phe mutant Nav1.4 channels 
 27 
upon test depolarization (Cummins and Sigworth, 1996).  The importance of the 
residues within the linker was also examined by internal peptide (one-letter 
amino acid nomenclature, KIFMK) application, bearing a similar triad motif.  
These studies demonstrated that upon removal of fast inactivation, the peptide 
mimetic could effectively restore fast inactivation suggesting a putative binding or 
receptor site for the inactivation gate (Eaholtz et al., 1994; Eaholtz et al., 1998; 
Eaholtz et al., 1999). 
Experiments using substituted cysteine accessibility methods, or SCAM, 
which allow sulfhydryl chemical modification of engineered cysteine (Cys) 
residues (Karlin and Akabas, 1998), further validated the structural importance of 
the inactivation gate motif by demonstrating that (1) the chemical accessibility of 
the residues in the triad motif changes during depolarization (Kellenberger et al., 
1996; Horn et al., 2000), (2) replacement of the aromatic Phe residue with a polar 
cysteine (Cys) causes incomplete inactivation, whereas modification of the Cys 
residue to include an aromatic group restored inactivation similar to unmodified 
channels (Chahine et al., 1997), (3) the hydrophobicity and aromatic side chain 
moiety Phe along with the location within the gate is critical for stabilizing 
inactivation (Deschenes et al., 1999), and (4) alterations within the triad motif 
critical for fast inactivation can disrupt the stability of local anesthetic binding 
(Vedantham and Cannon, 1999).  NMR structural analysis of an isolated 
inactivation gate also indicates the triad motif faces an aqueous accessible 
region, with the Phe residue at the apex of the hydrophobic cluster, freely 
modifiable at hyperpolarized potentials when channel are closed, and may pivot 
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around hinge regions to bind to a receptor site within the intracellular portion of 
the channel (Rohl et al., 1999).  Because the threonine (Thr) residue, 
downstream of the IFM motif, has been shown to be important for inactivation 
gating (Rohl et al., 1999), this dissertation will refer to the putative inactivation 
motif as a tetrapeptide (IFMT) motif within the D3-D4 linker.  Additional scanning 
and site-directed mutagenesis studies in the D3-D4 linker of several VGSCs also 
indicate that charged residues and residues available for phosphorylation, 
adjacent to the triad motif, serve unique functions during gating charge 
immobilization, inactivation gate stabilization, and channel modulation (Hille, 
2001; Ulbricht, 2005).  It is worthwhile to note that the inactivation gate motif 
(IFMT) is highly conserved in all isoforms of VGSCs (Catterall, 2000), which may 
suggest unique importance for gating.  An interesting study examining the 
importance of this hydrophobic motif during inactivation has shown that the motif 
can bind to a functional receptor site within Shaker K+ channels and block K+ flux 
(Patton et al., 1993).  Several lines of evidence support the importance of these 
residues for gating based on single-point mutations within the inactivation gate 
motif that are implicated in numerous channelopathies associated with a wide 
range of inherited neuronal and muscle disorders (Cannon, 2000; George, 2005; 
Meisler and Kearney, 2005; Koopmann et al., 2006; Catterall et al., 2008). 
An additional and somewhat controversial mechanism proposed to 
compete with inactivation gating has been postulated to underlie generation of a 
unique type of conductance defined as resurgent currents.  In contrast to typical 
inactivation gating that transitions the channels into a refractory state, an 
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endogenous particle that transiently binds and competes with the inactivation 
gate, readily unbinds during repolarization and allows a resurgence of current to 
flow before channels would otherwise reprime (Raman and Bean, 1997, 2001).  
Structurally, the putative open-blocking particle, hypothesized to be the C-
terminal tail of the auxiliary β4-subunit, has lower affinity for an overlapping 
inactivation “docking” motif compared to the inactivation gate motif (Grieco et al., 
2005).  Evidence supporting this competing mechanism came from studies that 
artificially slowed inactivation, upon toxin application, and increased the 
resurgence of Na+ currents upon membrane repolarization (Grieco and Raman, 
2004).  Thus, it was suggested that by slowing transition to a fast-inactivated 
state, the opportunity for the open-blocking particle to bind was increased.  
Additional mechanisms, suggesting production of these currents can be tuned via 
post-translational modification (Grieco et al., 2002) and the unique cellular 
background of neuronal cells (Chen et al., 2008), have also been proposed.  The 
TTX-s Nav1.6 channels appear to predominantly generate resurgent currents 
(Raman et al., 1997; Cummins et al., 2005); these currents may be 
physiologically relevant in that they allow production of subthreshold Na+ current 
relevant to repetitive AP firing which may be required for high-frequency firing in 
cerebellar Purkinje neurons (Raman and Bean, 1997).  However, despite the 
critical importance of inactivation gating the putative receptor or “docking” sites 
for the inactivation motif are still not well defined and the molecular details 
regarding the stabilizing interactions during inactivation are still debated.  
Additionally, since inactivation of VGSCs is critical for repolarization of the 
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membrane potential during AP propagation, understanding the molecular details 
involved in channel inactivation can provide valuable insight into (1) the 
complexity of inactivation gating and AP propagation, (2) how the process is 
regulated and can become deregulated, thus, leading to disorders, and (3) 
strategies for pharmacological intervention because several therapeutic agents 
target this gating state. 
From a structural standpoint, open-channel fast inactivation is thought to 
be tightly regulated by the D3 / S4 and (late) D4 / S4 translocation, coupling the 
voltage-dependent activation mechanisms to inactivation (Chahine et al., 1994; 
Chen et al., 1996; Kontis and Goldin, 1997; Kontis et al., 1997; Cha et al., 1999; 
Groome et al., 1999; Horn et al., 2000).  However, very little is known about the 
definitive sites required to bind or stabilize the inactivation gate.  Therefore, 
based on the aforementioned crystal structure of a voltage-sensitive K+ channel 
and gating charge immobilization studies, one would predict that the C-terminal 
segments linking S4 charge translocators to the pore may be involved in 
“docking” of, or interactions with, the putative inactivation gate.  The crystal 
structure of Kv1.2 (Long et al., 2005a) predicts the α-helical S4-S5 segments to 
be good candidates near the intracellular mouth of the channel pore where, 
based on the models for fast inactivation, the inactivation gate binds.  Indeed, 
interaction or “docking” sites for the mobile inactivation gate have been proposed 
to be localized to the D3 and D4 / S4-S5 linkers and the distal portions of the S6 
segments C-terminal to a flexible glycine hinge region within the aqueous pore 
(McPhee et al., 1994, 1995; Tang et al., 1996; Lerche et al., 1997; Smith and 
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Goldin, 1997; Filatov et al., 1998; McPhee et al., 1998; Tang et al., 1998; Popa et 
al., 2004).  However, these data are variable and inconsistent and, moreover, 
contradict the early models suggesting the inactivation gate must bind to 
residues within the channel pore to occlude Na+ movement.  Conclusions 
reached from these studies raise the following questions: (1) If the inactivation 
gate must bind within the channel pore why would mutations within the S4-S5 
intracellular loops of D3 and D4 impair channel inactivation, (2) Is it possible that 
these intracellular loops of D3 and D4 sit within the proposed pore of the channel 
formed by the S6-segments, (3) Is it possible there are multiple binding sites for 
the inactivation gate that involve the S6-segments and intracellular loops of D3 
and D4 working in a coordinated fashion to transition through a series of 
inactivated steps, and (4) Are structural differences in these regions key 
determinants in the variability of inactivation properties between VGSC 
subtypes?  These intriguing questions inspired me to further investigate the role 
of D3 and D4 / S4-S5 linkers in stabilizing the putative inactivation gate and how 
these interactions relate to the structural changes of the channel during 
inactivation.  Studies in this dissertation focus on residues in these regions of 
Nav1.7, highly expressed in the PNS, because several single-point mutations 
located in these cytosolic linkers have been implicated in unique disorders 
resulting in extreme pain. 
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E. VGSCs and peripheral neuropathic pain 
Neuropathic pain is pain that originates from pathology in the nervous 
system, both central (CNS) and peripheral (PNS), although a substantial amount 
of research has focused on neuropathic pain arising from peripheral regions.  In 
particular, peripheral neuropathic pain is associated with sensitization of the 
nociceptive, “pain-sensing” neurons as a result of changes in ion channels 
(transduction proteins) and additional key proteins (Campbell and Meyer, 2006).  
These proteins determine the excitability of the nociceptive neurons (Matzner and 
Devor, 1994; Scholz and Woolf, 2007; Costigan et al., 2009).  For example, 
expression and activity of several voltage-gated potassium channels (VGKCs) 
are important for setting resting membrane potential (RMP), repolarizing the 
membrane, and balancing AP firing frequency in excitable cells (Coetzee et al., 
1999).  Notably, manipulating the expression or gating of particular VGKC 
isoforms such as Kv1.1 (Clark and Tempel, 1998) and Kv4.2 (Hu et al., 2006) can 
increase sensitivity to mechanical and thermal nociceptive stimuli.  Altered 
function of these two isoforms can influence neuronal excitability (Rogawski, 
1985; Chi and Nicol, 2007) and would be expected to contribute to the population 
of potassium channels whose amplitudes are decreased under inflammatory 
conditions (Stewart et al., 2003).  Additionally, neuronal VGSCs, expressed in 
dorsal root ganglia (DRG) neurons, are hypothesized to play a critical role in 
peripheral sensitization (Devor, 2006).  Changes in neuronal DRG VGSC 
expression, which include a variety of pharmacologically and kinetically distinct 
populations (Kostyuk et al., 1981; Caffrey et al., 1992; Roy and Narahashi, 1992; 
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Elliott and Elliott, 1993; Ogata and Tatebayashi, 1993; Rizzo et al., 1994; Rush et 
al., 1998; Cummins et al., 1999), and functional properties can contribute to 
hyperexcitability in sensory neurons and to increased pain sensations.  For 
example, the slow inactivating TTX-r currents may prolong action potential (AP) 
duration, thus modulating changes in neurotransmitter release (Amir et al., 2006), 
whereas TTX-s currents, including some persistent (or non-inactivating) currents 
in CNS and PNS neurons, significantly influence AP threshold (Baker et al., 
1987; Crill, 1996; Cummins and Waxman, 1997).  With several breakthroughs in 
molecular biology, including the molecular cloning of rat VGSCs (Beneski and 
Catterall, 1980; Hartshorne and Catterall, 1981), a more detailed picture of the 
role of particular VGSCs in determining cellular excitability has taken shape. 
Na+ permeability was shown to play an important role in AP generation 
and propagation (Hodgkin and Huxley, 1952).  Therefore, it was hypothesized 
that alterations in the voltage-sensitive channels controlling Na+ conductance 
would impact AP properties.  However, this process was more intricate than 
originally postulated.  The pharmacologically and kinetically distinct populations 
of VGSC currents were shown to be comprised of nine VGSC isoforms (Catterall 
et al., 2005).  The evolutionary conservation of VGSCs has been thought to 
contribute to fine tuning mechanisms in excitable cells such as the DRG.  Adult 
DRG neurons express a complex array of TTX-s (Nav1.1, 1.3, 1.6, and 1.7) and 
TTX-r (Nav1.8 and 1.9) sodium channels which play important roles in AP firing 
properties (Rush et al., 2007) suggesting these isoforms would be ideal targets 
for developing therapeutic strategies aimed at alleviating pain perception.  For 
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example, the slow onset of closed-state inactivation and slow repriming 
properties of the TTX-s Nav1.7 are thought to lend to ramp current generation 
and amplification of subthreshold stimuli which determine AP threshold 
parameters.  TTX-s Nav1.6 channels, which rapidly recover from inactivation 
(reprime), contribute to high frequency firing.  Conversely, the relatively 
depolarized activation and inactivation characteristics of TTX-r Nav1.8 channels 
are major current contributors to AP upstroke.  Despite these distinctive gating 
features and relative contributions to AP firing, useful pharmacological 
intervention targeting specific VGSC isoforms, especially the TTX-s populations 
which contribute to nociception, remains extremely limited. 
Compelling evidence suggests that under peripheral neuropathic pain 
conditions ectopic activity in primary (nociceptive) sensory neurons increases, of 
which, VGSCs can contribute.  Changes in peripheral VGSC expression or 
gating kinetics, for example, during injury or with inherited channelopathies, 
respectively, have been proposed as modes to increase cellular excitability, thus 
contributing to nociception in primary afferent sensory neurons.  Clinical studies 
have shown that administration of VGSC blockers such as lidocaine are 
efficacious and relieve symptoms of neuropathic pain in patients with painful 
peripheral neuropathies (Kastrup et al., 1987; Arner et al., 1990; Ferrante et al., 
1996; Sindrup and Jensen, 1999).  Experimental evidence suggests expression 
of several peripheral VGSC isoforms are altered in animal-modeled injury 
conditions (Amir et al., 2006).  For example, Nav1.1 and 1.2 are down-regulated 
following axotomy (Kim et al., 2001); however expression of the Nav1.3 channel, 
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normally not found in adult DRG, is significantly up-regulated following complete 
and partial nerve injury and after induction of diabetes (Waxman et al., 1994; 
Black et al., 1999; Dib-Hajj et al., 1999; Kim et al., 2001; Craner et al., 2002).  Of 
interest, axotomy-increased Nav1.3 expression can be partially reversed (Leffler 
et al., 2002) by neurotrophic factors (glial cell-line derived neurotrophic factor; 
GDNF and nerve growth factor; NGF) which can experimentally rescue 
axotomized conditions (Fjell et al., 1999).  Additionally, expression of Nav1.6, 8, 9 
have all been shown to be differentially regulated under modeled neuropathic 
pain conditions (Amir et al., 2006).  Despite several mechanistic and behavioral 
studies indicating VGSC expression changes during modeled neuropathic pain 
conditions, few studies have genetically linked structural mutations that alter 
gating properties in “nociceptive VGSCs” to peripheral neuropathic pain.  
However, convincing evidence has accumulated in the past few years 
demonstrating that Nav1.7 channelopathies that alter activation and inactivation 
characteristics are implicated in painful neuropathic disorders. 
F. The Nav1.7 VGSC isoform and pain 
Research from this dissertation focuses primarily on the gating properties 
of the TTX-s VGSC isoform Nav1.7, originally referred to as hNE(9) or PN1, 
which was initially cloned from neuroendocrine cells (Klugbauer et al., 1995).  
Transcripts from this isoform were not identified in pituitary gland, heart, brain, 
liver or kidney suggesting Nav1.7 may be an evolutionary link between brain and 
muscle VGSCs (Klugbauer et al., 1995).  The protein structure of Nav1.7, 
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encoded by the SCN9A gene, is composed of 1977 amino acids and displays 
high homology to other isoforms in the VGSC superfamily (Catterall et al., 2005) 
with notable differences in the D1 / S5 extracellular loop and pore region, the D1-
D2 intracellular loop and the carboxy (COOH) terminus (Figure 1).  This isoform 
is predominantly expressed in neurons of the DRG and sympathetic ganglion 
within the PNS (Black et al., 1996; Sangameswaran et al., 1997; Toledo-Aral et 
al., 1997) compared to other isoforms previously mentioned.  Additional studies 
have shown that Nav1.7 immuno-staining is highly localized to the unmyelinated 
polymodal C-fibers of nociceptive neurons, suggesting Nav1.7 channels may play 
a role in regulating the highly afferent “second pain” carried by the slowly 
conducting C-fibers (Djouhri et al., 2003). 
The macroscopic kinetic features of Nav1.7 currents indicate these 
channels rapidly activate and inactivate (Klugbauer et al., 1995) in response to 
strong membrane depolarization in a similar manner to other TTX-s VGSCs, 
however these currents develop (Cummins et al., 1998) and recover (Cummins 
et al., 1998; Herzog et al., 2003b) from inactivation in a more distinct fashion.  
The modest development of inactivation at intermediate potentials (i.e., at -60 mV 
before the population of channels have reached an open or conducting state), 
indicates Nav1.7 channels slowly transition to closed-inactivated states, where a 
fraction of the S4 segments have activated, but channels are not in an open 
configuration (Oxford and Pooler, 1975; Armstrong, 2006).  The relatively slow 
transitions of Nav1.7 to and from closed-inactivated states are thought to 
contribute to production of physiologically relevant subthreshold currents in 
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response to slow depolarizing ramp stimuli at hyperpolarized potentials near 
resting membrane potential (RMP) for nociceptive DRG neurons (Rush et al., 
2006; Rush et al., 2007).  These Nav1.7 ramp currents have been proposed to 
play roles in amplifying subthreshold currents at relatively hyperpolarized 
voltages nearing AP firing threshold (Cummins et al., 1998; Herzog et al., 
2003b).  Thus, the ramp current generated by Nav1.7 channels is implicated as a 
critical component in determining AP firing threshold (Blair and Bean, 2002).  The 
gating properties of Nav1.7 channels are consistent with the firing rates of C-
fibers where these channels were localized based on the aforementioned 
immuno-staining results.  Taken together, Nav1.7 channels are thought to be 
critical determinants in setting threshold for APs in small-diameter nociceptive 
neurons. 
Indeed, peripheral tissue inflammation increases the amplitude of TTX-s 
currents in DRG neurons, which is paralleled by increased Nav1.7 transcript and 
protein levels (Black et al., 2004).  Additionally, the inflammatory cytokine, nerve 
growth factor (NGF), may contribute to the increased levels of Nav1.7 during 
inflammation because NGF can upregulate Nav1.7 (Toledo-Aral et al., 1995; 
Toledo-Aral et al., 1997; Gould et al., 2000).  The increase of Nav1.7 could 
increase neuronal excitability and modulate pain perception.  However, additional 
studies have shown that mice with the Nav1.7 gene selectively knocked out in 
nociceptive DRG neurons do not differ from wild-type counterparts in 
development of pain associated with a non-noxious mechanical stimulus or 
mechanoallodynia (Nassar et al., 2004).  Furthermore, because expression of 
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specific VGSCs can contribute to determining neuronal excitability (Rush et al., 
2006), mice with deleted Nav1.7, critical for amplifying subthreshold currents, and 
1.8, important for generating AP upstroke, channels were developed.  In these 
mice mechanoallodynia develops normally compared to wild-type mice (Nassar 
et al., 2005).  Additional studies have shown that Nav1.7 expression is increased 
in rat DRG under induced conditions of diabetic neuropathy using streptozotocin 
as a trigger (Hong et al., 2004).  Taken together, these results indicate Nav1.7 
plays an important role in inflammatory pain, but may not be a key regulator of 
neuropathic pain.  However, the possibility for compensatory mechanisms that 
may work to counterbalance channel knockouts cannot be ruled out in these 
animal models.  It should also be noted that, as discussed below, Nav1.7 is 
critical in diseases associated with extreme pain in humans. 
Interestingly, more than 20 single-point missense (gain-of-function) 
mutations, in the SCN9A gene encoding Nav1.7 have been identified to date, and 
convincingly linked to two separate peripheral neuropathic pain syndromes: 
Inherited erythromelalgia (IEM) and paroxysmal extreme pain disorder (PEPD).  
These are inherited autosomal dominant disorders with remarkably distinct 
phenotypes (Fertleman et al., 2006; Dib-Hajj et al., 2007; Estacion et al., 2008; 
Choi et al., 2009; Fischer et al., 2009; Han et al., 2009).  Although many cases 
described have been from an inherited origin, it should be noted that de novo 
mutations have been found (Yang et al., 2004; Fertleman et al., 2006; Han et al., 
2006; Harty et al., 2006).  IEM is characterized by intermittent attacks of extreme 
burning pain sensations associated with red, warm, and swollen hands, feet, 
 39 
arms and torso that, when provoked, can lead to multiple flares a day (Drenth 
and Michiels, 1992; Orstavik et al., 2004; Drenth et al., 2005).  These attacks 
initially occur within the first and second decades of life and can be triggered by 
mild warmth or exercise along with erythema and mild swelling in the areas of 
localized pain and are partially relieved by cooling these areas.  Although 
treatment with sodium channel blockers is usually ineffective, some patients with 
IEM have reported relief from local anesthetics such as lidocaine and mexiletine 
(Kuhnert et al., 1999; Davis and Sandroni, 2002; Legroux-Crespel et al., 2003; 
Nathan et al., 2005). 
Patients with PEPD, which was previously referred to as familiar rectal 
pain, report severe bouts of intense burning pain in the rectum, eye, and jaw 
(Hayden and Grossman, 1959; Fertleman et al., 2006; Fertleman et al., 2007).  
Initially, the pain can be localized to one or more of these areas during the 
attacks and then spreads towards the periphery.  The sharp burning pain in these 
patients is usually accompanied by tonic posturing and flushing of the lower limbs 
which can start as early as birth (or in utero) and an itch component.  Attacks 
associated with PEPD can be triggered by cold or visual irritants.  These 
individuals, in contrast to IEM patients, appear to respond well to the use-
dependent sodium channel inhibitor, carbamazepine, which preferentially binds 
to inactivated sodium channels. 
It is interesting to note that Nav1.7, along with other VGSC isoforms, can 
have alternative splice patterns yielding spliced variants of particular isoforms 
(Raymond et al., 2004).  Alternative VGSC splicing can alter channel kinetics, 
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pharmacological sensitivity and tissue distribution under pathological conditions, 
and can also be developmentally regulated (Sarao et al., 1991; Dietrich et al., 
1998; Alessandri-Haber et al., 2002; Tan et al., 2002; Zimmer et al., 2002; 
Copley, 2004; Fraser et al., 2005; Haufe et al., 2005; Onkal et al., 2008; Lossin, 
2009).  In particular, splicing within the exon 5  and 11 regions of the SCN9A 
gene result in long (L), short (S), adult (A) and neonatal (N) variants with 
differential biophysical properties and regulation (Chatelier et al., 2008) and 
expression patterns (Raymond et al., 2004).  Further evidence suggests that 
Nav1.7 splice variants are found in DRG neurons and that the splicing patterns of 
this isoform can change in response to spinal nerve ligation (Raymond et al., 
2004), common model for neuropathic pain (Kim and Chung, 1992).  Therefore, 
as discussed in more detail, I chose to examine the potential impact of splice 
variants on disease mutations. 
In addition to pain-producing channelopathies that result from single-point 
missense mutations in Nav1.7, there have been reports of individuals with a 
congenital inability to perceive any form of pain (CIP), but otherwise function 
normally except for deficits in olfaction (Goldberg et al., 2007) and changes in 
gait (Cox et al., 2006).  These people have distinct homozygous nonsense 
mutations in the SCN9A gene that result in a loss-of-function of Nav1.7 (Cox et 
al., 2006).  The mutations are hypothesized to yield prematurely truncated 
proteins or nonsense mediated mRNA decay and loss of function of Nav1.7 
channels (Cox et al., 2006; Goldberg et al., 2007).  Thus, mutations in Nav1.7 
channels resulting in a gain or loss-of-function suggest this channel may act as a 
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threshold sensor or gauge when interpreting stimuli as pain at critical interfaces 
between the periphery and central brain center in humans.  Taken together, 
these results indicate the interpretation of pain is complex, multifaceted process 
that may intricately involve Nav1.7 channels during signal transmission.  These 
observations further suggest channel dysfunction associated with IEM and PEPD 
may offer additional insight into the pathophysiology of pain. 
G. Understanding components critical to VGSC gating based on Nav1.7 
channelopathies 
In absence of a fully solved VGSC crystal structure, channel mutations 
have provided significant insight into the molecular mechanics of voltage-
dependent gating (Hille, 2001).  Furthermore, the myriad of perturbations in 
channel structure implicated in inherited disorders have greatly enhanced the 
knowledge of how VGSCs are involved in the physiology of pain and offer the 
potential to link functional consequences, at a molecular level, to clinical 
phenotypes (Cannon, 2000; George, 2005; Meisler and Kearney, 2005; 
Koopmann et al., 2006; Catterall et al., 2008).  Expression of recombinant 
channels in heterologous systems, such as hEK293 cells (refer to Methods), has 
provided great detail on the effects of mutations on functional properties of the 
channel and as such, has been useful in determining how changes in channel 
function likely result in distinct channelopathies.  Channelopathies, or inherited 
diseases caused by disturbances (such as mutations) in ion channel function, 
have been somewhat useful in practical translation of bench science to clinical 
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applications.  As described above, missense (gain-of-function) mutations in the 
SCN9A gene encoding Nav1.7 have been linked to the peripheral neuropathic 
pain syndromes: IEM and PEPD, inherited autosomal dominant disorders with 
distinct phenotypes hypothesized to arise from the specific alterations to Nav1.7 
gating based on the location of the mutation.  For example, specific mutations in 
clustered regions of the channel known to alter activation and inactivation have 
been identified in IEM and PEPD.  Many of the mutations overlap with additional 
inherited mutations in muscle and neuronal VGSCs suggesting these regions 
may be “hotspots” for mutation (Cannon, 2000; George, 2005; Meisler and 
Kearney, 2005; Koopmann et al., 2006; Catterall et al., 2008). 
IEM mutations are generally located within the voltage-sensing segments 
and the pore forming regions of the channel responsible for channel activation 
and opening.  Whole-cell voltage-clamp electrophysiological studies have 
demonstrated that IEM mutations predominantly affect activation and 
deactivation properties of the channel, resulting in a lowered threshold for 
activation response and increases in subthreshold currents in response to a 
depolarizing ramp stimulus (Dib-Hajj et al., 2007).  The hyperpolarizing shifts in 
activation threshold therefore, increase the Nav1.7 steady-state “window” of 
flowing current.  Together, the alterations in voltage-dependence associated with 
IEM mutations produces a depolarization of RMP in DRG neurons which reduces 
current threshold for the all-or-none AP firing and increases repetitive firing to a 
given stimulus compared to WT channels (Dib-Hajj et al., 2005; Rush et al., 
2006).  Because the majority of IEM mutations are in regions involved in 
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activation and opening, one can hypothesize that IEM mutations alter the 
structural characteristics such that one of four potential conclusions can be 
reached.  First, the mutations may alter the tight packing interactions and stability 
of a closed or default state at equilibrium potentials such that mutant channels 
now favor an open state and activate / open to subthreshold stimuli.  Second, the 
mutations within the voltage-sensing components of the channel destabilize the 
buried position of the S4 segments within the plasma membrane such that, they 
move more freely in response to a smaller depolarizing stimulus, or that they are 
partially activated at a resting or closed state thus requiring less activation energy 
to open.  Third, the mutations may uncouple the finely tuned mechanics of 
voltage-sensing and regulated channel opening.  Fourth, mutations within the 
pore domain may alter the energetics of Na+ flux through the pore in response to 
small depolarizations.  Unfortunately, these issues remain unresolved.  But the 
location of the IEM mutations and the phenotype associated with this disorder 
are quite intriguing when compared to a second set of mutations in Nav1.7 
implicated in PEPD. 
Mutations located in cytosolic linkers that lie within regions critical for 
inactivation, such as the D3-D4 inactivation gate motif and D3 / D4 S4-S5 linkers, 
have been genetically identified and implicated in PEPD.  Voltage-dependent 
characterization of some of the PEPD mutations within the inactivation gate 
demonstrates that these mutations shift the steady-state properties to more 
depolarized potentials, causing a persistent component to the decay phase of the 
inward ionic currents that appears to be reduced upon carbamazepine 
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application (Fertleman et al., 2006).  These results suggest PEPD mutations may 
increase window current by allowing channels to open at potentials that would 
normally inactivate channels.  Thus, these changes would be predicted to have 
effects on the refractory period of an AP.  However, the effects of several 
mutations outside of the putative inactivation gate on voltage-dependence and 
kinetic properties of Nav1.7 channels were not characterized.  Additionally, the 
effects of PEPD mutations on AP properties had not been evaluated.  Together, 
the origins of these disorders is intriguing because they suggest single-point 
mutations within the same VGSC isoform can predominantly alter specific modes 
of gating which, along with cellular background (Rush et al., 2006), may 
contribute to the location of pain perception and response to therapeutic agents. 
The spectral dichotomy of the effects of Nav1.7 mutations, on gating and 
perceived pain are of great interest, in particular those implicated in PEPD, 
because there is still debate regarding the mechanics of channel inactivation and 
the role of specific regions during transition to this state and the resulting 
conformational change.  Additionally, studies on sensory neuronal VGSCs, such 
as Nav1.7 or Nav1.8 are lacking and their role in nociception is still not completely 
understood.  These observations are also fascinating in that single-point 
missense mutations in the same VGSC isoform can produce two distinct 
disorders and may provide information regarding how alterations in gating activity 
lead to specific types of chronic pain.  Taken together, the PEPD mutations 
provide an excellent opportunity to better understand the intramolecular 
interactions of Nav1.7 that play an important role in transition to the inactivated 
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state and may be a useful tool in understanding the etiology of pain and 
development of more selective therapeutic agents. 
H. Hypothesis, specific aims, and summary of results 
The following studies in this dissertation focus on residues in these 
regions of Nav1.7 because several single-point mutations located in these 
cytosolic linkers have been implicated in PEPD and should yield insight into the 
complexities of stability of and transition to an inactivated state.  The overall 
hypothesis of this dissertation is that PEPD mutations differentially alter the 
voltage-dependent properties of inactivation and that understanding the 
biophysical consequences of specific PEPD mutations will provide mechanistic 
insight into how sodium channel alterations can contribute to chronic pain and 
other disorders of excitability.  Studies designed to test this hypothesis involved 
site-directed mutagenesis, whole-cell voltage and current-clamp 
electrophysiology, SCAM analysis and intramolecular cross-linking.  To this 
extent, I first asked if PEPD mutations in the D3 and D4 S4-S5 linkers alter 
voltage-dependent inactivation properties and channel kinetics in a manner 
similar to PEPD mutations within the inactivation gate motif.  Second, I asked if 
PEPD mutations in these cytosolic linkers destabilize inactivation, are the effects 
location and residue specific.  Finally, I inquired if the PEPD mutations affect 
transition to an inactivated state, and if the mutations alter AP characteristics and 
propagation.  Results from these studies demonstrate that (1) mutations within 
the S4-S5 linkers of D3 and D4 affect inactivation of Nav1.7 in a residue-specific 
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manner, (2) PEPD mutations within S4-S5 differentially alter transition to a 
closed-inactivated state compared to those in the putative inactivation gate, and 
(3) PEPD mutations increase neuronal excitability.  However, because the age-
onset, response to therapeutic agents, “pain-inducing” triggers, and location of 
the perceived pain between IEM and PEPD patients differ, questions pertaining 
to the contributing factors for these differences remained unanswered. 
Recent evidence suggested that alternative splice variants of Nav1.7 are 
found in DRG neurons and that spinal nerve ligation in rats, can alter the splicing 
patterns of this isoform (Raymond et al., 2004).  Therefore, the next question I 
asked was:  Can alternative splicing of Nav1.7 differentially affect the voltage-
dependent properties of mutations implicated in IEM and / or PEPD and could 
this begin to explain some of the differences in sites of pain perception between 
the two disorders?  The second aim of this dissertation was then, to examine the 
voltage-dependent effects alternative splicing of Nav1.7 has on the impact of 
mutations implicated in IEM and PEPD.  Results from these experiments (1) 
suggest an additive effect of Nav1.7 exon 5 alternative splicing and the PEPD 
mutation (I1461T) which could further impact the disease phenotype and (2) 
offered insight into how alternative splicing within exon 5 affects specific 
intramolecular interactions critical for voltage-dependent gating. 
We also considered the possibility that other contributing factors such as 
post-translational modifications and protein trafficking, cellular background, lipid 
environment, signaling mechanisms, and cellular reduction-oxidation balance 
may contribute to the differences noted between IEM and PEPD.  Based on work 
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from this dissertation and the location of Nav1.7 channels, an intriguing 
hypothesis we discussed was the potential for mutations implicated in PEPD to 
increase unique inward currents that flow through a channel population re-
opening during membrane repolarization, termed resurgent currents.  We 
hypothesized that inherited Nav1.7-PEPD mutations could produce resurgent Na
+ 
currents.  Although Nav1.6 channels appear to be the predominant generator of 
resurgent currents under normal conditions, we postulated that mutations that 
slow the rate of inactivation would increase resurgent currents because binding 
of the putative open-blocking particle to a theoretical receptor site may be 
enhanced.  The initial aim of this study was to determine if PEPD mutations that 
slow the rate of inactivation increase resurgent currents in DRG neurons.  Thus, 
we first evaluated the effects PEPD mutations had on the potential for Nav1.7 
channels, transfected into DRG neurons, to induce resurgent sodium currents.  
Exciting results from these studies demonstrated, for the first time that inherited 
mutations disrupting inactivation, associated with a variety of channelopathies 
(Nav1.4-PMC; Nav1.5-LQT3 / SIDS; Nav1.7-PEPD) increased resurgent sodium 
currents.  Additionally, because these currents flow at potentials near neuronal 
RMP, we showed that they could contribute to changes in neuronal and cardiac 
AP properties under computer-modeled conditions. 
Finally, lingering questions regarding the molecular mechanics of 
inactivation and the contribution inherited mutations have on the stability of the 
channel structure and the potential these mutations have to induce unique 
sodium currents were examined using voltage-dependent conformational 
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probing.  Thus, I asked if residues within the inactivation gate could directly 
interact with residues within the D3 / S4-S5 linker within a calibrated distance in a 
range of potentials.  Results from studies utilizing site-directed mutagenesis, 
based on the location of PEPD mutations, SCAM, and cross-linking demonstrate 
that at potentials sufficient to induce closed-state inactivation key “docking” 
residues, outside the aqueous channel pore, within D3 / S4-S5 can interact with 
the inactivation gate motif within a calibrated distance.  Therefore, mutations in 
these “hotspot” regions are appropriate to disrupt the stability of an inactivated 
state and contribute to increased resurgent currents, which together, can 
increase neuronal excitability. 
Overall, this dissertation addresses important questions regarding the 
molecular mechanics required during transition to an inactivated state and the 
biophysical consequences of mutations in “hotspot” regions of Nav1.7.  Recent 
evidence demonstrating Nav1.7 channels, highly expressed in DRG neurons, are 
essential in nociception (Dib-Hajj et al., 2007), as evidenced by the critical role 
these channels have in fine-tuning pain perception, validate the applicability of 
studying Nav1.7 for discovery of isoform-specific therapeutic targets for treatment 
of painful disorders. 
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II. MATERIALS AND METHODS 
A. Experimental cDNA constructs 
Functional properties of VGSCs were studied by expressing recombinant 
channels in hEK293 (human embryonic kidney) cells and dorsal root ganglia 
(DRG) neurons.  Constructs encoding the open reading frame for the voltage-
gated sodium channel (VGSC) α-subunit isoforms Nav1.4, 1.5, 1.6, and 1.7, 
auxiliary VGSC β-subunits (β1 and β2) and an shRNA plasmid targeting the rat 
Nav1.8 (rNav1.8) channels were used throughout the experiments in this 
dissertation.  The human Nav1.4 (hNav1.4) subtype was previously cloned 
(George et al., 1992).  The sub-cloned hNav1.4pRc / CMV (Chahine et al., 1998) 
channel insert was then sub-cloned into the RBG4 vector containing the rat 
Nav1.4 (rNav1.4) channel (Ukomadu et al., 1992) yielding a final hNav1.4pRBG4 
construct to facilitate linker swapping between human and rat channels and to 
use the same promoter to control expression of the two inserts (Cummins et al., 
2002).  The hNav1.5 channel insert, originally located in a pSP64T vector 
(Gellens et al., 1992), was further sub-cloned into a pcDNA 3.1 vector in the lab 
of Dr. Theodore R. Cummins to aid in expression.  The mouse Nav1.6 (mNav1.6) 
channel insert was sub-cloned from the pLCT1-A vector (Smith et al., 1998), which 
was modified from the pLCT1 oocyte expression vector (Smith and Goldin, 1998), 
and inserted into a modified pcDNA3.1 vector (Klugbauer et al., 1995) yielding an 
mNav1.6pcDNA3.1 construct (Herzog et al., 2003a).  The modified pcDNA 3.1 (-) 
vector allows for a low copy plasmid to be generated which aids in growing up 
 50 
channel constructs.  The hNav1.7 channel was previously cloned and constructed 
into the modified pcDNA 3.1 (-) vector (Klugbauer et al., 1995).  Subsequent 
mutations inserted into the constructs listed above for all of the experiments 
discussed were all designed and performed within the lab of Dr. Theodore R. 
Cummins. 
For select experiments recombinant VGSCs were expressed in DRG 
neurons.  Since a population of TTX-s and TTX-r Na+ currents are functionally 
expressed in DRG neurons, we isolated our currents of interest 
pharmacologically and using RNA silencing methods.  Recombinant channels 
used for rat DRG transfections were either naturally (Nav1.5), or mutated to be 
(Nav1.4, Nav1.6, Nav1.7), resistant to TTX.  Thus, to aid in isolation and 
characterization of sodium currents generated in DRG neurons by recombinant 
VGSCs, cDNA constructs for Nav1.4, Nav1.6, and Nav1.7 were modified with 
single point mutation to confer high resistance to TTX (Ki ~100 µM (Leffler et al., 
2005); referred to as Nav1.4r, 1.6r and 1.7r).  These mutations were engineered 
using the QuikChange XL (Stratagene, La Jolla, CA, U.S.A.) mutagenesis kit as 
previously described (Herzog et al., 2003b; Herzog et al., 2003a).  Nav1.5 
channels are natively resistant to TTX (Ki ~2 µM), therefore their sensitivity to 
TTX was not modified.  Additional channelopathy constructs (Nav1.4r-R1448P, 
Nav1.5-F1486L, Nav1.6r-I1477T and Nav1.7r-I1461T) were made by inserting the 
respective mutation into the TTX-r cDNA constructs using the QuikChange XL 
(Stratagene, La Jolla, CA, U.S.A.) mutagenesis kit following manufacturer 
instructions.  Mutations were confirmed by sequencing the entire insert region. 
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Experiments using hEK293 cells as an expression system for transfected 
VGSCs were co-transfected with auxiliary human β1 (hβ1) and β2 (hβ2) 
subunits.  Channel α-subunits were co-transfected with auxiliary β-subunits 
because studies have suggested the β-subunits play a role in trafficking and 
modulation of several VGSC isoforms and may be important for appropriate 
insertion and conformational stability in the membrane (Isom et al., 1992; Isom et 
al., 1995b; Isom et al., 1995a).  The auxiliary hβ1-subunit was sub-cloned into 
the pCD8-IRES (CD8: cluster of differentiation 8, IRES: internal ribosome entry 
site) vector yielding a pCD8-IRES-hβ1 construct.  The hβ2-subunit is located in 
the pEGFP-IRES vector yielding a pEGFP-IRES-hβ2 construct.  Plasmids for the 
hβ1 and hβ2 auxiliary VGSC subunits were used for transient transfection of 
hEK293 cells in their respective plasmid constructs (Lossin et al., 2002; Lossin et 
al., 2003).  For example, upon transfection with the hβ1 construct hEK293 cells 
will efficiently express both hβ1 and CD8, whereas the hβ2 construct will allow 
expression of hβ2 and EGFP.  Since CD8 and EGFP are useful biological 
markers we can determine transfection efficiency.  In particular, experiments in 
this dissertation utilizing transfected cell systems relied on expression of EGFP 
(Prasher et al., 1992; Chalfie et al., 1994) as a molecular determinant for 
patching cells because expression of the marker was assumed to correlate with 
channel and auxiliary subunit expression.  It is worthwhile to note that 
experiments performed by Andrew D. Piekarz from the lab of Dr. Theodore R. 
Cummins demonstrate that greater than 89% of hEK293 cells expressing an 
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extracellular CD8 marker also express the hβ2 auxiliary subunit using 
Dynabeads (Dynai®, Brown Deer, WI, and U.S.A.). 
A short hairpin RNA-mediated (shRNA) construct targeting the rat Nav1.8 
channel was also used in experiments with DRG neurons (Mikami and Yang, 
2005).  In short, this construct allowed the experimenter to knock down / silence 
the rat Nav1.8 mRNA and abolish endogenous rat Nav1.8 currents which could 
contaminate interpretation of results for the resurgent current studies.  Nav1.8 
currents are TTX-r and can interfere with characterization of recombinant 
channel properties.  Design of this construct (Mikami and Yang, 2005) was 
performed by identifying nineteen base pair targets for short interfering RNA 
within the coding sequence for rat Nav1.8.  A sense and antisense target 
sequence, linked by an 11 base pair loop (short hairpin construct) was then 
incorporated into an oligonucleotide reverse primer and PCR products were then 
sub-cloned into a Topo 2.1 vector (Invitrogen, Carlsbad, CA, U.S.A.).  The vector 
was sequenced and the U6-shRNA cassette was digested and sub-cloned into 
the pLL3.7 lentivirus shuttle vector.  Experiments utilizing this construct in rat 
DRG neurons were validated by knockdown of Nav1.8 ionic current, which has 
distinct activation and inactivation kinetics compared to other endogenous 
VGSCs.  Additionally, the rat Nav1.8-shRNA was in an IRES-EGFP vector, 
allowing transfected cells to be selected visually based on the ability to express 
the green fluorescent protein EGFP (Prasher et al., 1992; Chalfie et al., 1994). 
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B. Mutagenesis of voltage-gated sodium channels 
Site-directed mutagenesis of VGSCs were performed to characterize 
voltage-dependent effects of single-point missense mutations on several (Nav1.4, 
5, 6, 7) constructs.  Studies using a substituted cysteine accessibility method 
(SCAM) (Karlin and Akabas, 1998) involved engineering dual cysteine (Cys) 
mutations into the Nav1.7 constructs in order to perform chemical cross-linking of 
Cys residues.  Additional studies required engineering a second chimeric point 
mutation in disease mutant constructs to endow them with resistance to TTX.  
The properties of the channels were examined using voltage and current-clamp 
electrophysiology in the appropriate expression system.  Site-directed 
mutagenesis of VGSC constructs was performed using the channel constructs 
listed in the cDNA vectors section (above).  Mutagenic primers were designed 
(Vector NTI Advance 10, Invitrogen, Carlsbad, CA, U.S.A.) to introduce the 
correct base pair change and anneal to the same sequence on opposite strands 
of the plasmid(s).  Sequencing primers were ordered to verify mutated regions.  
QuikChange® II XL Site-Directed Mutagenesis Kits (Stratagene, La Jolla, CA, 
U.S.A.) were used according to the manufacturer’s protocol.  Mutant colonies 
were grown up following the QuikChange® protocol.  After antibiotic-resistant 
colonies had grown on antibiotic / LB agar plates, individual colonies were 
selected using a 100 µL pipette tip and transferred to a 14 mL round bottom 
Falcon tube (Becton Dickinson Labware, Franklin Lakes, NJ, U.S.A.) containing 5 
mL of LB broth and the appropriate antibiotic for mini culture initiation.  The mini 
cultures were then placed in a 37oC shaking incubator (I2400 Incubator Shaker, 
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New Brunswick Scientific, Edison, NJ, U.S.A.) according to the plasmid miniprep 
kit (GeneJET™ Plasmid Miniprep Kit, Fermentas Life Sciences Inc., Glen Burnie, 
MD, U.S.A.). 
Mini culture plasmid purification was performed according to 
manufacturer’s protocol.  Once the plasmid was purified and isolated, potential 
mutant constructs were screened using restriction enzyme digestion and 
confirmed by DNA sequencing using the corresponding sequence primers.  DNA 
sequencing was performed at the DNA Sequencing Core Facility in the 
Biochemistry Biotechnology Facility of Indiana University School of Medicine 
(Indianapolis, IN, U.S.A.).  After the sequence of the constructs was verified, 
maxi cultures were grown according to manufacturer’s protocol (NucleoBond® 
Xtra Maxi Plus, Macherey-Nagel, Easton, PA, U.S.A.) in 1000 mL culture flasks 
in a 37oC shaking incubator. 
When maxi cultures had grown, plasmid purification for downstream 
applications was followed according to manufacturer’s protocol.  After the maxi 
plasmid purification was complete, cDNA constructs were checked for purity 
(Nanodrop ND-1000 Spectrophotometer, Thermo Fisher Scientific Inc., 
Wilmington, DE, U.S.A.) and the concentration was brought to approximately 1 
µg / µL with double distilled water.  Purified constructs were then used for 
transfection and testing in an expression system. 
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C. Transient transfection of hEK293 cells 
Experiments utilizing human embryonic kidney (hEK293; American Type 
Culture Collection, Manassas, VA, U.S.A.) cells for expression of various VGSC 
constructs were done using a calcium-phosphate transient transfection method, 
unless otherwise noted (such as the stable hNav1.7r_M1627K hEK293 cell line 
which was selected based on neomycin / G418 resistance and cultured 
according to Dib-Hajj (2008) and used for voltage-clamp experiments with D4 / 
S4-S5 PEPD mutations).  In brief, hEK293 cells were grown under standard tissue 
culture conditions (37oC, 5% CO2) in serum-complete (10% fetal bovine serum 
(FBS; Cellgro, Herndon, VA, U.S.A.) / 1% Penicillin-Streptomycin (Invitrogen, 
Grand Island, NY, U.S.A.)) Dulbecco’s modified Eagle’s medium (DMEM; 
Invitrogen, Grand Island, NY, U.S.A.) until a confluent density of 70-80% was 
obtained for a 35 mm culture dish (Corning Inc.®, Corning, NY, U.S.A.).  At this 
point, the 10% serum-complete cell medium was exchanged out for a 5% 
reduced serum-complete cell medium and allowed to incubate under standard 
tissue culture conditions for approximately 30 minutes before the calcium-
phosphate precipitation. 
Next, transfection solutions (2M CaCl2, double-distilled water, and 2X HBS 
= 1.6 g NaCl, 0.021 g Na2HPO4, 1.3 g Na-HEPES / 100 mL; adjusted to pH 7.0) 
and cDNA were allowed to equilibrate to room temperature.  Various sets (i.e., 4 
X 1.5 mL for one transfection condition) of tubes were labeled.  The contents of 
the tubes were as follows: 
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Tube set 1     Tube set 2 
 
50 µL 2X HBS    2.8 µg total cDNA (2 µg α-subunit /  
      channel, 0.4 µg β1-subunit, 0.4 µg β2- 
      subunit) 
      5 µL 2M CaCl2    
      QS to 50 µL with double distilled water 
 
The contents of the tubes were allowed to sit for approximately 10 minutes 
before combination.  Tube 2 was then added to Tube 1 drop-wise with vigorous 
stirring using the 100 µL pipette tip.  Four to five bubbles were then slowly 
generated, from the bottom of the tube, using the pipette tip.  The calcium 
phosphate-DNA mixture was then incubated at room temperature for about 20-30 
minutes after which it was then added, drop-wise, to the hEK293 cells incubated in 
5% reduced serum-complete medium and slowly rocked until the mixture 
dissolved. 
The transfected cells were then left in the sterile Laminar tissue culture 
flow hood at room temperature for 15 minutes to allow the fine precipitate grains 
to settle onto the cells.  After 15 minutes, the culture dishes were checked for a 
fine, dusting of precipitate grains sprinkled throughout the cells before return to 
the incubator for 2.5-3 hrs.  Following this incubation, the 5% reduced serum-
complete cell medium was exchanged twice for 10% serum-complete cell 
medium to remove precipitate before returning the transfected cells, in 10% 
serum-complete cell medium, to the incubator overnight. 
Transfected cells were allowed to incubate for 24 hrs before re-plating 
onto 12 mm laminin-coated glass coverslips.  To re-plate the cells, a fire polished 
glass Pasteur pipette was used to break up the cells and split them at a 
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moderate density (1-2 drops per coverslip) into single wells of a 24 well plate 
(Costar 3524, Corning Inc.®, Corning, NY, U.S.A.) containing 500 µL of 10% 
serum-complete medium.  Transfected hEK293 cells were used for 
electrophysiological whole-cell patch clamp recordings 24-72 hrs post-
transfection.  Cells were selected based on the ability to express EGFP and used 
for data collection if whole-cell ionic current was obtained at greater than or equal 
to 1 nA to minimize signal to noise ratios during analysis. 
D. Harvest and preparation of rat DRG neurons 
Two to three month old male Sprague-Dawley rats (100-120 grams; 
Harlan Laboratories, Indianapolis, IN, U.S.A.) were used for DRG harvests under 
the Indiana University School of Medicine Laboratory Animal Resource Center 
Guidelines.  The animal room was artificially illuminated from 7:00 A.M. to 7:00 
P.M.  Animal care was in accordance with the Guide for the Care and Use of 
Laboratory Animals (National Institutes of Health publication 85-23, Bethesda, 
MD, U.S.A.) and approved by the Institutional Animal Care and Use Committee 
of the Indiana University School of Medicine.  Rat DRG neurons were studied 
after long-term culture (2-5 days). 
The rat DRG harvest was performed as previously described using lumbar 
L4-L5 DRGs (Caffrey et al., 1992; Herzog et al., 2003b; Dib-Hajj et al., 2009).  
Briefly, rats are, first, rendered unconscious by exposure to CO2 and decapitated 
to ensure sacrifice complying with the ethical guidelines described by the Indiana 
University School of Medicine.  Skin surrounding the spinal column was cut away 
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with sterile tools and the spinal column was removed by making two lateral 
incisions, one through the upper (rostral) axis, and one through the lower 
(caudal) axis.  The spinal column (~3-4 inches) was removed and excess muscle 
was trimmed away before cutting through vertebral column from the rostral to the 
caudal axis yielding two parts.  The vertebral column was then placed in a 10 mL 
Petri dish (Corning Inc. ®, Corning, NY, U.S.A.) with cold bicarbonate-free 
DMEM (bfDMEM).  DRG were manually isolated from the column using forceps 
and then placed in a clean Petri dish containing cold bfDMEM.  Once the L4 and 
L5 ganglia were isolated, forceps and fine scissors were used to trim nerve roots 
from ganglia.  Cells were then added to a cocktail of dissociation enzyme (2 
mg/mL collagenase A, D and 5 mg/mL protease) and bfDMEM and incubated at 
37oC with moderate shaking for approximately 40 minutes. 
Enzyme treated cells were then placed into a 15 mL conical tube with 
bfDMEM at a final volume of 7 mL using a sterile glass pipette.  Cells were 
broken apart using sterile fire polished pipettes in approximately 2-3 mL of 10% 
FBS / DMEM complete culture medium.  Cell aliquots of about 100 µL were then 
plated onto 12 mm glass coverslips coated with poly-D-lysine and laminin within 
the wells of a 24-well plate.  After 10-15 minutes wells were flooded with 500 µL 
of the complete culture medium and placed in an incubator.  Cultures were 
maintained at 37oC in a 5% CO2 incubator and the media was changed every two 
days until used for electrophysiological recordings. 
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E. Biolistic transfection of neurons 
The biolistic transfection method utilized the Helios Gene Gun System 
from BioRad Laboratories (Hercules, CA, U.S.A.).  Tubing, gold, 
polyvinylpyrrolidone (PVP), Tubing Prep Station, Helios Gene Gun, Gene Gun 
Barrels and Cartridge holders were ordered from BioRad Laboratories (Hercules, 
CA, U.S.A.).  Protocols for this transfection method were optimized according to 
the experimenter’s desired parameters to increase expression efficiency and 
health of transfected cells.  Optimized protocols were designed and modified 
based on the manufacturer’s instructions (Bio-Rad Laboratories Helios Gene 
Gun System) and a collaborating laboratory (Dib-Hajj et al., 2009).  Briefly, a 24 
inch piece of tubing was cut to fit the saddle of the Tubing Prep Station and 
ultrapure grade nitrogen (Praxair Inc., Indianapolis, IN, U.S.A.) was allowed to 
flow (0.3-0.4 LPM) through the plastic tubing for approximately 20 minutes to 
purge ambient oxygen contents and completely dry tubing.  A 15 mg (1:1 ratio of 
mg gold to µg cDNA) aliquot of gold microcarriers (1 µm size) was weighed.  
Fresh aliquots were made from stock solutions of PVP (20 mg/mL) and 
spermidine (1 M) using fresh, high grade (dehydrated) ethanol (EtOH; Spectrum 
Chemical MGF. CORP., Gardena, CA. U.S.A.).  Stock solutions were stored at -
20oC.  Final concentrations of PVP and spermidine aliquots are 0.05 mg/mL and 
0.05 M, respectively. 
Total volume of solutions was determined based on total cDNA volume.  
For experiments where rat DRG neurons were transfected, 10 µg of the rat 
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Nav1.8-shRNA and 5 µg of channel plasmid were used.  The calculated volumes 
of spermidine and 1 M CaCl2 added were at a 1:1 ratio based on the total volume 
of the cDNA.  Spermidine was added to the gold microcarriers and the complex 
was vigorously mixed by vortex and sonicated to break up large particles.  
Calculated amounts of cDNA were then added and mixed before adding 1 M 
CaCl2 drop-wise while on the vortex.  The complex was allowed to sit for 10 min 
before pelleting the complex and removing the liquid volume. 
The gold-DNA pellet was then washed and reconstituted three times with 
the fresh dehydrated EtOH.  After removal of the last EtOH wash, the gold-DNA 
complex was then washed out and reconstituted using the entire volume of the 
PVP aliquot and transferred to a 15 mL concial tube.  The contents of the conical 
tube were drawn into the nitrogen purged tubing using a syringe and were 
carefully placed back into the Tubing Prep Station saddle.  The complex rested in 
the tubing, undisturbed, for approximately 3-5 minutes before slowly removing 
the liquid (EtOH) contents with a syringe at a rate of 0.5-1.0 in/sec, after which 
the automatic rotation of the plastic tubing was started.  After this time, the 
nitrogen was turned back on at a flow of 0.3-0.4 LPM for approximately 20 min.  
Cartridges were cut and placed into the Helios Gene Gun cartridge holder and 
contents were shot using the helium pressure within the gene gun onto 24 well 
plates containing 12 mm glass coverslips of recently harvested (~24 hrs) rat DRG 
neurons.  Unused cartridges were placed in storage tubes with a dessicator 
pellet and stored in a dessicator at 4oC.  Transfected neurons expressed EGFP 
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and green fluorescence was visible within 24 hrs post-transfection.  Cells were 
patched 24-72 hrs post-transfection. 
F. Chemicals 
Experiments studying cysteine accessibility and cross-linking interactions 
made use of several methanethiosulfonate (MTS) reagents (Toronto Research 
Chemicals Inc., North York, ON, Canada).  A 10 mM stock solution of the 
reagents [2-(Trimethylammonium)ethyl] methane thiosulfonate bromide (MTSET; 
F.W. 278.24 g/amu), Sodium (2-sulfonatoethyl) methanethiosulfonate / 
Methanesulfonothioic acid, sodium salt (MTSES; F.W. 242.28 g/amu), and 
Benzyl methanethiosulfonate (MTSBn; F.W. 340.30 g/amu) were prepared fresh 
using sterile double distilled water.  Since the MTS reagents exhibit high 
reactivity in salt (nucleophile) solutions and rapidly undergo oxidation via 
hydrolysis the aliquots were prepared fresh before each individual recording by 
adding 65 µL of the 10 mM MTSET stock into 585 µL of the standard intracellular 
recording solution diluent to yield a 1 mM aliquot, unless otherwise noted.  Fresh 
stock solutions (10 mM) of the non-water soluble cysteine cross-linking 
compound 1, 1-Methanediyl bismethanethiosulfonate (MTS-1-MTS; F.W. 236.35 
g/amu) were prepared by dissolving the reagent with 3-5% DMSO/water diluents.  
Fresh aliquot solutions of MTS-1-MTS were prepared right before recording as 
outlined above to yield a final intracellular electrode concentration of 1 mM. 
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G. Solutions 
1. Standard extracellular bathing solution for hEK293 recordings 
The standard hEK293 extracellular bathing solution was used to bathe 
hEK293 cells during all whole-cell voltage-clamp electrophysiology experiments 
utilizing transfected and non-transfected hEK293 cells.  The chemical components 
used for this recording solution (at ~304 mOsm) consisted of (in mM):  140 NaCl, 
1 MgCl2, 3 KCl, 1 CaCl2, and 10 HEPES, pH 7.3 (adjusted with 1.0 N NaOH).  
Cells on glass coverslips were transferred to a recording chamber containing 250 
µL of bathing solution.  Whole-cell electrophysiology experiments using hEK293 
cells were performed in the presence and absence of 500 nM (25 µL of 5 µM 
TTX stock into 225 µL of extracellular bathing solution) TTX, depending on the 
experimental design. 
2. Standard extracellular bathing solution for rat DRG neurons 
The standard rat DRG extracellular bathing solution was used to bathe rat 
DRG neurons during all whole-cell voltage-clamp electrophysiology recordings 
utilizing transfected and non-transfected rat DRG neurons.  The composition for 
this solution (at ~300 mOsm) consisted of (in mM):  130 NaCl, 30 TEA Chloride, 
1 MgCl2, 3 KCl, 1 CaCl2, 0.05 CdCl2, 10 HEPES, 10 D-Glucose. Recording 
solutions were adjusted using 1.0 N NaOH and D-Glucose to maintain 
physiological pH and osmolarity values.  Cells on glass coverslips were 
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transferred to a recording chamber containing 250 µL of bathing solution.  Whole-
cell electrophysiology experiments using DRG neurons were performed in the 
presence and absence of 500 nM (25 µL of 5 µM TTX stock into 225 µL of 
extracellular bathing solution) TTX, depending on the experimental design. 
3.  Standard CsF dominant electrode solution for hEK293 recordings 
The standard CsF dominant electrode solution (at ~293 mOsm) used for 
all hEK293 cellular recordings, unless otherwise noted, consisted of (in mM) 140 
CsF, 10 NaCl, 1.1 EGTA, and 10 HEPES, pH 7.3 (adjusted with 1.0 N NaOH). 
4. Alternative CsCl electrode solution for hEK293 recordings 
The alternative CsCl/Cs-aspartate dominant electrode solution (at ~293 
mOsm) used for hEK293 electrophysiological recordings, primarily for the D3 / S4-
S5 Nav1.7-PEPD characterization experiments, consisted of (in mM) 50 CsCl, 70 
Cs-aspartate, 10 NaCl, 10 HEPES, 11 EGTA, 1 CaCl2, and 2 Mg-ATP, pH 7.3.  
The standard bathing solution consisted of (in mM) 140 NaCl, 1 MgCl2, 3 KCl, 1 
CaCl2, and 10 HEPES, pH 7.3 (adjusted with 1.0 N NaOH). 
5. Standard CsF dominant electrode solution for DRG neurons 
The standard CsF dominant electrode solution (at ~290 mOsm) used for 
all rat DRG recording experiments consisted of (in mM):  140 CsF, 10 NaCl, 1.1 
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EGTA, and 10 HEPES.  Recording solutions were adjusted using 1.0 N NaOH 
and D-Glucose to maintain physiological pH and osmolarity values. 
H. Whole-cell patch-clamp recordings for hEK293 and rat DRG recordings 
Fire-polished electrodes were fabricated from 1.7 mm VMR Scientific 
(West Chester, PA, U.S.A.) capillary glass using a Sutter P-97 puller (Novato, 
CA, U.S.A.).  For rat DRG recording experiments, the tip exterior contact surface 
of the fire polished electrodes was coated in sticky wax (KerrLab, Orange, CA) to 
minimize capacitive artifacts and increase series resistance compensation.  Cells 
on laminin-coated glass coverslips (12 mm) were transferred to a recording 
chamber containing 250 µL of bathing solution in the presence or absence of 500 
nM TTX to pharmacologically distinguish between TTX-s and resistant sodium 
currents.  The recording chamber was designed from a 35 mm cell culture dish 
(Corning Inc.®, Corning, NY, U.S.A.) filled with silicone elastomer base 
(Sylgard®, World Precision Instruments Inc., Sarasota, FL, U.S.A.) mixed with 
curing agent, and allowed to solidify.  After the solidification, a single 12 mm 
coverslip was placed in the center of the silicone and a razor blade scalpel was 
used to cut around the circular coverslip, and the loose inner portion was 
discarded.  The center portion of the recording chamber was large enough to 
house, without solution leak, a coverslip and approximately 250-300 µL of 
solution. 
Recording chambers containing transfected cells were set onto an Nikon 
Eclipse TE2000-U inverted microscope stage (Nikon Instruments Inc., Melville, 
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NY, U.S.A.) equipped with a white (Nikon TE2-PS100W) and fluorescent halogen 
light source (X-Cite® 120, Photonic Solutions Inc., Mississauga, ON, Canada), 
Nikon contrast objectives (10X and 40X), and dual Nikon ocular lenses.  The 
microscope was on an isolation  nitrogen infused air table (50-60 psi maintained 
air pressure) with a 2 inch stainless steel laminate (63-500 Series, Technical 
Manufacturing Company, Peabody, MA, U.S.A.) to counter effects of vibration on 
the microscope stage.  All electrophysiological experiments were performed on 
an air-table housed with a Faraday cage with multiple wires used to ground all 
metal surfaces to alleviate any aberrant electrical noise.  The wires were run 
together at a single point on the air-table allowing a single wire to be connected 
to the ground input of the amplifier. 
Detailed protocol for whole-cell voltage-clamp electrophysiology 
recordings can be found via online resources such as the Axon Guide to Patch 
Clamp (Axon Instruments, Foster City, CA, U.S.A.).  In brief, whole-cell patch-
clamp recordings were conducted using a HEKA EPC-10 amplifier (HEKA 
Instruments Inc., Bellmore, NY, U.S.A.) under voltage-clamp mode.  Recordings 
were obtained at room temperature (~22.0oC; monitored using a temperature 
gauge; Fisher Scientific, U.S.A.) after obtaining a Giga-ohm seal (glass pipette tip 
to cell lipid membrane; 1-20 GΩ) Cells were selected based on their, 
morphology, and ability to express EGFP.  However, for control experiments with 
rat DRG neurons, cells not expressing EGFP (non-transfected) were also utilized 
during recording experiments as controls.  A fresh polished pipette electrode 
(pipette resistance ~1.0-5.0 MΩ) back-filled with the appropriate intracellular 
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solution was used for each recording.  Offset potential was zeroed before 
patching the cell of interest.  A silver chloride (AgCl) coated silver wire was used 
as a reference electrode with one end connected to the ground input of the 
amplifier headstage and the AgCl coated end directly inserted into the bathing 
solution.  Capacitive artifacts were cancelled using the computer-controlled 
circuitry of the patch clamp amplifier.  Liquid junction potential for all solutions 
was not corrected for during experiments and data analysis.  Because for this 
dissertation, comparisons were always made between two groups of channel 
constructs or before and after drug application the relative shift would be within a 
predictable range for comparable groups and could be viewed as negligible.  
Series resistance errors, due to potential drop across the pipette and resistors in 
series with the pipette, were always compensated, typically between 70-90%, to 
be less than 3 mV during voltage-clamp recordings.  Leak currents were linearly 
cancelled by digital P/-N subtraction (Bezanilla and Armstrong, 1977). 
Membrane currents were sampled at 20 kHz and filtered at 5 kHz and tail 
currents were filtered at 10 kHz and sampled at 40 kHz.  For the majority of 
hEK293 and rat DRG experiments, data were collected only after five minutes of 
attaining the whole-cell configuration, this allowed adequate time for the 
electrode solution to equilibrate with the cytosol.  However, for the cysteine 
accessibility and cross-linking experiments investigating potential intracellular 
interactions, recordings started approximately one minute after whole-cell 
configuration was established.  Whole-cell patch recordings did not last more 
than 45 min and cells were not held in the standard bathing solution for more 
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than one hour.  Inward Na+ currents had a reversal potential of ~+65 mV, 
corresponding closely to the calculated Nernst potential, observed during the 
standard I/V protocol.  Data were acquired on a Windows-based Pentium IV 
computer (Dell Computers, Round Rock, TX, U.S.A.) using the Pulse program (v 
8.65, HEKA Elektronik, Germany). 
I. Standard patch-clamp protocol for voltage-clamp recordings 
Holding potential for all hEK293 recordings was set to -120 or -100 mV, 
unless otherwise noted as in the cysteine cross-linking experimental results 
section.  Holding potential for all rat DRG recordings was set to -100 mV.  
Current-voltage (I/V) relationships were determined by an incremental 
depolarizing step protocol, testing every + 5 mV for 50 or 100 ms, from at least -
80 to +60 mV.  To determine the fraction of channels transitioning to a fast-
inactivated state a double-pulse protocol (h∞/V) was employed which 
incrementally conditioned the channels from -150 to -10 mV for 100 or 500 ms 
before testing for the fraction of channels available at 0 mV.  Voltage-dependent 
deactivation kinetics were assessed by eliciting tail currents at a range of 
potentials after briefly activating the channels (0 mV, 0.5 ms).  The averaged 
voltage-plot for deactivation was compiled using time constants (τd) obtained 
from tail current recordings which were determined by fitting each decay 
component with a single-exponential equation.  Time course for the development 
of closed-state inactivation (CSI) was obtained using a time-varied conditioning 
pulse at various hyperpolarized potentials (mV) for 500 ms before testing for the 
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available fraction of channels at 0 mV for 20 ms.  Time constants (τ) were 
determined using a single-exponential fit.  Time course for the recovery from CSI 
was tested using a two-step protocol where the channels were conditioned at 
various potentials (mV) for 500 ms, then hyperpolarized to the holding potential 
for various times before testing for the fraction of channels available during a 
depolarizing step to 0 mV for 20 ms.  Recovery from open-state inactivation 
(OSI) was tested by pre-pulsing to a relatively depolarized potential (0 mV, 20 
ms) then hyperpolarized to various potentials between -120 to -60 mV for 
increasing time increments and were then tested for current available using a 
strong depolarizing stimulus to 0 mV for 20 ms.  Plotted values were fitted with a 
single exponential function to determine time constant (τ) values.  Generation of 
ramp current was assayed using a slow depolarizing ramp (0.27 mV/ms) stimulus 
from -120 mV to +40 mV at a holding potential of -120 mV.  Inward ramp current 
displayed is a result of dividing the individual traces by the peak transient Na+ 
current obtained during the I/V protocol, thus yielding the percentage of peak 
current for each recording. 
Channels capable of generating resurgent Na+ currents were tested using 
a two step protocol.  Cells were assayed for the ability to produce resurgent 
sodium currents using a step protocol that initially conditioned the cells to +30 
mV for 20 ms, from a holding potential of -100 mV, before repolarizing the 
membrane potential from 0 to -80 mV (in -5 mV increments) to test for resurgent 
current, then cells were returned to their holding potential.  Resurgent sodium 
currents display distinct features (Raman and Bean, 1997) and these were used 
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to determine if a cell generated resurgent currents.  For example, resurgent 
currents display a unique voltage-dependence where the peak resurgent currents 
are elicited by moderately hyperpolarized potentials relative to the holding 
potentials during the repolarizing steps.  For all cells identified with resurgent 
current in the current study, maximal peak currents during the repolarizing pulses 
were produced within a window of potentials from -35 to -50 mV and were first 
observed around -10 mV.  Additionally, these currents displayed unique gating 
kinetics within the window of potentials with a noticeably slower onset and decay 
phase.  This is in contrast with classic VGSC tail currents, which are observed 
instantaneously following hyperpolarizing steps and decay within a few 
milliseconds.  Currents were analyzed with leak subtraction on in PulseFit and 
were filtered at 1000 Hz to reduce noise but maintain the current waveform.  The 
resurgent current amplitude was measured relative to the leak-subtracted 
baseline.  The relative amplitude of the resurgent current was calculated as a 
percentage of the peak transient current by multiplying the peak resurgent 
current by 100 and then dividing by the peak transient current generated during a 
test pulse to -10 mV from a holding potential of -100 mV.  The average resurgent 
current amplitude for each VGSC construct was only calculated using data from 
those cells where resurgent current was detected.  Recordings contaminated 
with endogenous TTX-resistant currents, determined from steady-state 
inactivation plots were not used for further analysis.  Cells that expressed 
recombinant currents with peak transient sodium current amplitudes that were 
less than 5 nA were also excluded from the overall analysis because of 
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uncertainties associated with measuring resurgent current amplitude in cells that 
had small peak current amplitudes. 
J. Data analysis 
Voltage-clamp experimental data were analyzed using the Pulsefit (v 8.65, 
HEKA Electronik, Germany), Origin (v 7.0, OriginLab Corp., Northhampton, MA, 
U.S.A.), Prism (Prism v 4.0, GraphPad Software, La Jolla, CA, U.S.A.) and 
Microsoft Excel software programs. Normalized conductance-voltage (G-V) 
relationships were derived using Eq. 1: 
(1) GNa = Imax / (Vm – ENa) 
Where GNa is macroscopic sodium conductance, Imax is calculated as peak 
current in response to the test pulse, Vm is the test pulse voltage, and ENa is the 
measured Na+ equilibrium potential. Normalized availability curves were fit using 
a standard single-phase Boltzmann distribution for G/V, during the m∞/V protocol 
and steady-state fast-inactivation (h∞/V) data.  Midpoint (V1/2) and slope factors 
(Z) of (activation) conductance-voltage (G/V) and voltage-dependent steady-state 
fast inactivation curves were calculated using a standard single-phase Boltzmann 
distribution fit according to Eq. 2: 
(2) I (V) = Offset + 
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All data are shown as means ± S.E.M.  Comparison of frequency was 
determined using χ2 test.  Statistical significance was assessed with Microsoft 
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Excel using the 2-tailed Student’s unpaired t-tests.  Statistical significance of 
difference was accepted at P value less than 0.05. 
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III. RESULTS 
A. Paroxysmal extreme pain disorder (PEPD) mutations within the D3 / S4-
S5 linker of Nav1.7 cause moderate destabilization of fast inactivation 
Based on the evidence presented in the Introduction section of this 
dissertation, the initial hypothesis for this series of experiments was that Nav1.7 
mutations identified in different families with PEPD would destabilize sodium 
channel inactivation, but the biophysical consequences of this destabilization 
would depend on the location of the mutation.  Results from these studies were 
hypothesized to yield information about the putative “docking” sites critical for 
transition to an inactivated state. 
1. PEPD mutations within the D3 / S4-S5 linker have small effects on the 
voltage dependence of channel conductance but do not alter 
deactivation time constants 
The S4-S5 cytosolic linkers of several ion channels have been 
hypothesized to be a critical interface for inactivation gate “docking” interactions 
(Tang et al., 1996; Lerche et al., 1997; Smith and Goldin, 1997; Filatov et al., 
1998; McPhee et al., 1998; Tang et al., 1998; Popa et al., 2004) and the packing 
of a closed / resting configuration and stability of a splayed-open channel 
configuration (Chen et al., 2001; Lu et al., 2002; Long et al., 2005a; Ferrer et al., 
2006; Prole and Yellen, 2006; Soler-Llavina et al., 2006; Labro et al., 2008).  
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However, the structural role of residues within these cytosolic linkers during 
voltage-sensing / pore opening and stabilizing inactivation is not well understood.  
Thus, questions remain regarding the specific role of the S4-S5 linker during 
VGSC gating.  Intriguingly, several mutations implicated in PEPD lie within these 
regions of Nav1.7 (Figure 3).  Several mutations are highly localized to cytosolic 
linkers, D3 and D4 / S4-S5 and D3-D4, of Nav1.7 predicted to be critical 
components for inactivation gating.  While some of the PEPD mutations were 
characterized and shown to alter transition to an inactivated state, several 
residues within the D3 / S4-S5 linker mutated in PEPD had not been functionally 
characterized.  Therefore, our goal was to functionally characterize these D3 / 
S4-S5 PEPD mutations. 
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Figure 3.  Diagrammatic and sequence schemes of mutated regions within 
VGSC Nav1.7.  (A) Linear representation of VGSC α-subunit structure with 
putative inactivation motif labeled with amino acid residues IFMT.  Mutations 
within the D3 / S4-S5 and D3-D4 linker implicated in PEPD are indicated with 
filled red square symbols.  An adjacent and identical mutation (V1300F), not 
implicated in PEPD, is indicated with a filled blue square.  (B) Sequence 
alignment of human voltage-gated sodium channels.  Mutated residues 
implicated in PEPD are emphasized with bold lettering.  Underlined are regions 
of Nav1.7 mutated in this study which include adjacent hydrophobic valine 
residues (V1298, V1299, and V1300) within the D3 / S4-S5 cytosolic linker and 
the isoleucine within the putative inactivation motif (I1461) within the D3-D4 
cytosolic linker. 
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To determine the effects of previously uncharacterized PEPD mutations in 
D3 / S4-S5, hEK293 cells were transfected PEPD mutant and wild-type (WT) 
channel cDNA in order to establish the consequences of channel mutations on 
the voltage-dependent properties.  Rapidly activating and inactivating TTX-s 
sodium currents were observed in hEK293 cells transiently co-transfected with 
cDNA for either WT or PEPD mutant Nav1.7 channels and auxiliary hβ1 and hβ2-
subunits (Figures 3 and 4).  The Nav1.7-PEPD mutant construct design was 
based on the location and residue substitution of three inherited mutations 
identified in three different families (Fertleman et al., 2006).  Surprisingly, initial 
comparison of the current traces did not suggest any major differences in 
channel kinetics (Figure 4A) or current-voltage (I/V) properties (Figure 4B).  
However, expression levels of channels with the V1298F mutation (-144.4 ± 32.3 
pA/pF, n = 7) were significantly lower than WT (-332.6 ± 59.4 pA/pF, n = 11), 
V1299F (-213.3 ± 63.6 pA/pF, n = 9), and I1461T (-321.3 ± 63.8 pA/pF, n = 14) 
channels as determined by current density. 
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Figure 4.  Comparison of whole-cell ionic current traces and normalized 
current-voltage properties in CsF dominant electrode solution.  (A) 
Representative traces from WT and PEPD mutant Nav1.7 channels co-expressed 
with β1 and β2-subunits in hEK293 cells.  (B) Normalized current-voltage (I - V) 
properties were assessed using depolarizing step pulses.  Cells were held at -
120 mV.  The currents were elicited by 100 ms test pulses to various potentials 
from -80 to +90 mV stepped in increments of +5 mV.  The peak current evoked 
by each pulse, normalized to the maximum peak current, is plotted versus the 
pulse voltage. (C) Two-dimensional representation of native amino acid residues 
and mutated side chain moieties implicated in PEPD. 
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Voltage-dependent gating properties were investigated to determine the 
effects of D3 / S4-S5 PEPD mutations on transitions between conducting and 
non-conducting channel states.  The V1298F and V1299F mutations caused 
small, but significant (Table 1), depolarizing shifts in the voltage-dependence of 
channel conductance (G/V) and an increase in conductance slope factor for 
Nav1.7 channels.  These shifts were parameterized by fitting data to a single-
phase Boltzmann function and comparing the voltage at which 50% of the 
channel population (V1/2) was conducting Na
+ and the fitted slope factor (Z) at 
this voltage (Figure 5A).  A significant shift in the V1/2 of channel conductance or 
the slope factor for the PEPD mutation (I1461T) in the D3-D4 linker located in the 
putative inactivation gate was not observed, which suggests the I1461T mutation 
does not affect gating charge movement.  The effects of the PEPD mutations on 
deactivation, which involves rapid, voltage-dependent transitions from open to 
closed states via an integrated return of the S4 voltage sensors to a primed 
position, were also evaluated (Oxford, 1981; Kuo and Bean, 1994; Featherstone 
et al., 1998).  The voltage-dependent deactivation time constants (τd), examined 
by eliciting tail currents at a range of potentials after briefly activating the 
channels for the mutant PEPD channels, were not significantly affected when 
compared to WT (Figure 5B).  Taken together, these data suggest that PEPD 
mutations within the D3 / S4-S5 segments can have some impact on 
transmission of voltage-sensing, from the S4 segments, to pore conductance of 
Na+.  Although this does not appear to alter the coupling of S4 translocation to 
pore opening, it may affect the rate of S4 charge movement.  Conversely, the 
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I1461T mutation which is within the inactivation gate motif, did not affect 
activation or pore conductance suggesting this region may not be critical for the 
initial activation gating process. 
2. Mutations within the D3 / S4-S5 linker, implicated in PEPD, 
significantly shift the voltage dependence of the steady-state fast 
inactivation profile 
The voltage-dependence of fast inactivation for WT and PEPD mutant 
channels was tested using a two-step protocol (Figure 5C) to determine the 
fraction of channels transitioning to an inactivated (non-conducting) state in 
response to changes in membrane potential.  To ensure steady-state conditions 
(h∞) over the full range of potentials tested, 500 ms conditioning pulses were 
used.  The PEPD mutations (V1298F, V1299F, and I1461T) caused a significant 
depolarizing shift in the V1/2 of fast inactivation with no significant change in slope 
factor.  The V1/2 of inactivation (defined as the voltage at which 50% of the 
channel population has transitioned to a non-conducting state) was depolarized 
by ~20 mV for each mutant channel (Table 1) compared to WT, thus, resulting in 
an increased fraction of mutant channels available to conduct Na+ at more 
depolarized potentials.  The increased availability is likely due to decreased 
stabilization of the inactivated states.  To evaluate the contribution of decreased 
stabilization on the kinetics of the Na+ current decay phase, the time constants 
for inactivation (τh) during depolarization to various potentials using a Hodgkin-
Huxley (m3h) model to estimate open-state inactivation were calculated (Figure 
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5D).  At positive potentials (beyond -10 mV) the inactivation time constants for 
the PEPD mutant channels were significantly larger compared to WT channels 
(Table 2).  Therefore, the decay phase of raw current traces for the PEPD 
mutants at +10 mV, a potential where the mutant channel time constants seemed 
to plateau in response to further depolarizing steps in voltage, was compared 
(Figure 5E).  The decay phase of the current elicited for PEPD mutant traces was 
broader compared to WT (Figure 5E) and revealed a small persistent component 
(~6% normalized current remaining at 8 ms).  Thus, it is possible PEPD 
mutations disrupt the molecular interactions required to stabilize the fast-
inactivated state.  However, this effect may be due to either (1) destabilization of 
a putative “docking” site, outside of the channel pore, for the inactivation gate 
motif directly affecting stabilizing interactions or (2) indirect modifications of C-
terminal portions of the S6 segments which are required to be stabilized for the 
inactivation gate to bind within the intracellular mouth of the channel pore.  
Because the effects the PEPD mutations have on gating is measured based on 
changes in ion conductance through the pore, which is not a direct determinant 
of binding interactions, direct or indirect destabilization of transition to an 
inactivated state cannot be clearly defined.  Nevertheless, because the voltage-
dependent transition and the persistent current are affected with the PEPD 
mutations, one would postulate both direct and indirect changes may account for 
the destabilization. 
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Figure 5.  Effects of PEPD mutations within D3 / S4-S5 and D3-D4 linkers on 
voltage-dependent gating properties of Nav1.7.  (A) Comparison of the whole-
cell conductance-voltage properties (G/V), calculated from current-voltage (I/V) 
relationship.  (B) Voltage-dependent time constants for tail current deactivation 
(τd) at repolarization potentials ranging from -40 to -100 mV.  (C) Comparison of 
steady-state inactivation for WT and mutant channels from a holding potential of -
120 mV.  (D) Time-constants for open-state fast-inactivation as a function of 
voltage for WT and mutant channels.  The decay phases of currents elicited 
during channel activation protocol were fitted with a Hodgkin-Huxley type m3h 
model to estimate open-state inactivation time constants (τh).  (E) Representative 
normalized currents from whole-cell recordings of cells expressing either WT or 
PEPD mutant channels at +10 mV.  (F) Averaged inward ramp current (Iramp) 
traces (n = 6-14) elicited with a slow depolarizing (0.27 mV/ms) stimulus from a 
holding potential of -120 mV to +40 mV for PEPD mutant and WT channels.  
Ramp current amplitude is expressed as a percentage of the peak transient 
current elicited with a standard I/V protocol.  Plotted values for (A) and (C) were 
normalized and fit with a single-phase Boltzmann distribution for WT and PEPD 
mutant channels.  Voltage protocols are displayed within the insets. 
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Table 1.  Boltzmann parameters of channel activation and steady-state 
inactivation curves for WT and PEPD mutant Nav1.7 channels. 
 
 
Values derived for V1/2, the voltage of half maximal activation and inactivation, 
and the slopes were derived from Boltzmann distribution fits to the averaged and 
normalized (± S.E.M.) voltage-dependence of activation and steady-state 
inactivation curves. 
  
Voltage-dependence  
of activation  
 
Voltage-dependence  
of steady-state  
fast-inactivation 
       
Channel V1/2  
(mV) 
Slope  
(mV/e-
fold) 
n V1/2  
(mV) 
Slope  
(mV/e-
fold) 
n 
WT -28.9 ± 
0.2 
5.9 ± 0.2 
 
11 -77.6 ± 
0.1 
6.1 ± 0.1 
 
11 
V1298F -22.6 ± 
0.2 
6.4 ± 0.2 7 -57.8 ± 
0.2 
6.2 ± 0.2 7 
V1299F 
 
-24.4 ± 
0.2 
6.7 ± 0.2 9 -56.6 ± 
0.2 
6.1 ± 0.2 9 
I1461T -26.4 ± 
0.2 
6.0 ± 0.2 14 -58.8 ± 
0.2 
6.8 ± 0.2 14 
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Although impaired fast inactivation was observed with the PEPD 
mutations, the severity of the impairment produced by the I1461T mutation was 
much less than that previously reported for this mutation (Fertleman et al., 2007).  
Fertleman and colleagues observed a similar depolarizing shift in voltage-
dependence of inactivation; however a 40% non-inactivating component was 
reported.  One possible reason for the differences observed was that we co-
transfect the Nav1.7 cDNAs with auxiliary β1 and β2-subunits and they did not.  
This raises the question as to the role β-subunits play in modulating gating 
transitions.  Therefore, hEK293 cells were co-transfected with WT or I1461T 
constructs with and without β-subunits (using EGFP as our transfection control), 
to determine if this might influence the size of the non-inactivating component 
(Figure 6).  The inclusion or exclusion of β-subunits during hEK293 transfection 
did not increase the non-inactivating component of WT or I1461T currents.  Thus, 
these results suggest that the differences noted in the non-inactivating 
component between Fertleman et al. and our lab are not accounted for by the 
presence or absence of the auxiliary β1 and β2-subunits. 
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Figure 6.  Comparison of WT and mutant (I1461T) channels in the presence 
and absence of auxiliary β-subunits in CsF dominant electrode solution.  
(A) Representative traces for WT and mutant (I1461T) channels co-transfected 
with EGFP or β-subunits.  (B) Normalized fraction of available WT channels in 
response to changes in membrane potential co-transfected with EGFP or β-
subunits.  (C) Normalized fraction of mutant (I1461T) channels available over a 
range of tested potentials co-transfected with EGFP or β-subunits.  Data for (B) 
and (C) were fit using a standard single-phase Boltzmann distribution. 
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Another possible factor for the discrepancy between observations was that 
we used 140 mM CsF in our electrode solution and Fertleman et al. used 13 mM 
CsF.  Fluoride has been reported to alter persistent sodium currents in Nav1.3 
channels (Chen et al., 2000; Meadows et al., 2002).  Therefore, additional 
recordings of V1299F, I1461T and WT channels using a CsCl/Cs-aspartate 
dominant electrode solution that did not contain fluoride were performed (Figure 
7).  The voltage-dependence of channel conductance and steady-state fast 
inactivation obtained with this solution were depolarized compared to those 
obtained with fluoride as has been observed with other VGSC experiments, but 
we did not see evidence of incomplete steady-state inactivation.  However, the 
amount of persistent current observed at the end of 25 ms depolarizing pulses 
was slightly greater in the absence of fluoride for I1461T (~8% of peak) and 
V1299F (~15% of peak).  This data was consistent with observations suggesting 
VGSCs can mediate more pronounced persistent currents when recorded from 
an hEK293 expression system in the absence of intracellular fluoride ions (Chen 
et al., 2000; Meadows et al., 2002).  However, differences between the 
components of the electrode solutions between these experiments and those of 
Fertleman et al. do not completely explain the observation of a non-inactivating 
component (Fertleman et al., 2006).  Thus, one may reach the conclusion that 
Fertleman and colleagues did not use an appropriate duration for a conditioning 
pulse to examine transition to a fast-inactivated state for Nav1.7 channels which 
could lead to an exaggeration of the effects of mutations implicated in PEPD that 
affect inactivation. 
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Figure 7.  Comparison of whole-cell ionic current traces and normalized 
current-voltage properties in CsCl/Cs-aspartate dominant electrode 
solution.  (A) Representative traces from WT and PEPD mutant Nav1.7 
channels (V1299F and I1461T) co-expressed with hβ1 and hβ2-subunits in 
hEK293 cells.  (B) Normalized current-voltage (I/V) properties were assessed 
using depolarizing step pulses.  Cells were held at -80 mV.  The currents were 
elicited by 100 ms test pulses to various potentials from -80 to +70 mV stepped in 
increments of 5 mV.  (C) Voltage-dependence of activation was derived from the 
I/V data points to determine fraction of channels conducting in response to 
changes in voltage.  (D) Steady-state inactivation for WT and mutant channels 
determined using the protocol displayed within the inset from a holding potential 
of -80 mV. 
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3. PEPD mutant channels reveal an increased persistent component in 
response to a slow-duration depolarizing ramp stimulus 
Destabilization of the inactivated state can affect the region where steady-
state channel activation and inactivation overlap, resulting in an increased 
probability of channel re-opening before inactivating near resting membrane 
potential (RMP), and the development of persistent “window” currents (Hodgkin 
and Huxley, 1952).  Furthermore, it has been proposed that because persistent 
neuronal currents, or ramp currents (Iramp), are activated near RMP, these 
currents may influence AP threshold and cellular excitability (Crill, 1996).  
Therefore, in order to better quantify the persistent component observed above in 
the PEPD mutant channel traces, WT and PEPD mutant Nav1.7 currents evoked 
by a slow depolarizing ramp (0.27 mV/ms) stimulus, from a holding potential of -
120 mV, were examined.  A significant increase in the amplitude of the ramp 
currents elicited especially at more depolarized potentials for the mutations 
implicated in PEPD within the D3 / S4-S5 and D3-D4 intracellular linkers 
compared to WT channels in response to a slow depolarizing ramp stimulus was 
observed (Figure 5F).  Interestingly, the Iramp characteristics for the PEPD 
mutations revealed an impaired transition to a non-conducting state, confirming a 
destabilized channel configuration at more depolarized potentials.  As mentioned 
previously, Nav1.7 channels are thought to contribute to setting the threshold for 
AP firing.  Therefore, an increase in the peak ramp current elicited and the 
persistent component revealed at more depolarized voltages suggests the PEPD 
mutations may (1) alter threshold of AP at potentials when channels would 
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normally transitioning to closed-state inactivation (CSI), thus, reducing AP 
threshold and (2) prolong the AP duration, when channels are transitioning to 
open-state inactivation (OSI) during the falling phase of an AP where the 
membrane is repolarizing to RMP.  These voltage-dependent changes may be 
relevant in patients whose sensitivity for non-noxious stimuli, originating the 
rectal, ocular and mandibular regions, is heightened.  However, the location for 
the pain perception cannot be fully explained by the voltage-dependent gating 
changes alone because these patients do not experience pain throughout the 
body as would be expected based on the expression patterns of Nav1.7 
channels. 
4. PEPD mutations within the D3 / S4-S5 linker differentially affect 
development of closed-state inactivation (CSI) compared to the I1461T 
PEPD mutation 
Before reaching an open (ion conducting) state, VGSCs can transition to 
an inactivated state during small depolarizing steps, to relatively negative 
potentials, thereby reducing the population of channels available for activation by 
stronger depolarizing steps (Oxford and Pooler, 1975; Bean, 1981).  
Furthermore, transition to the closed-inactivated state (CSI) can play an 
important role in Na+ channel response during sub-threshold depolarizations 
(Cummins et al., 1998).  Therefore, the effects the PEPD mutations have on 
development of CSI were tested.  A time varied conditioning pulse to -60 mV was 
implemented, from a holding potential of -120 mV, followed by a test pulse to 0 
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mV for 20 ms, to determine the fraction of channels available.  A conditioning 
voltage of -60 mV was utilized because this potential is near RMP for nociceptive 
sensory neurons, thus, changes in VGSC gating properties near this potential 
may have a large impact on AP threshold (Herzog et al., 2001; Renganathan et 
al., 2001; Rush et al., 2006; Rush et al., 2007).  Consistent with our steady-state 
inactivation data, a decrease in the fraction of mutant channels transitioning to a 
closed-inactivated state at this potential was observed compared to WT (Figure 
8A).  Additionally, a significant difference in the time constants (τ-60) for CSI 
between PEPD mutations in the D3 / S4-S5 and D3-D4 (inactivation gate) linker 
was noticed (Table 2).  Surprisingly, the PEPD mutations within the D3 / S4-S5 
linker (V1298F and V1299F) displayed time constants smaller than those for both 
the WT channels and channels with the mutation within the putative inactivation 
gate (I1461T), indicating a faster transition to closed-inactivated states for the D3 
/ S4-S5 PEPD mutants.  These results together, suggest the transition rate and 
binding sites for inactivation are altered with the PEPD mutations at potentials 
critical for transition to closed-inactivated states. 
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Figure 8.  Effects of D3 / S4-S5 PEPD mutations on inactivation kinetics.  
(A) Development of CSI near RMP (n = 5-16).  (B) Time course for recovery from 
CSI near resting membrane potential (n = 7-10).  (C) Recovery from OSI to a 
primed channel state (n = 4-6).  Plotted values were fit with a single exponential 
function to determine time constant values (τ).  Development and recovery 
protocols are displayed within the insets. 
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5. Mutations associated with PEPD disrupt the stability of inactivation and 
increase the recovery rate from CSI 
The decrease in the inactivation time constant (τ-60) and incomplete 
development of CSI for the PEPD mutations within the D3 / S4-S5 linker are 
intriguing because they suggest that these residues may play a direct role in 
stabilizing the closed-inactivated state of Nav1.7.  Therefore, the inactivation 
kinetics were next examined by evaluating the effects the PEPD mutations had 
on recovery from CSI by pulsing cells to -60 mV for 500 ms and then allowing 
channels to recover at -90 mV for varied time increments before testing for 
available current (Figure 8B).  All of the PEPD mutant channels tested (V1298F, 
V1299F, and I1461T) recovered from CSI faster than WT.  The recovery time 
constants (τ-90) for the PEPD mutant channels were significantly faster (3-8 fold) 
than those for WT channels (Table 2).  Thus, these faster recovery rates likely 
contribute to the incomplete development of CSI for the PEPD mutant channels 
at this potential. 
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Table 2.  Development and recovery inactivation time constant values for 
WT and PEPD mutant Nav1.7 channels. 
 
 
Time constant values for development (τ-60) of and recovery (τ-90) from CSI.  
Additionally, we obtained time constant values for development (τ0) of and 
recovery (τ-90) OSI.  Voltage-derived time constant values for development of OSI 
at 0 mV were determined by fitting the decay phases of currents elicited for WT 
and mutant channels using a Hodgkin-Huxley m3h function.  Development of CSI 
and recovery from OSI and CSI data were fit using a single-exponential function 
and time constant values were calculated and averaged from individual cell 
recordings. 
 
Channel 
Development time 
constant (τ) 
(ms) 
 
n 
Recovery time 
constant (τ) 
(ms) 
 
n 
Closed-state inactivation     
WT 74.2 ± 8.2 16 46.9 ± 3.3 6 
V1298F 49.3 ± 2.7 4 9.7 ± 0.9 7 
V1299F 31.7 ± 3.5 8 7.3 ± 1.1 8 
I1461T 68.8 ± 3.2 5 15.6 ± 1.2 10 
Open-state inactivation     
WT 0.6 ± 0.1 11 30.6 ± 5.6 6 
V1298F 1.0 ± 0.03 7 9.6 ± 0.7 4 
V1299F 0.8 ± 0.1 9 4.2 ± 0.7 5 
I1461T 0.8 ± 0.03 14 13.0 ± 2.1 5 
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6. D3 / S4-S5 and D3-D4 PEPD linker mutations allow Nav1.7 
channels to recover from open-state inactivation (OSI) faster than 
wild-type (WT) channels 
Because we observed a depolarizing shift in the V1/2 of steady-state 
inactivation (h∞) and changes in the kinetics of CSI for PEPD mutant channels 
compared to WT we also examined channel recovery from open-state 
inactivation (OSI).  VGSCs quickly transition to an open-inactivated state after 
reaching an ion-conducting (open) state (Hodgkin and Huxley, 1952; Hoyt, 1971; 
Goldman and Schauf, 1972; Armstrong et al., 1973; Armstrong and Bezanilla, 
1977; Bezanilla and Armstrong, 1977).  To examine recovery from OSI cells a 
two-step protocol was implemented.  Cells were conditioned at depolarized 
potentials (0 mV, 20 ms) before hyperpolarizing the membrane potential (-90 mV) 
for varied times and then testing for available current (0 mV, 20 ms).  We chose a 
recovery potential of -90 mV based on our steady-state inactivation (h∞) data 
which shows that a large population (~90%) of WT channels are available for ion 
conductance at this potential.  All PEPD mutant channels recovered from OSI 
faster than WT channels with significant decreases in recovery time constants (τ-
90) (Figure 6C).  This is consistent with a decreased fraction of mutant channels 
transitioning to the fast open inactivated states at 0 mV. 
Notably, upon inspection of the development and recovery rates for all of 
the mutant constructs, the development of CSI is incomplete at 1000 ms 
indicating that the interactions required to stabilize the inactivated state are 
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disrupted.  However, the rate of development for the inactivation gate mutation 
(I1461T) is not affected suggesting the rate at which the inactivation gate motif 
binds to a putative “docking” site is not altered, however the stability, presumably 
from the amino acid substitution, is significantly reduced such that the 
inactivation gate does not bind with high affinity to the putative “docking” site.  
These results are confirmed upon observation of the recovery rates for all PEPD 
mutant channels including the I1461T.  The recovery kinetics for all PEPD mutant 
channels is accelerated compared to WT channels, most notably within the initial 
phase of the protocol.  Taken together, these results indicate that the mutations 
(V1298F and V1299F) located in the D3 / S4-S5 linker, a proposed interface for 
voltage-sensing and inactivation stability, alter both development and recovery 
from -60 mV along with the stability of inactivation, whereas a mutation located 
solely in the inactivation gate component primarily affects recovery rate and 
affinity of the inactivation reaction.  Thus, the development and recovery for all 
PEPD mutant constructs contribute to the changes noted in the ramp current 
properties at potentials negative to the activation threshold (Figure 5F).  Using a 
pharmacologic analogy and imagining the inactivation gate acts as a “ligand” 
binding to a theoretical “receptor” site, the mutations in these regions have the 
ability to alter both affinity and potency of this stabilizing reaction and suggest 
these regions are part of a critical interaction unit required for proper inactivation 
gating. 
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7. An adjacent and identical mutation within the D3 / S4-S5 linker, not 
implicated in PEPD, displays unique voltage-dependent and kinetic 
properties compared to neighboring PEPD mutations 
Based on amino acid sequence analysis and helical wheel projections, it 
has been proposed that the D1-D4 / S4-S5 linkers of VGSCs adopt a highly 
conserved α-helical secondary structure (Lerche et al., 1997; Filatov et al., 1998).  
The secondary structure of the linkers would indicate that residues may interact 
based on their orientation around the α-helix.  To test this possibility, an adjacent 
and identical residue (V1300F), not implicated in PEPD, was mutated within the 
S4-S5 linker of D3 to examine the location-specific effects of the valine to 
phenylalanine substitutions within the S4-S5 linker.  This mutant channel 
produced currents with rapid conductance and inactivation characteristics (Figure 
9A).  The I/V properties of the V1300F mutant in comparison to WT channels 
were further examined (Figure 9B).  The V1300F mutation resulted in a 
decreased probability of the channel population opening at voltages near 
activation threshold (-40 mV), which were sufficient to allow sodium flux through 
WT channels.  This suggests the V1300F mutation decreases the initial voltage-
sensitivity required for D3 activation and thus, impairs the fraction of channels 
available to open.  As such, the voltage-dependent properties and kinetics of 
gating for the V1300F mutant channel were evaluated in a similar manner as 
described for the PEPD mutations. 
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Figure 9.  An adjacent and identical mutation within the D3 / S4-S5 linker of 
Nav1.7, not implicated in PEPD, displays altered voltage-dependent channel 
properties in a manner distinct from PEPD mutations.  (A) Representative 
current trace for the V1300F mutant channels co-expressed with β1 and β2 
obtained from a holding potential of -120 mV to elicit inward Na+ current in a CsF 
dominant electrode solution.  (B) Normalized current-voltage (I/V) plot 
comparison of WT and V1300F mutant channels.  (C) Steady-state gating 
characteristics of WT and V1300F mutant channels determined from separate 
activation and inactivation pulse protocols.  Voltage-dependent conductance 
properties were derived from I/V data and the steady-state inactivation profiles 
were determined using stepwise conditioning pulses (D) Voltage-dependent 
deactivation characteristics were examined for WT and V1300F channels using 
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the protocol displayed within the inset.  (E)  Open-state fast-inactivation (OSI) 
time constants (τh) were determined using a Hodgkin-Huxley (m
3h) type fit to the 
decay phase of individual current traces in a similar manner as described for 
Figure 5D.  (F) Representative current trace for WT and mutant channels at +10 
mV emphasizing the decay phase for each trace.  (G) Averaged inward ramp 
current (Iramp) elicited in response to slow depolarizing stimulus (0.27 mV/ms) for 
WT and V1300F channels utilizing the same protocol that was used to examine 
PEPD mutant channels.  Ramp current amplitude is expressed as a percentage 
of the peak transient current elicited with a standard I/V protocol.  (H) Bar graph 
interpretation of percent peak inward current during the slow depolarizing ramp 
stimulus for all channels examined in this study (n = 6-14).  A significant increase 
in percent peak current is denoted with a single asterisk (*), whereas a significant 
decrease in percent peak current is symbolized with a double asterisk (**). 
 97 
When comparing WT and mutant G/V characteristics, a significant 
depolarizing shift in the V1/2 of conductance (-18.50 ± 0.20 mV) and increase in 
the activation slope factor (6.92 ± 0.18 mV/e-fold) was observed for the V1300F 
mutant channel, and a small, but significant, hyperpolarizing shift in V1/2 of 
steady-state inactivation (-81.96 ± 0.15 mV) with no significant change in 
inactivation slope factor (6.39 ± 0.13 mV/e-fold) (Figure 9C).  Additionally, in 
contrast to the adjacent PEPD mutations, the V1300F mutation significantly 
increased the voltage-dependent deactivation time constants (τd) at -60 and -40 
mV (Figure 9D) and had little effect on OSI at potentials near +10 mV (Figures 
9E and F).  We also compared Iramp elicited using a slow depolarizing stimulus 
(0.27 mV/ms) for WT and mutant channels (Figure 9G) and noticed a significant 
decrease in the percent peak current remaining for the V1300F mutant channels 
compared to WT (Figure 9H).  This was in contrast to the adjacent PEPD 
mutations that significantly increased ramp current elicited  Consistent with this, 
an enhanced transition to CSI for the V1300F mutant channels, and a significant 
decrease in the time constant (τ-60) for CSI compared to WT were observed 
(Figure 10A).  However, this mutation did not significantly alter the time constants 
for recovery from CSI or OSI compared to WT (Figures 10B and C). 
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Figure 10.  Comparison of kinetic profiles for development and recovery 
from inactivated (OSI and CSI) states for V1300F mutant and WT channels.  
(A) Development of CSI at -60 mV for V1300F and WT channels was examined 
using a two-step pulse protocol shown within the inset.  (B) Recovery from CSI 
was tested experimentally using a two-step pulse protocol shown within the inset 
to determine the fraction of WT and mutant channels that recover at -90 mV.  (C) 
Recovery from OSI was evaluated using a two-step protocol with a strong 
conditioning pre-pulse to 0 mV followed by a time-varied hyperpolarizing pulse (-
90 mV) and a test pulse (0 mV) to determine the fraction of channels recovering 
from OSI. 
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8. Voltage-dependent slow inactivation properties for PEPD mutant 
channels are altered in a manner distinct from V1300F mutant 
channels 
In addition to transitioning to a fast-inactivated state, VGSCs can transition 
to an additional inactivated state called slow-inactivation, that occurs over 
seconds or even minutes, and slowly recovers (Vilin and Ruben, 2001).  As 
evidence of the physiological importance of slow inactivation, mutations that 
decrease the fraction of channels accumulating in a slow-inactivated state in 
response to changes in voltage may play an important role in determining cellular 
excitability in skeletal muscle (Cummins and Sigworth, 1996; Bendahhou et al., 
2002) and computer-modeled DRG neurons (Sheets et al., 2007).  The effects of 
the Nav1.7 PEPD mutations on transition to a slow-inactivated state have not 
been determined.  Therefore, the voltage-dependent properties of slow 
inactivation for WT and each of the mutant channels were examined using an 
extended (10 sec) conditioning pulse followed by a brief hyperpolarizing pulse 
that allowed for recovery of fast-inactivated channels, before testing for the 
available population of channels (Figure 11).  Interestingly, all of the PEPD 
mutant channels decreased the voltage-dependent transition to a slow-
inactivated state when compared to WT.  Results for the PEPD mutant channels 
were in contrast to the non-PEPD mutant channel (V1300F) which did not 
decrease transition to the slow-inactivated state compared to WT.  Both WT and 
V1300F channel availability were fit well (r2 = 0.99) with a double-phase 
Boltzmann distribution, suggesting that the population of channels transitioned 
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between two slow-inactivated states.  However, the PEPD mutant channel 
transition to slow inactivation was fit well with a single-phase Boltzmann 
distribution.  Therefore, it is possible that in addition to their role in impairing fast 
inactivation, the D3 / S4-S5 mutations implicated in PEPD also affect the voltage-
dependent transition to a slow-inactivated state. 
These results are intriguing based on the controversy regarding the 
coupled nature of the fast and slow inactivation mechanisms (Featherstone et al., 
1996; Vedantham and Cannon, 1998; Hilber et al., 2002) and the proposal for 
separate independent voltage-sensing components for each process (Ruben et 
al., 1992; Casini et al., 2007).  Results from experiments in this section of the 
dissertation are consistent with the two gating states when compared to WT, in 
that, the PEPD mutations appear to (1) destabilize fast inactivation and shift the 
voltage-dependence rightward and (2) shift the voltage-dependent transition to a 
slow-inactivated state rightward and modify the occupancy in a particular 
component of slow inactivation such that the majority of PEPD mutant channels 
can be fit into one population. 
These results demonstrate that the PEPD mutant channels can increase 
the window current primarily by shifting transition to an inactivated state.  This is 
in contrast to an adjacent non-PEPD mutation within the D3 / S4-S5 linker that 
reduces the size of window current and overlap between activation and 
inactivation gating.  This effect may be due to a constrained voltage-sensitivity for 
activation and a moderate voltage-dependent uncoupling between activation and 
inactivation.  Taken together, these results demonstrate that mutations along the 
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D3 / S4-S5 linker can differentially affect voltage-dependent channel gating and 
the stability of pore conductance and inactivation. 
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Figure 11.  Comparison of the derived voltage-dependent slow inactivation 
properties for WT and mutant channels during transition between distinct 
states.  All D3 / S4-S5 (V1298F, V1299F, and V1300F) and D3-D4 (I1461T) 
linker mutant channels were tested experimentally to determine the fraction of 
channels transitioning to slow-inactivated states in response to changes in 
voltage.  To examine this transition we used a pulse protocol that included a +10 
mV stepwise conditioning pulse from -130 mV to +10 mV for 10 seconds, and 
then quickly hyperpolarized cells to -120 mV to allow rapid recovery of fast-
inactivated channels before testing for available channels for 20 ms at +10 mV.  
WT and V1300F channels were fit using a double-phase Boltzmann distribution 
whereas PEPD mutant channels were fit using a single-phase Boltzmann 
distribution. 
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B. Nav1.7-PEPD mutant channel M1627K within D4 / S4-S5 alters transition 
to an inactivated state and renders DRG neurons hyperexcitable 
1. Nav1.7-M1627K located in the S4-S5 of D4 and implicated in 
PEPD, shifts voltage-dependent properties and increases ramp 
currents similarly to D3 / S4-S5 PEPD mutations 
The voltage-sensing S4 segment of D4 in VGSCs is crucial for coupling 
voltage-dependent channel activation to inactivation (Chahine et al., 1994; Chen 
et al., 1996; Cha et al., 1999).  Residues within the adjacent D4 / S4-S5 linker of 
VGSCs play a unique role in stabilizing a fast-inactivated configuration (Tang et 
al., 1996; Filatov et al., 1998; McPhee et al., 1998).  Of interest, an inherited 
PEPD mutation (M1627K), within this cytosolic region of Nav1.7 which replaces a 
highly conserved methionine (Met, M) for a positively charged lysine (Lys, K), 
had originally been identified in a patient from France (Fertleman et al., 2006).  
Charge-substituted mutations in the S4-S5 segments of D3 and D4 slow 
transition to an inactivated state using engineered scanning mutagenesis (Smith 
and Goldin, 1997; Filatov et al., 1998) and site-directed mutagenesis based on 
locations of inherited channelopathies (Cannon, 2000; Meisler and Kearney, 
2005; Koopmann et al., 2006; Catterall et al., 2008).  This mutation occurs within 
a highly conserved Met doublet in the S4-S5 of D4 of VGSCs that plays an 
important role in stabilizing transition to an inactivated state (Filatov et al., 1998) 
and may tune gating properties in response to oxidative modifications 
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(Kassmann et al., 2008) suggesting this Met doublet may lie within a “hotspot” 
region of VGSCs prone to mutation which cause gating defects  Therefore, we 
investigated the effects of a novel M1627K mutation on voltage-dependent 
channel properties and action potential (AP) firing.  This mutation was identified 
in the SCN9A coding exons from an English patient diagnosed with PEPD. 
Human embryonic kidney (hEK293) cell lines, stably expressing TTX-r 
forms of the WT (Nav1.7r) and mutant (Nav1.7r-M1627K) VGSCs were used to 
determine changes in channel properties.  The M1627K mutation slowed decay 
rates of current traces (Figure 12) elicited during an I/V protocol, but did not 
statistically alter the voltage-dependent activation and deactivation channel 
properties compared to WT (Figure 13A and B).  These results are in agreement 
with those demonstrating the VGSC S4 segment of D4 is a critical component for 
coupling activation to inactivation (Chahine et al., 1994; Chen et al., 1996; Cha et 
al., 1999; Chanda and Bezanilla, 2002) and could suggest the tethered S4-S5 
interface for voltage-sensing transmission may be more important during 
inactivation and gating charge immobilization compared to activation.  However, 
evidence indicating that the D4 / S4 gating charge movement during membrane 
repolarization is not limited by inactivation gate binding or immobilizing the return, 
argues against a potential role for the S4-S5 interface during inactivation.  
Notably, these discrepancies are hard to resolve in the absence of a crystal 
structure snapshot at several voltage-dependent states or chemically modifiable 
direct interactions at a range of voltages. 
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Figure 12.  M1627K currents decay slower than WT Nav1.7 currents.  
Representative WT (A) and M1627K (B) Nav1.7 currents are shown.  Cells were 
held at -100 mV and currents were elicited with 50 ms test pulses to potentials 
ranging from -80 to +40 mV.  For better comparison, WT and M1627K currents 
elicited with -30 mV (C) and +25 mV (D) depolarizations are shown 
superimposed.  Although the rate of activation is not apparently altered, the 
decay phase is substantially faster for WT currents. 
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Similar to other PEPD mutations, the charge-substituting M1627K 
mutation significantly depolarized the midpoint of steady-state fast inactivation 
(approximately +20 mV) and decreased the slope factor (Figure 13C).  However, 
the fraction of current remaining available after the -10 mV inactivation prepulse 
was not significantly different between WT (1.3 ± 0.3%) and M1627K (1.9 ± 
0.5%) channels.  By contrast, the voltage-dependence of slow inactivation of 
Nav1.7r currents was moderately altered by the M1627K mutation (Figure 13D).  
Ten second pre-pulses, followed by 100 ms recovery pulses to -120 mV to allow 
recovery from fast-inactivation, preceded the test pulse (to 0 mV for 20 ms) to 
determine the fraction of current available.  The M1627K mutation reduced the 
fraction of slow-inactivated channels that occurred at -80, -70 and -60 mV, which 
might contribute to increased channel availability at normal resting membrane 
potentials. 
As noted above, PEPD mutant channels exhibited slower current decay 
characteristics (Figure 12) compared to WT channels.  Therefore, we 
investigated the rates of inactivation for WT and M1627K mutant channels.  Upon 
inspection of gating kinetics, we observed significant differences in the time 
constants for current inactivation between WT and M1627K channels.  The rate 
of OSI was quantified by fitting the decay phase of the macroscopic current with 
a single exponential function.  The time constants estimated from these fits are 
plotted as a function of the test potentials (Figure 13E).  The time constants were 
much larger for M1627K currents than for WT currents over voltages range from -
30 to +40 mV.  At -30 mV, for example, WT currents inactivated with a time 
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constant of 5.8  0.8 ms (n = 6) whereas M1627K currents inactivated with a time 
constant of 9.9  1.3 ms (n = 6).  At +25 mV WT currents inactivated with a time 
constant of 0.44  0.01 ms (n = 6) and M1627K currents inactivated with a time 
constant ten times larger (4.9  0.4 ms, n = 6).  These differences were 
statistically significant.  We also examined the development of CSI at voltages 
ranging from -90 to -50 mV (Figure 13E, triangular symbols).  Cells were stepped 
to the inactivation potential (from a holding potential of -100 mV) for increasing 
durations, and then stepped to the test potential (0 mV) to measure the fraction 
of the remaining available channels.  The data from these cells were fitted with a 
single exponential function.  Interestingly, the time course for the development of 
inactivation from the closed state was not significantly altered by the M1627K 
mutation, indicating that the M1627K mutation has a greater effect on OSI than 
CSI. 
The time course for recovery from fast inactivation (repriming) of WT and 
M1627K channels was measured at recovery voltages ranging from -140 to -60 
mV.  Fast inactivation was induced with 20 ms inactivating pre-pulses to -20 mV.  
The time course for recovery from inactivation for both WT and M1627K currents 
could be fitted with single exponential functions.  Recovery from inactivation was 
significantly faster for M1627K channels than for WT channels (Figure 13F).  For 
example, the time constant for recovery of WT channels ( = 92  11 ms, n = 7) 
was almost 4-fold larger at -70 mV than the corresponding time constant for 
M1627K channels ( = 26  3 ms, n = 7). 
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Figure 13.  The M1627K mutation alters inactivation properties of Nav1.7.  
(A) Normalized peak current-voltage relationship for WT (filled squares, n = 11) 
and M1627K (open circles, n = 15) channels.  Cells were held at -100 mV and 
currents were elicited with 50 ms test pulses to potentials ranging from -80 to +40 
mV.  (B) Time constants for tail current deactivation at repolarization potentials 
ranging from -40 to -100 mV for WT (filled squares, n = 8) and M1627K (open 
circles, n = 9) Nav1.7 channels.  Time constants were obtained with single 
exponential fits to the deactivation phase of the currents.  (C) Comparison of 
steady-state fast inactivation for WT (filled squares, n = 11) and M1627K (open 
circles, n = 15) Nav1.7 channels.  Currents were elicited with test pulses to 0 mV 
following 500 ms inactivating pre-pulses.  (D) Comparison of slow inactivation for 
WT (filled squares, n = 3) and M1627K (open circles, n = 4) Nav1.7 channels.  
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Slow inactivation was induced with 10 s pre-pulses, followed by 100 ms pulses to 
-120 mV to allow recovery from fast inactivation.  A test pulse to 0 mV for 20 ms 
was used to determine the fraction of current available.  (E) Time constants for 
development of fast inactivation as a function of voltage for WT (filled symbols, n 
= 6) and M1627K (open symbols, n = 6) Nav1.7 channels are shown.  Open-
channel inactivation time constants were measured at voltages ranging from -45 
to +40 mV by fitting the decay phase of currents elicited with depolarizing pulses 
with single exponentials.  The time constants for development of closed-state 
inactivation were estimated from single exponential fits to time courses measured 
at inactivation potentials ranging from -90 to -50 mV for WT (filled triangles, n = 
6) and with M1627K (open triangles, n = 6) Nav1.7 channels.  (F) Recovery from 
inactivation kinetics are faster for M1627K mutant channels (open circles, n = 7) 
than for WT Nav1.7 channels (filled squares, n = 7).  Time constants were 
estimated from single exponential fits to time courses measured at recovery 
potentials ranging from -140 to -60 mV.  The recovery from inactivation voltage 
protocol involved prepulsing the cell to -20 mV for 20 ms to inactivate all of the 
current, then stepping the membrane potential back to the recovery potential for 
increasing recovery durations prior to the test pulse to 0 mV.  The maximum 
pulse rate was 0.5 Hz. 
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We also examined the currents induced in WT and M1627K channels by 
small, slow depolarizations (ramp stimulus).  Figure 14A shows the ramp current 
recorded from a M1627K cell producing a current with peak amplitude of 2.8 nA, 
compared to the ramp current recorded from a WT cell producing a comparable 
current with a peak amplitude of 3.4 nA.  The ramp currents elicited with slow 
ramp (0.27 mV/ms) depolarizations from -100 to +20 mV were expressed as a 
percentage of peak current (Figure 14B) and the relative amplitude of the ramp 
currents were significantly larger for M1627K channels (7.0 ± 1.0%; n = 9) than 
for WT channels (1.0 ± 0.2%; n = 7).  We compared the relative amplitude of the 
ramp currents with the extent of overlap between the voltage-dependence of 
activation and steady-state fast inactivation (Figure 14C).  As shown, the relative 
amplitude of the WT and M1627K ramp currents, and the voltage-dependence of 
these currents, correlates reasonably well with the respective overlap between 
the voltage-dependence of activation and steady-state fast inactivation.  Taken 
together, the voltage-dependent shifts in inactivation for the M1627K mutation 
share common features with the other PEPD mutations identified in the D3 / S4-
S5 and D3-D4 inactivation gate that have been characterized in experiments 
outlined in this dissertation.  It is interesting to note that although some of the 
IEM mutations characterized, for example A863P (Dib-Hajj et al., 2005; Han et 
al., 2006; Harty et al., 2006), can shift steady-state inactivation by +10 mV, 
symptoms described do not overlap with those for PEPD, suggesting genetic 
factors, cellular background, or modulating factors may contribute to the distinct 
clinical manifestation of these disorders and responsiveness to therapeutic 
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agents.  The M1627K mutation, similar to the other PEPD mutations 
characterized in the experiments above, increased ramp current elicited during a 
slow depolarizing ramp stimulus for Nav1.7 channels.  Since the ramp currents 
generated by Nav1.7 channels have been shown to be important for AP threshold 
properties (Cummins et al., 1998; Rush et al., 2007), depending on cellular 
background (Rush et al., 2006), we anticipated the M1627K mutation would 
increase AP response to subthreshold stimuli.  Thus, we hypothesized that the 
M1627K mutation would alter excitability in the nociceptive neuronal background 
in which they are present. 
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Figure 14.  The M1627K mutation increases the amplitude of currents 
elicited by slow ramp depolarizations.  (A) Representative ramp currents 
elicited by 600 ms long ramp depolarizations from -100 to +20 mV are shown 
recorded from a hEK293 cell expressing WT channels (black trace) and from one 
expressing M1627K channels (gray trace).  The peak transient current amplitude 
elicited in the WT cell was larger (3.4 nA) than that of the M1627K cell (2.8 nA).  
(B) The average relative ramp current (ramp current divided by peak transient 
current amplitude) is larger for M1627K cells (gray trace, n = 9) than for WT cells 
(black trace, n = 7).  (C) The properties of the averaged ramp currents are 
compared to the overlap between the voltage-dependence of activation (derived 
from the current-voltage relationship) and steady-state fast inactivation.  The 
inverted amplitude of the WT ramp current was scaled so that it corresponded to 
the peak overlap between WT activation and steady-state fast inactivation (black 
shaded area).  As can be seen, voltage-dependence of the WT ramp current 
corresponds to the region of overlap.  Furthermore, the relative amplitude and 
voltage-dependence of the M1627K ramp currents corresponds to the overlap 
between M1627K activation and steady-state fast inactivation (gray shaded 
area). 
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2. Nav1.7-PEPD mutations render DRG neurons hyperexcitable 
In addition to examining channel properties in response to changes in 
membrane potential, a collaborative effort was put forth between the Cummins 
and Waxman laboratories to investigate the effects of Nav1.7r-M1627K mutant 
channels on AP firing activity (performed by Dr. Mark Estacion; Waxman 
laboratory) because previous studies had not looked at these parameters.  
Recordings were obtained from transfected rat DRG neurons of similar size (Dib-
Hajj et al., 2008) and were chosen based on EGFP expression.  Expression of 
M1627K mutant channels caused a significant reduction in the threshold to 
generate APs without altering input resistance, resting membrane potential 
(RMP), or AP amplitude between the two groups.  Of note, neurons expressing 
M1627K channels fired more APs in response to a supra-threshold graded 
stimuli (1 sec long depolarizing current injection) and to stimuli 3X, and above, 
threshold calibrated to individual experimental (WT and M1627K) groups (Dib-
Hajj et al., 2008). 
Taken together, these results demonstrate that single-point PEPD 
mutations, within the S4-S5 linkers of D3 and D4, increase neuronal excitability in 
rat DRG, in part, because of altered inactivation properties of Nav1.7 channels.  It 
is worthwhile to note that although single-point missense mutations implicated in 
the painful disorders IEM and PEPD alter distinct gating properties of Nav1.7 
channels; both increase neuronal excitability in nociceptive DRG neurons.  
Therefore, additional modulating factors must contribute to the perceived 
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locations, temperature-dependent and environmental triggering mechanisms, 
and age-onset of pain in addition to response to different therapeutic agents. 
C. Alternative splicing of Nav1.7 exon 5 increases the impact of the painful 
PEPD mutant channel I1461T 
1. Abbreviated background regarding Nav1.7 alternative splicing 
The sequence conservation between each of the segments in various 
VGSC isoforms is likely to contribute to their broad similarities (ion selectivity and 
voltage-dependence), whereas differences in the coding sequence between 
isoforms may play a role in evolutionary adaptation, such as pharmacological 
sensitivities (TTX-s vs. TTX-r), kinetic properties (fast vs. slow activating / 
inactivating channels), or transcriptional processes important for regional 
distributions and channel trafficking.  As such, single-point missense mutations in 
“hotspot” regions of the channel, critical for precise gating, can disrupt the ability 
of the channel to transition between states and alter the configuration required to 
stabilize the channels at a particular membrane potential. 
As previously mentioned there are notable differences between patients 
with IEM and PEPD, even though the disorders have been implicated to distinct 
single-point missense mutations in the Nav1.7 channel highly expressed in the 
peripheral and sympathetic nervous system.  Although the mutations differentially 
alter gating of Nav1.7, one would not predict this would be the sole cause for 
such wide variation between the two groups.  For example, patients with different 
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IEM or PEPD mutations report differential age onsets (Drenth et al., 2005; 
Fertleman et al., 2006; Dib-Hajj et al., 2007)  The contributing factors to these 
differences are not clear.  However, post-translational modification, alternative 
splicing, and expression of auxiliary β-subunits have been reported to modulate 
sodium current properties (Catterall et al., 2005).  For instance, as stated in the 
background of this dissertation, alternative splicing of Nav1.7 has been shown to 
alter channel kinetics, pharmacological sensitivities, and tissue distribution under 
pathological conditions, and can also be developmentally regulated.  Additional 
evidence suggests that alternative splice variants of Nav1.7 are found in dorsal 
root ganglia (DRG) neurons and that under modeled neuropathic pain conditions 
in rats splicing patterns of this isoform can change (Raymond et al., 2004).  
Furthermore, a recent study (Chatelier et al., 2008) has reported that alternative 
splice variants of Nav1.7 exon 5 “neonatal” and “adult” (5N and 5A), which differ 
by two amino acids (L201V, N206D) in the D1 / S3-S4 linker, differentially affect 
the amplitude of currents generated in response to a slow depolarizing ramp 
stimulus.  The gating characteristics of an additional set of Nav1.7 splice variants 
occurring from alterations to exon 11 “long” and “short” (11L and 11S) were also 
studied.  Alternative splicing in this region, which differs by an 11 amino acid 
stretch included or excluded from the D1-D2 loop between the 11L and 11S 
variants, impacted current properties which was shown to be differentially 
modified by PKA regulation (Chatelier et al., 2008). 
We explored the option as to whether alternative splicing of Nav1.7 could 
contribute to the discrepancies between IEM and PEPD.  Thus, we hypothesized 
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that alternative splicing of Nav1.7 may functionally impact IEM and PEPD, acting 
as a disease modifier, based on the expression patterns of the particular splice 
variants of this isoform.  We hypothesized that, in addition to the gating changes 
in Nav1.7 due to IEM or PEPD mutations which are sufficient to cause extreme 
pain, alternative splicing could contribute to the regional differences in perceived 
location of pain and age-onset between IEM and PEPD.  Indeed, alternative 
VGSC splicing has been shown to increase ramp currents in Nav1.7 channels.  
Additionally, IEM and PEPD mutations also alter Nav1.7 ramp current properties.  
Together, alternative splicing may, in an additive manner, contribute to the 
chronic pain induced by these mutations.  Therefore, we investigated whether 
alternative splicing of exon 5 might impact the functional consequences of IEM 
(I136V) and PEPD (I1461T) mutations.  Results from these experiments (1) 
suggest an additive effect of the Nav1.7 exon 5 alternative splicing and the PEPD 
mutation (I1461T) which could further impact the disease phenotype and (2) offer 
insight into how alternative splicing within exon 5 affects specific intramolecular 
interactions critical for voltage-dependent gating. 
2. Splicing of exon 5 moderately alters WT Nav1.7 channel properties 
Wild-type (WT) Nav1.7 exon 5 (Figure 15) splice variants (5N and 5A) 
produced rapid activating and inactivating inward sodium current upon 
membrane depolarization (Figure 16A).  Initial comparison of the current traces 
did not suggest noticeable differences in channel kinetics or expression levels of 
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the 5N (-374.3 ± 65 pA/pF, n = 13) compared to the 5A (-320.7 ± 44 pA/pF, n = 
11) form. 
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Figure 15. Location of exon 5 splicing region and Nav1.7 mutations 
implicated in IEM and PEPD.  (A) Depicted above is a linear representation of 
the VGSC α-subunit and the corresponding D1 / S3-S4 region for exon 5.  The 
coding region of Nav1.7 exon 5, located in the D1 / S3-S4 region, is noted with a 
pink star (*).  Numerical position, amino acid mutation, and locations of the tested 
mutant channels in this study are designated with a green filled (IEM) or red filled 
(PEPD) square.  Tested IEM mutant construct was D1 / S1 I136V and the tested 
PEPD mutant construct was D3-D4 I1461T located within the putative 
inactivation gate of Nav1.7.  (B) Sequence alignment of Nav1.7 D1 / S3 through 
the region D1 / S4.  Exon 5 amino acid differences, located within the D1 / S3-S4 
linker, between the 5N versus the 5A splice forms are highlighted with grayed 
letters.  Conserved native charged residues are illustrated with an encompassing 
rectangle in the sequence alignment.  A substituted charged residue in the D1 / 
S3-S4 of the Nav1.7 5A form is emphasized with a star and a dashed line leading 
to the amino acid structural differences at physiological pH.  In the 5N form there 
is an uncharged asparagine (N) residue characterized by the grayed amide 
moiety, whereas the 5A residue is a charged aspartic acid (D), with the charged 
moiety also noted in gray. 
 119 
Changes in activation (m∞/V), determined by whole-cell ionic conductance, 
and inactivation (h∞/V), determined by the fraction of channels available after a 
500 ms conditioning prepulse, were examined for the WT splice variants by 
comparing their respective midpoints (V1/2) and slope factors (Z) in response to 
changes in command voltage (Figure 16B). Additionally, the rapid, integrated 
transition from channels activating and opening to closing, or deactivation, was 
evaluated (Figure 16C).  In agreement with Chatelier et al. (2008) a small 
hyperpolarizing (~2 mV) shift in the V1/2 of activation for the WT 5A variant was 
observed, whereas changes in steady-state inactivation and deactivation kinetics 
(τd), at potentials from -100 to -40 mV, were not observed (Table 3). These 
results suggest the D1 / S3-S4 splicing differences between the two Nav1.7 
splice variants do not significantly alter steady-state activation, deactivation, or 
inactivation properties in response to changes in membrane potential. 
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Figure 16.  Effects of exon 5 alternative splicing on WT Nav1.7 channels. (A) 
Representative sodium current traces for WT exon 5N versus 5A channels 
elicited using an incremental depolarizing step protocol.  (B) Normalized fraction 
of channels available (G/V) during steady-state activating (m∞/V) and fast-
inactivating (h∞/V) protocols.  (C) Deactivation kinetics were compared using 
single-exponential fits to tail currents.  (D) Time course for the development of 
closed-state inactivation (CSI) at -60 mV.  The bar graph inset represents the 
averaged time constant (τ-60) values for the recordings ± S.E.M.  (E) Channel 
ramp current generation was assayed using a slow depolarizing ramp (0.27 
mV/ms) stimulus from -120 mV to +40 mV at a holding potential of -120 mV.  
Illustrated are the averaged (n = 5-6) ramp current traces for each splice variant.  
Averaged data for the WT 5N variant is colored in black and the 5A splice variant 
is colored in gray. 
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The relatively slow transitions of Nav1.7 to and from closed-inactivated 
states are thought to contribute to production of physiologically relevant ramp 
current in response to slow depolarizing stimuli at hyperpolarized potentials near 
resting membrane potential for nociceptive DRG neurons (Rush et al., 2006; 
Rush et al., 2007).  These Nav1.7 ramp currents have been proposed to play 
roles in amplifying subthreshold generator potentials at relatively hyperpolarized 
voltages (Cummins et al., 1998; Herzog et al., 2003b).  Thus, the ramp current 
generated by Nav1.7 channels is implicated as a critical component in 
determining AP firing threshold (Blair and Bean, 2002).  For these reasons, as 
well as recent reports suggesting differences in ramp current between Nav1.7 
splice variants (Chatelier et al., 2008), we examined development of and 
recovery from a closed-inactivated state (CSI) at -60 mV and changes in the 
ramp currents.  Development of CSI (τ-60) for the WT 5N (60.4 ± 6.3 ms, n = 11) 
compared to the 5A (73.4 ± 12.2 ms, n = 11) form was not significantly different 
(Figure 16D).  Comparison of the recovery from -60 mV did not reveal a 
significant difference between the time constants for WT 5N (10.4 ± 1.1 ms, n = 
8) and 5A (9.5 ± 0.7 ms, n = 10).  The ramp current generated in response to a 
slow depolarizing ramp stimulus (0.27 mV/ms) by the 5A variant was increased 
by approximately 40% compared to the 5N form (Figure 16E).  Although this 
increase was not significantly different between the two WT splice variants, it is 
consistent with results from Chatelier et al. (2008).  This relatively small increase 
in ramp current could, in part, be due to the moderate shift in activation and the 
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trend towards a slowed development of CSI that was observed compared to the 
WT 5A splice variant. 
3. Exon 5A PEPD mutant channel affects activation, deactivation, 
CSI, and ramp current properties 
We next examined the effects alternative splicing has on a PEPD mutation 
(I1461T) located within the putative D3-D4 intracellular inactivation gate (Figure 
15).  The I1461T mutation, and other PEPD mutations that have been previously 
characterized in the 5N splice variant, shift the voltage-dependence of steady-
state inactivation in the positive direction, slow the rate of open-state fast-
inactivation and increase the amplitude of ramp currents at positive potentials 
compared to WT 5N channels (Fertleman et al., 2006; Dib-Hajj et al., 2008; 
Jarecki et al., 2008).  The whole-cell inward sodium currents generated by the 
I1461T 5N and 5A splice variants were similar (Figure 17A) and current 
expression was not statistically different between the 5N (-171.2 ± 26 pA/pF, n = 
12) and the 5A (-179.2 ± 27 pA/pF, n = 12) variants.  Steady-state inactivation 
properties (h∞/V) were not significantly different, however the ~5 mV 
hyperpolarizing shift in the midpoint of activation (m∞/V) for I1461T 5A was 
significantly different compared to the 5N form (Figure 17B, Table 3).  
Furthermore, the deactivation time constants (τd) for the I1461T 5A form were 
slowed compared to the 5N.  For example, deactivation at -60 mV, a potential 
near RMP for nociceptive neurons, was significantly slowed for the 5A splice 
variant (Figure 17C). 
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Figure 17.  Alternative splicing modifies the voltage-dependent properties 
of the Nav1.7-PEPD mutation (I1461T) located in the putative inactivation 
gate. (A) Shown above are representative whole-cell sodium current traces for 
the exon 5N and 5A forms of the I1461T mutant channel.  (B) Comparison of 
conductance voltage (G/V) properties and steady-state fast inactivation in 
response to changes in membrane potential.  (C) Changes in channel 
deactivation for the PEPD mutant were determined at a range of membrane 
potentials by observing tail current properties.  Inset figure shows representative 
traces elicited during a deactivating protocol.  (D) Development plot for the 
I1461T splice variants during transition to a closed-inactivated state at -60 mV.  
(E) Averaged ramp current elicited in response to a slow depolarizing stimulus for 
I1461T mutant channels.  Traces were compiled from 5-10 individual recordings 
and then plotted versus membrane potential. 
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Examination of CSI at -60 mV also revealed the I1461T 5A channels 
transition to a close-inactivated state with a significantly slower time constant (τ-
60) than the 5N channels (Figure 17D).  However, recovery from CSI was not 
significantly different between the 5N (4.7 ± 0.3 ms, n = 11) and the 5A (4.9 ± 0.2 
ms, n = 11) variants.  Taken together, these data indicate that, at -60 mV, the 5A 
variant of the I1461T channels has a higher probability of remaining in an 
activated state, and may be more likely to transition to an ion-conducting state at 
more hyperpolarized voltages compared to the I1461T 5N variant.  When the 5A 
PEPD mutant ramp current was compared to the 5N channels an increase in 
peak ramp current elicited was observed at all potentials tested.  Furthermore, 
the 5A PEPD mutant channels displayed a more hyperpolarized onset of ramp 
current activation (Figure 17E).  These results demonstrate that the I1461T 5A 
splice variant significantly increases ramp current amplitude at negative and 
positive potentials compared to the 5N variant (Figure 19A). 
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Table 3. Comparative Boltzmann parameters of the voltage-dependence of 
channel activation and steady-state fast-inactivation curves for the 
respective splice variants of WT, IEM (I136V) and PEPD (I1461T) Nav1.7 
channels. 
 
 
Values for V1/2, the voltage of half-maximal activation and inactivation, and the 
slope factors were derived from Boltzmann distribution fits to the individual 
recordings and averaged to determine the mean and standard error of the mean 
(± S.E.M) displayed above. 
   
Voltage-dependence of 
activation  
 
Voltage-dependence of 
steady-state fast-
inactivation 
        
Splice 
form 
Channel V1/2  
(mV) 
Slope  
(mV/e-
fold) 
n V1/2  
(mV) 
Slope  
(mV/e-
fold) 
n 
 
 
5N 
WT -25.7 ± 
1.3 
6.2 ± 0.3 
 
13 -76.8 ± 
1.0 
5.09 ± 
0.2 
12 
I1461T -22.4 ± 
1.4 
6.2 ± 0.2 12 -55.9 ± 
1.2 
5.2 ± 0.1 12 
I136V 
 
-37.5 ± 
1.7 
5.1 ± 0.3 5 -78.1 ± 
2.0 
5.7 ± 0.2 5 
 
 
5A 
WT -27.7 ± 
0.9 
5.8 ± 0.3 11 -76.2 ± 
1.1 
5.5 ± 0.1 12 
I1461T -26.8 ± 
0.8 
5.9 ± 0.2 12 -57.6 ± 
0.9 
5.0 ± 0.1 12 
I136V -36.9 ± 
1.8 
6.0 ± 0.4 7 -79.3 ± 
2.1 
5.8 ± 0.2 7 
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4. D1 / S1 IEM mutant channel properties are not affected by exon 5 
alternative splicing 
Mutations associated with IEM are commonly located in D1 and D2 and 
predominantly shift the voltage-dependence of activation to more hyperpolarized 
potentials without disturbing steady-state inactivation (Dib-Hajj et al., 2007).  We 
examined the effects of alternative splicing on a nearby D1 / S1 (Figure 15) IEM 
mutation (I136V), which exhibits a delayed age of onset for pain sensations 
compared to other IEM mutations (Cheng et al., 2008).  The currents generated 
by the 5N and 5A splice variants of the I136V mutant were similar (Figure 18A) 
with no statistical difference in current expression between the 5N (-339.1 ± 85 
pA/pF, n = 6) and the 5A (-214.9 ± 31 pA/pF, n = 9) variants.  Further inspection 
of the voltage-dependent channel characteristics did not yield significant 
differences between the I136V splice variants for the ability to activate during the 
m∞/V protocol, inactivate during the h∞/V protocol, or deactivate (τd) at the range 
of transmembrane potentials measured (Figures 16B-C).  Additionally, no 
changes in the ability of the I136V-IEM splice variants to transition to a closed-
inactivated state were observed at -60 mV (Figure 18D). Recovery from CSI 
between the 5N (10.5 ± 1.0 ms, n = 3) and the 5A (10.5 ± 2 ms, n = 3) IEM 
variants also did not differ. 
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Figure 18.  Alternative splicing of exon 5 in Nav1.7 does not affect gating 
properties of the D1 / S1 IEM mutant channels.  (A) Characteristic inward 
sodium traces for the I136V-IEM splice forms.  (B) Steady-state activating and 
inactivating properties of I136V are displayed and plotted with respect to 
membrane potential to determine the fraction available at the range potentials 
depicted.  (C) Voltage-dependent deactivation properties of I136V 5N and 5A 
splice variants are illustrated in the graph and representative traces are shown 
within the inset.  (D) Development of closed-state inactivation at -60 mV is 
unchanged when comparing the I136V splice forms.  No significant difference in 
the time constants was observed at -60 mV.  (E) Changes in ramp current 
elicited during a slow-depolarizing stimulus for the I136V splice variants were not 
observed. 
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The ramp current elicited for the D1 / S1 IEM mutant was not statistically 
different when comparing the percentage of peak current between the splice 
variants (Figure 18E).  It is interesting to note that, in contrast to WT and I1461T 
channels, there was not even a hint of an increase in ramp current amplitude.  
These results indicate that differences in the splice variants do not affect the 
I136V mutant channel properties. 
Since a majority of the IEM mutations have been shown to primarily alter 
the voltage-dependent activation and deactivation properties (Dib-Hajj et al., 
2007) the relatively small shifts induced by the 5A splice variant on voltage-
dependent activation may be masked.  The I136V mutation alone shifted the 
midpoint of activation by approximately -8 mV compared to WT, which is much 
larger than the shift observed for the WT-5A compared to WT-5N splice variants.  
Our results suggest that IEM mutations are not additively affected by the 5A 
splicing.  However, our results for the PEPD (I1461T) splice variants are 
intriguing because they indicate that the impact of PEPD mutations and exon 5 
changes are additive.  Our results also demonstrate that the 5A splice variant of 
WT channels moderately hyperpolarizes the midpoint of activation and increases 
ramp current, which are in agreement with Chatelier et al. (2008).  Since the 
stability of the inactivated conformation is decreased by the I1461T mutation, the 
effects of the 5A alternative splicing for the I1461T channels would be predicted 
to amplify the overlap between channels opening versus inactivating (window 
current) and increase the probability of channel opening in an additive manner 
(Figure 20).  Interestingly, upon inspection of ramp current properties for the 
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I1461T-5A splice variant there appears to be three components when compared 
to the 5N variant.  The 5A variant results in an increased ramp current threshold, 
responding at more negative potentials, an increase in peak ramp current, and a 
persistent element along the range of positive potentials compared to the 5N 
splice variant.  This indicates that the activation profile for the 5A variant, in 
addition to the inherent defects in inactivation, contribute to the triple-phase 
characteristics of the ramp currents generated and would therefore affect 
transition from closed to open states.  The effects of the I1461T-5A splice variant 
would therefore alter the rate and voltage-dependence of transition to open and 
inactivated gating states (Figure 20). 
Structural implications suggest the charge replacement between the 
variants could contribute to the shift in the activation properties of the 5A variant.  
The coding region for Nav1.7 exon 5 includes a portion of the D1 / S3 segment 
through the C-terminal end of the positively charged D1 / S4 (Raymond et al., 
2004).  The residue differences between the 5N and the 5A variants are localized 
to the extracellular portion of the D1 / S3 and the D1 / S3-S4 cytosolic linker 
(Figure 19B). Interestingly, the residue difference in the cytosolic linker of the 5A 
variant contains a polar, negatively charged (acidic) residue (Asp206) compared 
to the 5N variant which retains a polar, non-charged Asn at the 206 position at a 
physiological pH (Figure 19B).  This acidic residue substitution could contribute 
an additional negative charge to the electrostatic field surrounding the D1 / S4 
(Asamoah et al., 2003; Sigg and Bezanilla, 2003).  Additionally, the Asp206 may 
form electrostatic interactions with N-terminal residues in the mobile D1 / S4 
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charge translocator, which is laden with positive residues (Cha and Bezanilla, 
1998; Sorensen et al., 2000). 
Together, based on our data with the I1461T PEPD mutation (Figures 17 
and 20), we predict that the changes induced by splicing are likely have a 
functional impact on other disease mutations that alter inactivation and this could 
be useful in understanding the underlying molecular mechanisms.  It is likely that 
expression patterns of splice variants in human populations are altered during 
painful conditions (Raymond et al., 2004; Fraser et al., 2005; Altier et al., 2007) 
and may result in unique differences in response to pharmacological agents (Tan 
et al., 2002).  However, one cannot exclude the possibility of additional factors 
such as cellular background or post-translational modifications that regulate 
expression patterns or gating properties of specific VGSCs during pain 
transduction in response to a perceived painful stimulus, shifting pain threshold 
and altering interpretation of a given stimulus. 
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Figure 19.  Summary of changes observed in ramp current and potential 
mechanistic implications for the charge substitution difference between the 
Nav1.7 5N and the 5A splice variants in the D1 / S3-S4 linker.  (A) Summary 
bar graph of the percent of peak current determined for each channel.  Denoted 
on the y-axis are the channel types (WT and numbered IEM or PEPD mutants).  
The x-axis represents the percentage of peak ramp current elicited for the splice 
variants in each group, where the 5N forms are highlighted in blackened or filled 
horizontal bars, and the 5A forms are highlighted with unfilled bars.  Raw 
numerical data were determined by selecting the peak ramp current elicited from 
each trace, filtered at 250 Hz to reduce stochastic noise, and then divided by the 
peak transient sodium current elicited during an activating protocol, then 
multiplied by 100 to yield the percent of peak current for individual recordings.  
Raw data was then compiled and averaged to determine group mean and 
standard error.  Statistical significance was set at p < 0.05 and noted with a star 
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(*).  (Ba) Sequence alignment of Nav1.7 D1 / S3 through the region D1 / S4.  
Exon 5 amino acid differences, located within the D1 / S3-S4 linker, between the 
5N versus the 5A splice forms are highlighted with grayed letters. Conserved 
native charged residues are illustrated with an encompassing rectangle in the 
sequence alignment.  A substituted charged residue in the D1 / S3-S4 of the 
Nav1.7 5A form is emphasized with a star and a dashed line leading to the amino 
acid structural differences at physiological pH.  In the 5N form there is an 
uncharged asparagine (N) residue characterized by the grayed amide moiety, 
whereas the 5A residue is a charged aspartic acid (D), with the charged moiety 
also noted in gray.  (Bb) Structural diagram of the Nav1.7 D1 / S3-S4 
transmembrane segments and the adjoining extracellular linker predicted for the 
5A splice variant.  Single-letter residues from the above sequence alignment are 
inserted along predicted exon 5 coding region chain from the upper portions of 
the segments and the linker region.  Native charged residues conserved between 
the splicing forms are highlighted with the corresponding charge (+ or -) within 
the segments and linker regions.  Residue substitutions between the 5N and the 
5A variants are grayed and highlighted with an arrow. Note that the charge 
substitution within the linker between the splice variants occurs near the highly 
charged S4 segment of D1. 
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Figure 20.  State-occupancy diagram illustrates increased open-state 
probability for 5A PEPD mutant channels.  Simplified three-state diagram of 
transitions between closed (C), open (O), and inactivated (I) where movement 
between the states is dependent on membrane potential and time.  Illustrated in 
the model on the left of the reaction arrow are theoretical transitions between 
each state for a WT 5N splice form.  To the right of the reaction arrow are the 
effects the PEPD mutation (I1461T) has on transition between the simplified 
states, primarily on the stability of the inactivated configuration highlighted with 
dotted lines.  Also noted to the right of the reaction arrow are the effects the 5A 
alternative splicing substitutions have (highlighted by the grayed arrow) on the 
simplified transitions. 
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D. Inherited mutations implicated in neuronal and muscle channelopathies 
can generate resurgent sodium currents in DRG neurons 
1. Abbreviated introduction of resurgent currents and a potential role 
as a disease modifier in voltage-gated sodium channelopathies 
Over two hundred different missense mutations in seven VGSCs have 
been identified as causing disorders of excitability, or channelopathies, in 
humans (Cannon, 2000; George, 2005; Meisler and Kearney, 2005; Koopmann 
et al., 2006; Catterall et al., 2008).  Although these channelopathies are relatively 
rare, understanding the functional consequences of the disease mutations 
provides invaluable insight into the roles that VGSCs play in normal and 
abnormal excitability.  Mutant channels have been extensively studied in non-
excitable heterologous expression systems, providing substantial knowledge; 
however a major concern is that the functional properties of VGSCs in neurons 
and muscle cells are not always accurately reproduced in non-excitable cells.  A 
prime example of this phenomenon is VGSC resurgent currents.  The properties 
of the coined term, resurgent currents, originally described in cerebellar Purkinje 
neurons, involved a “resurgence” of inward sodium currents during membrane 
repolarization (Raman and Bean, 1997).  As described earlier (refer to 
Background section of dissertation) the “resurgence” of sodium currents, whose 
predominant generator is Nav1.6 channels (Raman et al., 1997; Raman and 
Bean, 1999b; Cummins et al., 2005), flowed when the channels should be 
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inactivated and thus reducing to the AP refractory period and high frequency 
firing (Raman and Bean, 1997, 1999a, b, 2001).  Artificial slowing of VGSC 
inactivation via toxin application can induce resurgent currents in Purkinje 
neurons isolated from Nav1.6 knock-out mice (Grieco and Raman, 2004), 
indicating that other VGSCs, besides Nav1.6, may have the capacity to generate 
resurgent sodium currents.  While resurgent VGSC currents have been recorded 
from neurons, it has not been possible to record resurgent currents in non-
excitable heterologous expression systems (Raman et al., 1997; Cummins et al., 
2005; Chen et al., 2008) and it is not known if VGSC mutations that cause 
channelopathies alter resurgent currents. 
Nav1.7 channels, highly expressed in DRG neurons, are essential in 
nociception as evidenced by single point missense mutations causing a spectrum 
of pain syndromes, including PEPD, and nonsense mutations resulting in human 
insensitivity to pain (Dib-Hajj et al., 2007).  However, the means by which these 
channels are regulated (or deregulated) during cellular hyperexcitability and their 
overall contributions to increased pain perception are still debated (Amir et al., 
2006; Cummins et al., 2007).  As shown earlier in this dissertation, the potential 
contribution alternative splicing has on impact of painful mutations in Nav1.7 was 
explored (Jarecki et al., 2009).  Additional factors that may modulate excitability, 
and thus pain perception, include changes in, for example, post-translational 
modifications and protein trafficking, cellular background, lipid environment, 
signaling mechanisms, and cellular oxidation-reduction balance (Scholz and 
Woolf, 2002; Woolf and Ma, 2007; Costigan et al., 2009).  One intriguing 
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hypothesis from our laboratory suggested that post-translational modifications 
and cellular background which may increase resurgent sodium currents could 
play a unique role in the spectrum of disorders associated with Nav1.7 point 
mutations.  Although Nav1.7 channels were previously shown to not produce 
resurgent currents (Raman and Bean, 1997; Cummins et al., 2005), the 
possibility that Nav1.7-PEPD mutations, which, as we have shown, slow and 
destabilize inactivation, increase cellular excitability, and contribute to increases 
in pain perception, allow for generation of resurgent currents had not been 
explored.  Therefore, in a collaborative effort with fellow graduate student Andrew 
D. Piekarz and Theodore R. Cummins, we asked if the inherited Nav1.7-PEPD 
mutation (I1461T) would enable Nav1.7 channels with the ability to produce 
resurgent currents. 
2. An inherited Nav1.7-PEPD disease mutation (I1461T) that 
destabilizes inactivation produces resurgent current in DRG 
neurons and increases action potential firing 
We first asked if a mutation in Nav1.7 that slows inactivation and causes 
paroxysmal extreme pain disorder (PEPD) (Jarecki et al., 2008) could generate 
resurgent sodium currents.  Nav1.7 channels, highly expressed in DRG neurons, 
are essential in nociception as evidenced by single-point missense mutations 
causing a spectrum of pain syndromes, including PEPD, and nonsense 
mutations resulting in human insensitivity to pain (Dib-Hajj et al., 2007).  Although 
Nav1.7 channels have been shown to not produce resurgent currents, PEPD 
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mutations destabilize inactivation, shifting the voltage-dependence and 
decreasing the rate of inactivation (Dib-Hajj et al., 2008; Jarecki et al., 2008).  
Therefore, we hypothesized that PEPD mutations might induce resurgent 
currents.  We studied the Nav1.7-PEPD mutation I1461T, which is located within 
the highly conserved D3-D4 inactivation particle (IFMT) critical for VGSC 
inactivation (Stuhmer et al., 1989; Patton et al., 1992; West et al., 1992).  
Modified WT Nav1.7 (Nav1.7r) and Nav1.7-I1461T (Nav1.7r-I1461T) channels that 
generate currents that can be pharmacologically isolated were expressed in adult 
rat DRG neurons as described in the Methods.  In DRG neurons, robust 
transfected current was observed for wild-type (WT) and mutant Nav1.7 channels 
(Figure 21A and B).  In addition to the recombinant channel of interest, neurons 
were also co-transfected with a second plasmid encoding for both EGFP, to help 
identify transfected neurons, and a specific Nav1.8-shRNA, to minimize 
endogenous Nav1.8 currents as described in detail in the Methods section (refer 
to Figure 23 for an example).  In DRG neurons, the I1461T PEPD mutation 
impaired inactivation (Figure 21C and D; Table 4) but did not alter activation of 
Nav1.7r channels.  The persistent component (Iper), measured at the end of a 50 
ms pulse to -10 mV, was also significantly larger for the I1461T channels than for 
wild-type Nav1.7r channels (Iper = 0.2 ± 0.2% of peak transient current for wild-
type, n = 13 and 1.0 ± 0.3% for Nav1.7r-I1461T, n = 22). These changes were 
identical to those observed for wild-type and I1461T Nav1.7 channels expressed 
in human embryonic kidney 293 (hEK293) cells (Jarecki et al., 2008). 
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Figure 21.  Currents generated by recombinant Nav1.7 channels expressed 
in DRG neurons.  (A) Representative Nav1.7r current traces recorded from a 
transfected DRG neuron.  (B) Representative Nav1.7r-I1461T current traces 
recorded from a transfected DRG neuron. Currents were elicited with step 
depolarizations to voltages ranging from -80 to +40 mV from a holding potential 
of -100 mV.  (C) The painful mutation I1461T slows the rate of inactivation of 
Nav1.7r.  The black trace is wild-type Nav1.7r and the red trace is Nav1.7r-
I1461T.  Currents were elicited with a step depolarization to +10 mV. (D) Steady-
state inactivation curves for Nav1.7r (black data) and Nav1.7r-I1461T (red data) 
channels expressed in DRG neurons.  Cultured adult rat DRG neurons were 
transfected with the recombinant VGSC construct and Nav1.8-shRNA and 
recordings were done in the presence of 500 nM TTX. 
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Surprisingly, in DRG neurons both wild-type Nav1.7r and Nav1.7r-I1461T 
channels also generated resurgent sodium currents (Figure 24).  The 
characteristic properties of resurgent sodium currents differed from those 
observed for tail currents, assayed during a deactivation protocol, and transient 
currents, elicited during an I/V protocol (Figure 22).  Resurgent sodium currents 
were observed in 5 of 21 neurons transfected with wild-type Nav1.7r (Figure 24A 
and B), with an average amplitude, expressed as a percentage of the peak 
transient sodium current elicited with a test pulse to -10 mV, of 1.0 ± 0.5% for 
these five neurons.  By contrast, 20 of 30 neurons expressing Nav1.7r-I1461T 
channels produced resurgent sodium current (Figure 22C and D).  The frequency 
of observing resurgent with Nav1.7r-I1461T channels was significantly increased 
(Chi squared < 0.05) compared to wild-type Nav1.7r channels.  Moreover, the 
relative amplitude of the resurgent current (2.0 ± 0.1%) was also significantly 
greater for Nav1.7r-I1461T than for wild-type Nav1.7r channels.  Because all 
PEPD mutations characterized, to date, result in slower inactivation of Nav1.7 
(Dib-Hajj et al., 2008; Jarecki et al., 2008) we predict all PEPD mutations are 
likely to increase resurgent current generation. 
 140 
 
Figure 22.  Quantification of resurgent current amplitude.  Sodium currents 
recorded from two different neurons expressing Nav1.6r currents are shown.  
Currents were elicited with a 20 ms pulse to +30 mV followed by a 100 ms pulse 
to -40 mV from a holding potential of -100 mV.  Rapid tail currents can be seen in 
the recordings from both neurons (A and B).  In addition, robust resurgent 
current, with slower onset and decay than the tail currents, can be seen in the 
recording shown in (B).  The amplitude of the resurgent current is measured 
relative to the baseline obtained at the holding potential.  Tail currents are not 
included in the measurement of resurgent current amplitudes through judicious 
use of the measurement cursors in the analysis program. 
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Figure 23.  Properties of endogenous and biolistically transfected 
recombinant VGSC currents in the presence and absence of TTX and / or 
Nav1.8-shRNA.  (A) Representative TTX-resistant currents recorded from a 
cultured adult rat DRG neuron in the presence of 500 nM TTX.  Currents were 
elicited with voltage steps ranging from -80 to +40 mV in 10 mV increments.  
These currents show the kinetic properties typical of Nav1.8 currents.  (B) 
Representative currents recorded from a cultured adult rat DRG neuron 
transfected with Nav1.8-shRNA but no recombinant VGSC construct.  Scale is 
the same as in (A) for comparison.  In the presence of TTX, very little sodium 
current is elicited.  This demonstrates the Nav1.8-shRNA transfection combined 
with application of 500 nM TTX effectively blocks the majority of endogenous 
voltage-gated sodium currents in cultured DRG neurons.  (C) Steady-state 
inactivation curves for endogenous Nav1.8 currents (filled circles) recorded from 
the same neuron used in (A), a transfected neuron expressing recombinant 
Nav1.5r current without evidence of Nav1.8 contamination (closed squares) and a 
transfected neuron expressing recombinant Nav1.5r current with ~20% 
contamination by endogenous Nav1.8 currents (open triangles).  Nav1.8 
contamination is evidenced by the biphasic voltage-dependence of steady-state 
inactivation.  Recordings were done in the presence of 500 nM TTX and 
recombinant Nav1.5r was co-transfected with Nav1.8-shRNA.   (D) Resurgent 
currents are not detected in control neurons in the presence of 500 nM TTX.  
Currents are recorded from the same neuron used in (A) and are magnified 30x 
relative to the peak current elicited with a test pulse to -10 mV.  (E) Resurgent 
currents are not detected in neurons transfected with Nav1.8-shRNA but no 
recombinant VGSC construct in the presence of 500 nM TTX.  Currents are 
recorded from the same neuron used in (B) and are shown on the same scale as 
in (D) for comparison. 
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Figure 24.  Resurgent currents are produced by recombinant Nav1.7 
channels expressed in DRG neurons.  Representative current traces recorded 
from DRG neurons expressing wild-type Nav1.7r that did not (A) and that did (B) 
generate resurgent currents.  Representative current traces recorded from DRG 
neurons expressing Nav1.7r-I1461T channels that did not (C) and that did (D) 
generate resurgent currents.  Resurgent currents were larger on average for 
Nav1.7r-I1461T than for wild-type Nav1.7 channels.  Currents are magnified 30x 
relative to the peak transient current (elicited with a pulse to -10 mV) to 
emphasize the resurgent current components.  (E) Resurgent current voltage 
protocol.  (F) Voltage-dependence of resurgent current shown in (D). 
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Based on work done in cerebellar Purkinje neurons (Raman et al., 1997), 
we anticipated that increased resurgent sodium currents generated by PEPD 
mutations may result in spontaneous and / or repetitive APs in DRG neurons.  To 
test this, we performed computer simulations of DRG neuron excitability.  We 
used an established model of DRG neuron excitability (Sheets et al., 2007), with 
modifications only to the appropriate sodium channel formulation, simulated and 
evaluated the impact of the I1461T mutation and resurgent currents on AP firing.  
The resurgent current blocking factor was implemented using a previously 
described strategy without modifications (Khaliq et al., 2003).  In our model, 
developed and simulated by Dr. Theodore R. Cummins, the blocking factor 
induced resurgent current was 1.0% of the peak transient current in the modeled 
wild-type Nav1.7 conductance and 2.0% of the peak transient current in the 
modeled Nav1.7-I1461T conductance.  The computer simulations of AP firing in 
DRG neurons indicate that while the destabilization of inactivation caused by the 
I1461T mutation is sufficient to decrease the threshold for eliciting an AP, 
inclusion of the resurgent current blocking factor leads to high-frequency trains of 
APs.  It is important to note that even when the transition rate expressions for the 
blocking factor were adjusted so that the wild-type resurgent current was doubled 
(2% of peak), a 70 pA stimulus still only elicited a single action potential in the 
model neuron.  These results indicate the resurgent current blocking factor and 
the I1461T mutations act synergistically to increase neuronal excitability and that 
resurgent currents probably contribute to the extreme pain sensations associated 
with PEPD mutations (Jarecki et al., 2010). 
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3. A cardiac LQT3 / SIDS mutation that slows inactivation increases 
resurgent Nav1.5 current and broadens action potential waveform in 
a modeled myocyte 
Disease mutations that impair inactivation have also been identified in 
several other VGSCs, including Nav1.1 and Nav1.3 mutations associated with 
epilepsies, Nav1.4 mutations associated with skeletal muscle myotonias, and 
Nav1.5 mutations associated with cardiac arrhythmias (Cannon, 2000; George, 
2005; Meisler and Kearney, 2005; Cannon, 2006; Koopmann et al., 2006).  Over 
50 different disease mutations that impair inactivation have been characterized.  
However, these mutations have all been characterized in heterologous 
expression systems that do not support the generation of resurgent sodium 
currents.  Therefore, we next used the DRG expression system to determine if 
the Nav1.5 long-QT type 3 / sudden infant death syndrome (LQT3 / SIDS) 
associated mutation F1486L (Wang et al., 2007) could generate increased 
resurgent currents.  As has been previously shown in hEK293 cells (Wang et al., 
2007), the F1486L mutation, which is also located in the IFMT inactivation 
particle, slowed the rate of inactivation, increased the fraction of persistent 
currents and shifted the voltage-dependence of activation in the depolarizing 
direction (Table 4).  However, 9 of 18 transfected DRG neurons expressing wild-
type Nav1.5 generated resurgent currents (Figure 25A and B; Table 4).  In our 
expression system the Nav1.5-F1486L LQT3 / SIDS mutation significantly 
increased the relative amplitude of the resurgent currents (Table 4).  Eight out of 
seventeen neurons expressing Nav1.5-F1486L channels generated resurgent 
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currents with average relative amplitude of 2.0 ± 0.4% (Figure 25C and D; Table 
4). 
As resurgent sodium currents are activated during repolarization, 
increased resurgent currents in Nav1.5 would be expected to broaden the AP, 
increase the QT interval and thus contribute to the potentially lethal cardiac 
arrhythmias associated with LQT3 / SIDS mutations.  Mathematical modeling 
was performed by Dr. Theodore R. Cummins using a modified mathematical 
model of cardiac AP firing (Luo and Rudy, 1994; Courtemanche et al., 1998) to 
simulate the impact of the F1486L LQT3 / SIDS mutation and resurgent currents.  
The cardiac myocyte model was previously implemented by Ingemar Jacobson in 
the NEURON simulation environment (Hines and Carnevale, 1997).  Simulated 
models of resurgent sodium currents and computer simulations of a cardiac 
myocyte (Courtemanche et al., 1998) indicate that an increase in resurgent 
currents in Nav1.5 broaden the cardiac AP and increase the QT interval (Jarecki 
et al., 2010). 
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Figure 25.  Resurgent currents are produced by Nav1.5 channels.  
Representative current traces recorded from DRG neurons expressing wild-type 
Nav1.5 that did not (A) and that did (B) generate resurgent currents.  
Representative current traces recorded from DRG neurons expressing LQT3 / 
SIDS Nav1.5-F1486L channels, emphasized in blue, that did not (C) and that did 
(D) generate resurgent currents.  Resurgent currents were larger on average for 
Nav1.5-F1486L than for wild-type Nav1.5 channels.  Currents were elicited with 
the standard resurgent current protocol shown in Figure 24E and are magnified 
30x relative to the peak current amplitude. 
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4. A D4 / S4 PMC mutation in Nav1.4 that replaces a charged residue 
and uncouples fast inactivation generates resurgent sodium 
currents 
We next asked if a mutation that slows inactivation of Nav1.4 and causes 
paramyotonia congenita (PMC) could induce resurgent sodium currents.  We 
studied the R1448P mutation (Featherstone et al., 1998) which alters the 
outermost extracellular charged residue in the sodium channel voltage sensor 
that couples channel activation and inactivation (Chahine et al., 1994).  
Interestingly, while this mutation slows the inactivation of Nav1.4 currents by ~10-
fold (Figure 26A) it causes a hyperpolarizing shift in the voltage-dependence of 
inactivation (Table 4).  In a previous study, resurgent sodium currents were not 
detected in any of 41 DRG neurons transfected with wild-type skeletal muscle 
sodium channel Nav1.4r (Cummins et al., 2005).  While we, again, did not detect 
resurgent currents in any of 11 neurons expressing wild-type Nav1.4r (Figure 
26B), 13 of 20 neurons expressing Nav1.4r-R1448P channels generated 
resurgent currents (Figure 26C), with an average relative amplitude of 4.8 ± 0.7% 
of peak.  Thus, at least for Nav1.4, slowing the rate of inactivation seems to be 
crucial to the production of resurgent sodium currents and the impact of the 
mutation on the voltage-dependence of inactivation may be less important.  It 
should be noted that while the R1448P mutation does not alter the voltage-
dependence of activation, it slows deactivation (the rate at which open channels 
transit to the closed state) (Oxford, 1981; Featherstone et al., 1998), and slower  
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Figure 26.  A paramyotonia congenita mutation induces resurgent currents 
in Nav1.4.  (A) The paramyotonia congenita R1448P mutation, highlighted in 
green, causes a pronounced slowing of the rate of Nav1.4r inactivation.  Currents 
were elicited with a step depolarization to +10 mV.  Resurgent currents were not 
detectable in any of the neurons expressing wild-type Nav1.4r channels (B).  By 
contrast, the majority of neurons expressing Nav1.4r-R1448P channels 
generated robust resurgent currents (C).  Resurgent currents were elicited with 
the protocol shown in Figure 24E and are magnified 20x relative to the peak 
current amplitude. 
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deactivation might also contribute to enhanced resurgent currents, especially in 
combination with slower inactivation. 
Resurgent currents generated by Nav1.4 are likely to increase repetitive 
AP firing in skeletal muscle, which is one of the hallmarks of PMC.  However, it 
should be noted that patients with PMC can also experience episodes of muscle 
weakness or paralysis in addition to myotonia (Heatwole and Moxley, 2007).  
Although resurgent currents could clearly contribute to myotonic activity 
associated with PMC, incomplete inactivation observed with mutant PMC 
channels is likely to be an important factor in muscle weakness associated with 
PMC (Cannon, 2006). 
5. A homologous inactivation gate mutation engineered into Nav1.6 
channels dramatically increases resurgent currents and 
destabilizes transition to an inactivated state 
Since Nav1.6 appears to be the predominant generator of resurgent 
currents in cerebellar Purkinje neurons and DRG neurons (Raman et al., 1997; 
Cummins et al., 2005), we next compared the amplitude of resurgent currents 
generated by Nav1.6 channels with those produced by the Nav1.4, Nav1.5 and 
Nav1.7 disease mutations.  Resurgent currents were detected in 8 of 14 DRG 
neurons expressing wild-type Nav1.6r channels, with an average relative 
amplitude of 2.4 ± 0.3% of the peak current (Figure 27A).  This relative amplitude 
is similar to that produced by the Nav1.7r-I1461T PEPD mutant and the Nav1.5-
F1486L LQT3 / SIDS mutant, but slightly smaller than that produced by the
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Figure 27.  Nav1.6 channels generate large resurgent currents.  
Representative resurgent currents recorded from a neuron expressing wild-type 
Nav1.6r (A) and Nav1.6r-I1477T (B) channels.  The current traces are magnified 
20x (A) and 5x (B) relative to the peak current.  (C) Comparison of the relative 
resurgent current amplitude, expressed as a percentage of peak transient 
current, for wild-type and mutant voltage-gated sodium channels.  * indicates 
significant difference (p < 0.05) between wild-type and mutant channels for a 
given isoform.  Color-coding is conserved throughout figures in this section. 
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Nav1.4r-R1448P PMC mutant (Figure 27C).  This indicates that the resurgent 
currents produced by the disease mutants are indeed likely to have important 
impact on cellular excitability. 
Remarkably, gain-of-function disease mutations, to date, have not been 
identified in Nav1.6 channels.  To determine the potential impact of mutations in 
Nav1.6 that impair inactivation, we asked if a mutation in Nav1.6 (I1477T) 
corresponding to the I1461T mutation in Nav1.7 could increase resurgent sodium 
currents generated by Nav1.6.  The Nav1.6r-I1477T mutation shifted the voltage-
dependence of inactivation in the depolarizing direction, slowed the rate of 
inactivation and significantly increased the persistent sodium current (Table 4).  
Resurgent currents were observed in 7 of 14 neurons expressing Nav1.6r-I1477T 
channels.  Notably, these currents were approximately 8-fold larger than those 
produced by either wild-type Nav1.6r or Nav1.7r-I1461T PEPD channels, with an 
average relative amplitude of 15.3 ± 3.4% (Figure 27C).  These data suggest that 
mutations impairing inactivation of Nav1.6 may be lethal due to the proclivity of 
Nav1.6 to generate resurgent currents.  Upon sequence alignment of the D3-D4 
residues of Nav1.6 and 1.7, I noticed a non-conserved residue, five amino acids 
upstream from the Nav1.7-I1461 location.  The residue at the 1456 position in 
Nav1.7 is a Leu, with an aliphatic side chain, and is a Phe, with a bulky side chain 
in Nav1.6.  It is intriguing to hypothesize that this non-conserved residue 
difference between Nav1.6 and 1.7 may contribute to the proclivity of Nav1.6 
channels to generate resurgent currents compared to Nav1.7.  Future studies, 
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performed by me, using point-chimeras will be performed to further investigate 
these differences. 
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Table 4.  Biophysical properties of wild-type and mutant Nav1.4, 5, 6 and 7 
sodium channels tested for resurgent currents. 
 
1V½ inactivation is the mid-point voltage of the steady-state inactivation curve as 
determined with a standard Boltzmann distribution fit.  2Tau-h: time constant for 
current decay during +10 mV step depolarization.  3Persistent current measured 
at 50 ms during step depolarization to +10 mV and reported as a percentage of 
peak current amplitude elicited by the step depolarization.  4Resurgent sodium 
current measured with protocol shown in Figure 24E and reported as a 
percentage of the peak current amplitude elicited by a step depolarization to -10 
mV.  The average resurgent current amplitude is only calculated from those cells 
where resurgent current was detected.  * indicates significant difference for 
mutant channels compared to respective wild-type channel (p < 0.05). 
 
Construct 
 
V½ inactivation
1 
(mV) 
 
Tau-h
2
 
(ms) 
 
Persistent 
current
3 
(%) 
 
Resurgent 
current
4
 (%) 
Nav1.7r -80.1 ± 1.6 
n = 25 
0.85 ± 0.06 
n = 23 
0.19 ± 0.16 
n = 13 
1.0 ± 0.5 
n = 5 (of 21) 
Nav1.7r-I1461T -61.8 ± 1.3 * 
n = 37 
1.07 ± 0.07 * 
n = 35 
1.04 ± 0.25 * 
n = 13 
2.0 ± 0.1 * 
n = 20 (of 30) 
Nav1.5 -88.1 ± 1.7 
n = 20 
0.9 ± 0.07 
n = 20 
0.2 ± 0.08  
n = 15 
0.6 ± 0.1  
n = 9 (of 18) 
Nav1.5-F1486L -80.1 ± 1.6 
n = 18 
1.31 ± 0.14 * 
n = 15 
0.64 ± 0.15 * 
n = 10 
2.0 ± 0.4 * 
n = 8 (of 17) 
Nav1.4r -77.3 ± 2.1 
n = 11 
0.34 ± 0.03  
n = 11 
0.17 ± 0.13 
n = 10 
None detected 
(out of 11) 
Nav1.4r-R1448P -91.1 ± 2.4 * 
n = 20 
3.92 ± 0.25 * 
n = 21 
0.95 ± 0.28 * 
n = 20 
4.2 ± 0.6 * 
n = 13 (of 20) 
Nav1.6r -71.3 ± 1.9 
n=17 
1.02 ± 0.1 
n = 17 
0.69 ± 0.16 
n = 11 
2.4 ± 0.3 
n = 8 (of 14) 
Nav1.6r-I1477T -58.6 ± 1.2 * 
n = 18 
1.25 ± 0.09 
n = 18 
7.4 ± 0.68 * 
n = 14 
15.3 ± 3.4 * 
n = 7 (of 14) 
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Together, results from this study provide the first evidence that inherited 
channelopathies resulting from mutations that slow VGSC inactivation can 
increase resurgent sodium currents.  We have also shown with simulated models 
how the increase in resurgent current along with inherited mutations that slow 
inactivation can impact AP properties.  Thus, an increase in resurgent currents, 
with mutations implicated in several inherited channelopathies, provides 
evidence for a novel mechanism by which AP firing may be affected. 
From a structural standpoint, it is intriguing to note that (1) these effects 
are not only observed with inherited mutations within the putative D3-D4 
inactivation gate motif (IFMT), but also with mutations in a voltage-sensing 
component (D4 / S4) critical for coupling activation to inactivation and (2) the 
effects can be observed in several VGSC isoforms upon transfection into a 
cellular background appropriate to produce resurgent currents.  This suggests 
that although Nav1.6 channels appear to be the predominant generator of 
resurgent currents, other VGSC isoforms have the ability to produce resurgent 
currents under certain conditions, indicating additional factors such as cellular 
background, post-translational mechanisms, tissue expression, presence of 
auxiliary subunits, or protein chemistry must also play an important role.  This 
could broadly be explained by assuming mutations that affect inactivation 
properties may be sufficient to shift the balance of resurgent current production 
into a window of resolution and potentially of physiological importance, but may 
not be the only component necessary.  However, as we have demonstrated, 
altered gating and channel stability is one mechanism that allows several VGSC 
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isoforms to generate resurgent sodium currents to flow during membrane 
repolarization.  Additionally, since VGSC isoforms have been suggested to derive 
their unique voltage-dependent gating characteristics and pharmacological 
sensitivities from residue differences in well-conserved regions of the channel, it 
is interesting to hypothesize the role non-conserved amino acid residues may 
play in tuning the threshold for susceptibility of the VGSC isoforms to production 
of resurgent currents. 
However, in light of the structural perturbations caused by these single-
point mutations implicated in the channelopathies outlined above, the 
intramolecular interactions required to stabilize an inactivated state are still 
unclear.  We have shown that Nav1.7 channel stability during transition to an 
inactivated state is crucial for proper voltage-dependent gating (Dib-Hajj et al., 
2008; Jarecki et al., 2008) and orchestration of AP firing (Dib-Hajj et al., 2008).  
The importance of this transition is confirmed by the numerous therapeutic 
agents targeted to stabilize inactivation or an “inactivated-like state” (Butterworth 
and Strichartz, 1990; Fozzard et al., 2005).  Additionally, unpublished work from 
our laboratory has shown that perturbations that alter transition to an inactivated 
state can affect the binding affinity of therapeutic agents targeted to stabilize 
inactivation.  We have also described a novel mechanism by which inherited 
mutations that alter inactivation gating can increase resurgent currents (Jarecki 
et al., 2010) hypothesized to be via an increased probability of an open-blocking 
particle to bind within the putative “docking” sites for the inactivation gate (Raman 
and Bean, 2001; Grieco and Raman, 2004; Grieco et al., 2005).  Thus, a central 
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question to understanding the dysfunction in gating and the consequences this 
has on the physiological system is: where does the inactivation gate “dock” and 
how do specific interactions stabilize the channel during depolarization such that 
Na+ flux is occluded after the activation gates open? 
E. Residues located in the D3 / S4-S5 linkers of Nav1.7 directly stabilize a 
fast-inactivated configuration 
1. Abbreviated introduction for probing intramolecular interactions in 
ion channels 
I next investigated the intramolecular interactions involved in inactivation 
using site-directed mutagenesis, whole-cell electrophysiology, and protein 
chemistry.  In addition to scanning and site-directed mutagenesis, ion channel 
topology and the regions critical for gating and ion flux have been explored using 
a wide variety of chemical tools and manipulations.  Ion channel biologists have 
innovatively used tools such as synthesized ligands, tethered blockers, unnatural 
amino acid incorporation (Morin and Kobertz, 2008; Ahern and Kobertz, 2009), 
residue crosslinking and modification (Karlin and Akabas, 1998; Horn et al., 
2000) as well as several fluorometric approaches (Blunck et al., 2005; Gorostiza 
and Isacoff, 2008) to probe the architecture of voltage-sensitive ion channels, 
thus expanding on previous hypotheses and shedding new light on the dynamic 
nature of ion channel gating hypothesized by Hodgkin and Huxley in their series 
of seminal electrophysiology experiments (1952).  One such approach, defined 
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as the substituted cysteine accessibility method, or SCAM (Karlin and Akabas, 
1998), has been coupled with voltage-clamp electrophysiology and extensively 
used to elucidate information about the intramolecular confines of channel 
proteins such as the ligand-gated nicotinic acetylcholine receptor α-subunit 
(nAchR), gamma aminobutyric acid (type A) receptors (GABAAR), as well as 
voltage-gated channels such as potassium (Kv) and sodium (Nav) channels (Hille, 
2001).  Briefly, SCAM allows for the chemical modification of substituted cysteine 
(Cys) residues in the presence of a variety of modifying reagents.  These 
modifying reagents have the ability to add charged, hydrophobic, or 
photoreactive moieties to the sulfhydryl group on available Cys residues, used as 
a labeling reporter, via a nucleophilic attack reaction which occurs within 
seconds.  An additional set of compounds have been designed and synthesized 
to covalently crosslink available Cys residues within a calculated distance based 
on the alkyl chain spacer in between the bi-functional reactive groups.  The 
advantage to using this type of method to probe ion channel structure allows the 
Cys modifying reagents to provide a measurable change in the function of the 
channel which can then be monitored using electrophysiological techniques to 
dissect information concerning the timecourse, state-dependence and 
membrane-sidedness of the accessibility of the introduced Cys (Akabas et al., 
1992). 
Because the coupling of SCAM with electrophysiology has yielded 
significant insight into state-dependent structural interactions, this inspired me to 
probe the D3 / S4-S5 of Nav1.7 for interactions with the putative inactivation gate 
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at a range of potentials that allow the channels to transit between closed, 
opened, and inactivated states.  Residues (D3 / S4-S5, V1298, V1299, V1300; 
D3-D4, I1461) for modification were determined based on the location of 
mutations described in the first section of the Results within this dissertation 
(Jarecki et al., 2008) which differentially affected inactivation properties.  The first 
hypothesis for this study was that single Cys residues substituted at the 1298 
and 1299 position, but not the 1300 position, within the D3 / S4-S5 and 1461 
position within the D3-D4 inactivation gate would disrupt the stability of 
inactivation and increase the persistent inward “leak” of Na+ at depolarized 
potentials (Figure 28).  These studies would take advantage of chemical 
modifying reagents that add a positively charged group to available Cys residues 
within the intracellular portion of the channel.  Therefore, if inactivation is 
destabilized upon modification one explanation could be disruption of a putative 
“docking” site for the inactivation gate.  Thus, the second hypothesis of this study 
was that the V1298 and V1299 residues within the D3 / S4-S5 linker, mutated in 
PEPD, can directly interact with the inactivation gate (probed using an 
engineered Cys at the 1461 position within D3-D4) at potentials more negative 
than those required to fully activate and open the Nav1.7 channel using dual Cys 
substitutions.  These studies would utilize the crosslinking reagents that 
covalently modify, and essentially “lock” two nearby substituted Cys residues 
within a calculated distance (Figure 29).  Together, results from these studies 
should yield insight into the probability of residues within the D3 / S4-S5 linker of 
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Nav1.7 serving as a putative “docking” site during transition to an inactivated 
state. 
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Figure 28.  Chemical modification and electrophysiological readout with an 
accessible engineered cysteine mutation upon internal MTSET application.  
(A) Cartoon of an engineered cysteine (Cys) residue depicting the sulfhydryl 
modifying reaction in the absence (left) and presence (right) of MTSET and the 
added charged moiety donated by MTSET.  The modification is emphasized with 
blue highlight.  (B) Anticipated electrophysiological readout of current properties 
in response to a depolarizing step to -10 mV from -120 mV.  To the left is a 
current trace recording with a step described above following transitions from 
closed (C), opened (O) and inactivated (I) in the absence of MTSET.  To the right 
is the same trace from the left with an additional, hypothetical current trace in the 
presence of MTSET emphasized in blue highlight with altered stability of an 
inactivated state. 
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Figure 29.  Illustrations of cysteine amino acid modification in the presence 
and absence of the covalently crosslinking reagent MTS-1-MTS and the 
predicted effects on the currents assayed using whole-cell voltage-clamp 
electrophysiology.  (A) Cartoon of an unmodified cysteine (Cys) residue in the 
absence (left) and presence (right) of MTS-1-MTS and the ensuing covalent 
modification of nearby sulfhydryl groups within a specified distance.  The donated 
moiety is highlighted in green.  (B) Electrophysiological output in the absence 
and presence of the covalent crosslinker (MTS-1-MTS) using a similar protocol 
described in Figure 28.  The hypothetical modification of the current trace upon 
crosslinking is highlighted in green coloring. 
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2. Cysteine substitution within D3 / S4-S5 and D3-D4 inactivation gate 
produces functional channels without dramatically altering gating 
properties 
Native residues within the D3 / S4-S5 (V1298, V1299, V1300) and D3-D4 
(I1461) linkers of Nav1.7 were each individually substituted to a cysteine (Cys) 
which has a reactive sulfhydryl group in the side chain.  This yielded a single Cys 
replacement in four separate constructs (V1298C, V1299C, V1300C, and 
I1461C).  An additional Cys substitution, adding a Cys at the 1461 position into 
each of the D3 / S4-S5 single Cys constructs yielded dual Cys constructs 
(V1298C_I1461C, V1299C_I1461C, and V1300C_I1461C).  The dual Cys 
constructs were critical for testing direct interactions using the covalent MTS 
crosslinking reagent.  The Cys substitution, for all constructs, replaces an alkyl 
side chain with a sulfhydryl group and would not be predicted to increase the 
rigidity or steric hindrance of the secondary structure as in the case of 
replacements with tryptophan (Trp), tyrosine (Tyr), phenylalanine (Phe), or 
proline (Pro) (Voet and Voet, 1990).  The functionality of the constructs was 
tested using whole-cell voltage-clamp electrophysiology.  Robust rapidly 
activating and inactivating sodium currents were observed in hEK293 cells 
transiently transfected with wild-type (WT) and Cys mutant Nav1.7 channels 
(Figure 30). 
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Figure 30.  Comparison of whole-cell ionic current traces for wild-type (WT) 
and single / dual cysteine (Cys) modified Nav1.7 channels.  Currents were 
elicited during incrementally depolarizing steps of +5 mV, from -80 mV to +60 
mV, from a holding potential of -120 mV.  Construct nomenclature is denoted 
above the family of current traces for each group.  Color-coding is conserved 
throughout this section of the dissertation. 
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Initial comparison of the current traces did not suggest any major 
differences in channel kinetics and generation of functional constructs indicated 
the Cys substitutions were well-tolerated and did not disrupt the ability of Nav1.7 
channels to open and inactivate in response to depolarizing steps (Figure 30).  
Since all of the Cys substitutions within Nav1.7 are novel and therefore have not 
been characterized, the next step was to characterize the voltage-dependent 
gating properties in order to better develop protocol to probe interactions with the 
MTS reagents.  Voltage-dependence of activation and inactivation was 
investigated to determine the effects of the single Cys substitutions on transitions 
between conducting and non-conducting states.  A majority of the Cys 
substitutions did not significantly alter activation (Table 5) and deactivation 
properties compared to WT, suggesting the Cys substitution did not affect S4 
gating charge movement or pore stability during opening (Figure 31A-C).  
However, the V1300C mutation significantly shifted the activation threshold 
(Figure 31A) and V1/2 by approximately +6 mV (Figure 31C, Table 5) and 
appeared to accelerate deactivation kinetics (Figure 31B) compared to WT.  
Upon comparison of the inactivation properties, neither the V1298C nor V1299C 
significantly altered the steady-state inactivation V1/2, whereas the V1/2 for both 
the V1300C and I1461C was depolarized by +6 and +13 mV, respectively (Figure 
31C, Table 5).  It is worth noting that these shifts in steady-state gating properties 
may be via different mechanisms.  For example, as has been shown by work in 
this dissertation and other labs, the primary effect of mutations within the D3-D4 
inactivation gate is on the stability of inactivation.  This effect is observed with the 
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Figure 31.  Effects of single Cys substitutions within D3 / S4-S5 and D3-D4 
linkers on voltage-dependent gating properties of Nav1.7.  (A) Normalized 
current-voltage (I/V) properties for each construct.  (B) Voltage-dependent time 
constants for deactivation (τd) surveyed at several potentials along the x-axis and 
fit with a single-exponential.  (C) Normalized voltage-dependence of steady-state 
activation and inactivation fit with a single-phase Boltzmann function.  (D) Time 
constants for development of open-state fast inactivation (OSI) as a function of 
voltage for WT and mutant channels.  The decay phases of currents elicited 
during channel activation protocol were fitted with a Hodgkin-Huxley type m3h 
model to estimate open-state inactivation time constants (τh).  (E) Time constants 
for development of closed-state inactivation (CSI) assayed at -50, -60, and -70 
mV.  Time constants for each construct at the potentials mentioned were 
obtained for single current traces elicited during a CSI development protocol and 
then averaged for graph plotting.  Protocol for each graph is described within the 
Methods section. 
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I1461C substitution.  However, the depolarizing shifts in activation and 
inactivation, observed with the V1300C substitution, may be due to a decreased 
sensitivity to changes in voltage and D3 / S4 gating charge movement, thus 
shifting both the activation and inactivation properties in a depolarizing direction 
by approximately the same displacement voltage (+6 mV).  It is also worthwhile 
to note that when the I1461C mutation was engineered in the background of the 
other constructs, yielding dual Cys constructs, activation properties were not 
significantly (Table 5) affected, however there was a trend towards shifting the 
inactivation V1/2 to more depolarized potentials which reached statistical 
significance with the V1300C_I1461C construct. 
Comparison of development of OSI (Figure 31D) did not indicate any 
significant differences between the constructs at potentials positive to -20 mV 
when the open probability is approaching maximum based on the G/V plot 
(Figure 31A).  Additionally, examination of development of CSI (Figure 31E) did 
not suggest statistical difference between the single Cys constructs, compared to 
WT, at -60 and -50 mV which are potentials where VGSC D3 gating charge 
displacement can occur prior to channel opening (Chanda and Bezanilla, 2002) 
and the channels can transit to a closed-inactivated state (Vandenberg and 
Bezanilla, 1991; Armstrong, 2006).  However, the V1300C substitution appeared 
to moderately slow development of CSI at the range of potentials listed which 
would be expected based on the depolarizing shift in the steady-state activation 
and inactivation responses.  Further investigation of the recovery time constants 
from CSI, determined with a -60 mV conditioning pulse, and OSI, determined 
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with a conditioning pulse to 0 mV, did not yield significant changes to the 
recovery time constants from CSI or OSI for any of the modified constructs 
compared to WT (Table 6).  However, again, a tendency for accelerated recovery 
was observed for the dual Cys constructs.  Taken together, although there 
appeared to be small shifts in the steady-state activation and inactivation 
properties for some of the constructs, the general trend of gating within potentials 
used to assay for transitions to and from open and inactivated states is within a 
predictable voltage range. 
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Table 5.  Boltzmann parameters of channel activation and steady-state 
inactivation curves for WT and Cys mutant channel constructs. 
 
Values derived for V1/2, the voltage of half-maximal activation and inactivation, 
and the slopes were derived from Boltzmann distribution fits to the averaged and 
normalized (± S.E.M.) voltage-dependence of activation and steady-state 
inactivation curves. 
  
Voltage-dependence  
of activation  
 
Voltage-dependence  
of steady-state fast-
inactivation 
       
Channel V1/2 
(mV) 
Slope 
(mV/e-
fold) 
n V1/2 
(mV) 
Slope 
(mV/e-
fold) 
n 
WT -29.0 ± 
1.1 
5.6 ± 0.3 6 -80.5 ± 
1.7 
6.0 ± 0.2 6 
V1298C -27.4 ± 
2.2 
6.0 ± 0.5 5 -79.4 ± 
1.5 
6.4 ± 0.4 5 
V1298C_I1461C -32.5 ± 
3.3 
6.0 ± 0.3 4 -79.0 ± 
2.8 
6.3 ± 0.2 5 
V1299C -29.0 ± 
1.7 
5.5 ± 0.2 4 -78.7 ± 
3.1 
5.3 ± 0.2 4 
V1299C_I1461C -28.1 ± 
2.0 
5.9 ± 0.5 7 -75.0 ± 
1.8 
6.4 ± 0.2 7 
V1300C -22.9 ± 
1.5 
5.6 ± 0.2 4 -74.0 ± 
1.0 
5.7 ± 0.1 5 
V1300C_I1461C -28.7 ± 
1.9 
5.6 ± 0.3 5 -67.5 ± 
1.0 
5.7 ± 0.2 5 
I1461C -25.6 ± 
1.2 
6.0 ± 0.2 5 -67.1 ± 
1.0 
5.5 ± 0.2 5 
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Table 6.  Recovery inactivation time constant values for WT and Cys 
mutant channel constructs. 
 
 
Channel 
Recovery time 
constant (τ) 
(ms) 
 
n 
Closed-state inactivation (CSI)   
WT 13.4 ± 3.1 5 
V1298C 8.6 ± 0.9 4 
V1298C_I1461C 7.6 ± 0.7 4 
V1299C 16.4 ± 5.8 4 
V1299C_I1461C 12.8 ± 1.8 7 
V1300C 10.2 ± 0.9 5 
V1300C_I1461C 6.3 ± 0.2 5 
I1461C 6.5 ± 0.5 5 
Open-state inactivation (OSI)   
WT 13.3 ± 4.4 4 
V1298C 7.8 ± 0.8 4 
V1298C_I1461C 7.1 ± 1.1 4 
V1299C 16.3 ± 5.6 4 
V1299C_I1461C 8.6 ± 1.0 6 
V1300C 10.6 ± 0.9 5 
V1300C_I1461C 5.8 ± 0.2 5 
I1461C 5.5 ± 0.5 5 
 
Time constant values for recovery from closed (CSI) and open-state (OSI) 
inactivation.  Recovery from CSI was determined by conditioning the cells to -60 
mV and obtaining time constant values for recovery to -120 mV.  Recovery from 
OSI was determined by conditioning the cells to 0 mV and obtaining time 
constants for recovery to -120 mV.  Detailed protocol can be found in the 
Methods section.  Data for recovery from OSI and CSI was fitted using a single-
exponential function and time constant values were calculated and averaged 
from individual cell recordings. 
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3. Residues (C1298 and C1299) within the Nav1.7 D3 / S4-S5 linker 
are accessible to MTSET modification and are critical sites for 
transition to an inactivated state 
Previous work described within this dissertation has demonstrated that 
specific residues within the D3 / S4-S5 of Nav1.7 are critical for the stability of 
inactivation utilizing site-directed mutagenesis.  The previous studies were 
motivated by an inherited Nav1.7 channelopathy, implicated in PEPD, caused by 
single-point missense mutations within cytosolic regions important for inactivation 
gating.  Our results showed that mutation of two highly-conserved Val residues 
(V1298 and V1299) to the bulky side-chain Phe residue (V1298F and V1299F) 
destabilized transition to an inactivated state, whereas mutation of an adjacent 
and identical residue (V1300F), not implicated in PEPD, did not (Jarecki et al., 
2008).  Based on those results, two alternative hypotheses were formulated for 
the mechanism of the apparent destabilized inactivation.  First, I hypothesized 
that the V1298F and V1299F PEPD mutations altered direct “docking” sites for 
the inactivation gate upon depolarization.  Second, I postulated that the 
mutations may be indirectly affecting the inactivation gate binding within the pore 
by disrupting critical interactions with residues in the C-terminal portions of the 
D3 / S6 segment.  To determine if direct interactions with the inactivation gate 
were disrupted, these Val (V1298 and V1299) residues, along with the adjacent 
V1300 residue, were mutated to Cys residues, which have the ability to be 
chemically modified, and were exposed to the membrane-impermeable Cys 
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modifying reagent MTSET (via the pipette) at various potentials.  Since the Cys 
substitutions did not result in an increased persistent component or dramatically 
alter the transition to an inactivated state, it was assumed that the substitutions 
were mild and well-tolerated and thus did not dramatically alter potential 
intramolecular interactions.  However, I hypothesized that upon application of 
MTSET accessible Cys residues will be modified and if they are critical for 
stabilizing inactivation will result in an increased persistent current component at 
potentials that should yield complete inactivation (Figure 28).  The changes in 
current properties should resemble those observed for a Cys mutation within the 
D3-D4 inactivation gate in the presence of MTSET, as the native residue is on 
the accessible face (Rohl et al., 1999) of the inactivation gate motif (West et al., 
1992), critical for inactivation.  Three specific holding potentials were chosen 
based on the characterization data for the Cys mutant constructs compared to 
WT and a protocol was developed to minimize occupancy in additional transition 
states (Figure 32).  A holding potential of -120 mV allows a large fraction of 
channels to reside in a closed (primed) state and transition from this initial state 
to open and inactivated states upon depolarization.  An intermediate holding 
potential of -60 mV, theoretically allows a fraction of channels to populate a 
closed-inactivated state, where the S4 voltage sensors are predicted to start to 
translocate charge (Chanda et al., 2004; Armstrong, 2006).  A depolarized 
holding potential of -20 mV allows for a fraction of the channels to populate open 
and open-inactivated states.  Using these holding potentials, I can probe for 
intramolecular interactions that occur to stabilize different states of the channel 
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upon depolarization.  I hypothesized that at hyperpolarized potentials, when a 
large population of channels are in a closed state and the inactivation gate 
accessible, MTSET would modify the V1299C, and the I1461C, but not the 
V1300C channels.  However, upon depolarization, when the inactivation gate 
starts to interact with “docking” sites to occlude sodium flux, the V1299C, and 
I1461C channels would no longer undergo modification.  Because the effects 
observed in the characterization studies, as well as those for the PEPD mutant 
studies listed in a previous section, for the V1298 and V1299 mutant channels 
are similar, only the V1299C channel was used for further comparison with the 
MTS reagents. 
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Figure 32.  Voltage-dependent transitions for WT and Cys mutants can be 
assayed using specific electrophysiological test protocols.  (A) Simplified 
state-occupancy diagram outlining transitions of interest between closed (C), 
opened (O), and inactivated (I) states.  (B) Hypothetical transition scheme tested 
using a step protocol pulsing every 10 sec to test for available sodium current.  
Color scheme used throughout the figure to outline state transitions is conserved 
in the voltage-step protocol. 
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This hypothesis was tested using transiently transfected cells in the 
presence and absence of intracellular MTSET application.  Recordings were 
started within one minute after establishing whole-cell configuration because the 
reaction occurs rapidly upon exposure to modifying reagents (Kellenberger et al., 
1996; Karlin and Akabas, 1998) and electrode solution equilibration with the 
cytosol.  Since residue accessibility is the rate-limiting step in modification, the 
electrophysiological readout of changes in current properties should be observed 
within minutes after application if substituted Cys residues are accessible.  As 
shown in Figure 33A, in the absence of MTSET, hereafter referred to as controls, 
none of the WT or Cys mutant channels were modified by the holding potentials 
(-120, -60, and -20 mV) used.  These results indicate that the Cys mutations did 
not affect the properties of rapid activation or inactivation during the test 
protocols.  However, upon intracellular application of MTSET, accessible 
residues were modified at -120 mV leading to a reduction in the population of 
channels stabilized in an inactivated state, thus increasing the persistent inward 
sodium current during the decay phase of the current trace for the V1299C, and 
I1461C channels.  The rapid onset of the inward component, reflecting activating 
and ion-conducting transitions was not altered.  This change in current properties 
was not observed for WT channels.  This effect was not surprising because upon 
alignment of the predicted intracellular regions of Nav1.7 there are no native Cys 
residues, and therefore one would not expect WT Nav1.7 channels to be modified 
with MTSET.  The highly reactive sidechain of Cys residues, which readily forms 
covalent disulfide bonds important for several biological functions, are primarily 
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found on the extracellular portions of VGSCs since most intracellular 
compartments have a reducing environment which significantly reduces the 
stability of disulfide bonds (Voet and Voet, 1990).  Additionally, even though the 
V1300C was accessible and modifiable at -120 mV, the effect on the decay 
phase of the current was not nearly as large for the other single Cys modified 
channels.  This suggests the V1300 residue, although accessible, may not be 
important for stability of an inactivated configuration.  Still, it is hard to completely 
rule out the possibility that the V1300 residue may be located on an inner turn, 
facing the intracellular portion of the lipid membrane, of the predicted α-helical 
secondary structure of D3 / S4-S5 linker which houses approximately 3.6 
residues / turn (Filatov et al., 1998), and may not be as accessible as the 
neighboring Val residues.  Computer-based homology modeling studies that I 
carried out suggests this could be the case.  However, the current snapshots 
compared at 10 min after MTSET application allows for a majority of the 
modification to take place at the concentrations used in this study (Kellenberger 
et al., 1996; Karlin and Akabas, 1998), and therefore may argue against the 
complete lack of accessibility for V1300C. 
Intriguingly, the single Cys mutant channels did not appear to be modified 
at more depolarized holding potentials compared to WT (Figure 33, middle and 
right panels).  Based on my hypothesis, this effect may be due to structural 
rearrangements along a gradient of depolarization that alter intramolecular 
interactions during transition to and from CSI and OSI, such that putative D3 / 
S4-S5 “docking” sites may no longer be available for modification.  As stated 
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above, this could be caused by direct interaction with the inactivation gate motif.  
However, the inactivation gate motif has also been hypothesized to “dock” to 
sites within the intracellular mouth of the aqueous channel pore (Armstrong and 
Bezanilla, 1977), formed by the S6 segments of voltage-sensitive channels 
(Doyle et al., 1998).  If this is indeed the case, I should be able to test for direct 
stabilizing interactions of the D3 / S4-S5 and the inactivation gate motif at a 
range of potentials before and after the channel activation gates open and the 
channel adopts an open / ion-conducting configuration.  Therefore, I should be 
able to determine if it is possible for the inactivation gate motif to interact directly 
with residues outside of the pore at potentials more negative than those required 
to open the channel.  These types of interactions during depolarization may 
begin to shed light into distinct roles of the inactivation gate “docking” sites during 
intersegment gating current immobilization between D3 and D4 (Cha et al., 1999; 
Sheets and Hanck, 2005). 
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Figure 33.  WT and single Cys mutant Nav1.7 accessibility to MTS 
modification at varied holding potentials.  Normalized snapshots at 10 min of 
representative current traces in the absence (A) and presence (B) of 500 µM 
MTSET performed for all constructs (WT, V1299C, V1300C, and I1461C) at 
holding pulses of -120, -60, and -20 mV to test for available sodium current using 
the protocol outlined in Figure 32.  Preparation of MTSET is described in detail 
within the Methods section of this dissertation.  Color-coding is conserved 
throughout this experimental section of the dissertation. 
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4. Proximity for direct interactions between the inactivation gate motif 
and residues within D3 / S4-S5 can be detected at potentials more 
negative than those required for Nav1.7 channel opening 
In order to probe the proximity for direct intramolecular interactions over a 
range of holding potentials (Figure 32) at which the mobile inactivation gate may 
“dock” to intracellular regions of the Nav1.7 channel upon depolarization, mutant 
channels, with two Cys residues engineered into potential interacting sites within 
the cytosolic D3 / S4-S5 linker and the D3-D4 inactivation gate motif were 
utilized.  Because these dual Cys channels are functional and conduct sodium 
currents in response to depolarization, it is unlikely that the engineered Cys 
within the intracellular linkers spontaneously form covalent disulfide bonds with 
one another or with any other amino acid side chain within the reducing 
environment of the cytosol.  First, the reactivity of the dual Cys channels was 
tested with MTSET modification to current properties.  Because MTSET attaches 
a charged moiety to accessible Cys residues, as shown above, I hypothesized 
that the addition of the I1461C mutation to the background of the other D3 / S4-
S5 single Cys constructs would affect the inactivation decay component of the 
current traces.  This was hypothesized because the C1461 substitution enabled 
Nav1.7 channels to be modified by MTSET resulting in a destabilized transition to 
an inactivated state.  Indeed, upon inspection of the control (Figure 34A) and 
MTSET treated (Figure 34B) groups the C1461 substitution enhanced response 
in the dual Cys channel V300C_I1461C to MTSET at all holding potentials 
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tested.  This indicates that the I1461C mutation engineered into this construct is 
dominant residue site contributing to current modification (compare Figures 33B 
and 34B).  Comparison of the dual Cys current traces at -60 and -20 mV holding 
potentials did not suggest any additional modification in the presence of MTSET 
compared to the single Cys traces (compare Figures 33B and 34B).  These 
results demonstrate that upon depolarization, to either -60 or -20 mV, the 
intramolecular rearrangement of the cytosolic regions of the channel are packed 
in a new configuration where the (D3 / S4-S5) C1299 and (D3-D4) inactivation 
gate CI1461 residues are not accessible to MTSET modification upon 
intracellular exposure.  One hypothesis is that the two residues may occlude 
MTSET modification via direct and stabilizing interactions with one another.  
Since these regions of the channel have been proposed to be dynamic and 
flexible a direct interaction between the two residues was tested using a bi-
functional crosslinking reagent that forms a covalent bond between two nearby 
Cys residues within a calculated distance, thus acting like a molecular caliper to 
approximate distances upon depolarization. 
 180 
 
Figure 34.  Representative current trace comparisons for dual Cys and WT 
channels in the presence and absence of MTS modification at three 
different holding potentials.  Transfected cells expressing WT or dual Cys 
channels were tested under control conditions (A) at three different potentials (-
120, -60, and -20 mV) or in the presence of intracellular application of 500 µM 
MTSET (B) at the same holding potentials for controls.  All current traces were 
normalized and shown at 10 min after whole-cell configuration was established. 
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Several crosslinking reagents have found application in mapping the 
interactions of mobile regions in ion channels during electrophysiological 
experimentation (Horn et al., 2000; Popa et al., 2004; Prole and Yellen, 2006; 
Bell et al., 2008; DeCaen et al., 2008).  For studies in this dissertation, a bi-
functional MTS crosslinking reagent (MTS-1-MTS) was used to probe for 
potential “docking” interactions between the D3 / S4-S5 linker and the D3-D4 
inactivation gate motif.  The MTS-1-MTS reagent should crosslink nearby Cys 
residues within a ~5 Å distance based on the spacer size in between the 
functional groups (Green et al., 2001; Loo and Clarke, 2001).  Upon crosslinking 
of nearby Cys residues, based on the state-dependent accessibility of the 
engineered Cys residues I predict that the channels would be “locked” in a 
particular voltage-dependent conformation (Figure 29).  However, because the 
Cys residues were modifiable with the MTSET reagent at a holding potential of -
120 mV, I would not anticipate covalent crosslinking to occur at this potential.  I 
would hypothesize that the inactivation gate has not been triggered to move 
towards a “docking” site at this hyperpolarized potential when gating charges 
have not been displaced, however upon depolarization and channel 
rearrangement, during S4 voltage-sensing, the coupled movement of activation 
to inactivation would favor transition to an inactivated configuration stabilized by 
theoretical “docking” or interacting sites. 
These theoretical interactions were probed at different holding potentials, 
as before, in the presence of intracellular MTS-1-MTS application.  Examination 
of WT channels with MTS-1-MTS at all potentials tested did not reveal any 
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changes in current amplitude over the timecourse (~20 min) of recording (Figure 
35A).  These results indicate that the MTS-1-MTS reagent is not covalently 
modifying any native residues within WT channels at the range of potentials 
tested.  Additionally, these results suggest the MTS-1-MTS reagent is not 
significantly altering the ability of WT channels to respond to changes in voltage 
and to open and close during the duration of the experiment.  However, the D3 / 
S4-S5 and D3-D4 dual Cys mutant construct (V1299C_I1461C) yielded 
quantitative insight into a potential interaction between the inactivation gate and a 
proposed “docking” site outside of the mouth of the aqueous pore.  As 
hypothesized, at a holding potential of -120 mV when a large population of the 
channels are in a closed state, the ability to covalently crosslink the two Cys 
residues was unlikely as depicted in Figure 35B (black squares).  Conversely, 
upon holding the membrane potential at -60 mV (Figure 35B; red squares), when 
the probability of channels transitioning to a closed-inactivated state is increased 
(Figure 32), apparent crosslinking was observed between the two Cys residues 
engineered at the 1299 and 1461 positions.  These results indicate that the two 
Cys residues at these locations can come into contact with one another within a 
distance of ~5 Å or less allowing the MTS-1-MTS to covalently crosslink the two 
Cys residues.  This interaction supports the hypothesis that the mobile 
inactivation gate can “dock” to sites outside of the channel pore at potentials 
more negative than those required to open the activation gate and transition the 
channel to an ion-conducting configuration.  The MTS-1-MTS crosslinker likely 
decreases current amplitude because it locks the channels in the inactivated 
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state.  Thus, I next probed for interactions at a holding potential of -20 mV, which 
allows for a majority of the channels to open and inactivate from an open 
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Figure 35.  State-dependent channel conformation locking upon application 
of an MTS crosslinking reagent.  (A-C) WT and dual Cys mutant constructs 
(V1299C_I1461C and V1300C_I1461C) were exposed to intracellular application 
of 500 µM MTS-1-MTS at different holding potentials (-120, -60, and -20 mV) and 
currents were recorded soon after whole-cell configuration was established.  
Preparation of MTS-1-MTS is described in detail in the Methods section of this 
dissertation.  Currents were normalized to the peak current recorded over the 
approximately 20 min timecourse.  (D-F) Control recordings at a holding potential 
of -60 mV for channels upon intracellular application of vehicle control (DMSO) or 
in the absence of any reagent added to the electrode solution.  Timecourse for 
changes in whole-cell currents were determined in a similar manner as those for 
the MTS-1-MTS experimental studies above.  Initial increase in current before 
500 sec is due to the components of the electrode solution, notably CsF, which 
has been shown to increase sodium current amplitude over time.  Color-coding is 
conserved in all images within this particular figure. 
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configuration (OSI), based on the voltage-dependent properties displayed in 
Figure 31.  Interestingly, a decrease in the current at a holding potential of -20 
mV was not observed (Figure 35B; blue squares).  These results have three 
explanations.  First, the mobile inactivation gate may “dock” at a second site 
within the channel pore at this holding potential of -20 mV, compared to -60 mV, 
upon opening of the channel activation gates.  This interpretation is hard to 
validate with the current model and available Cys residues.  To confirm this type 
of interaction, an additional construct with a Cys residue located at the 
intracellular mouth of the pore would need to be tested along with the Cys 
substitution in the inactivation gate.  Second, it is also possible that the 
accessibility of the Cys substituted at the 1461 or 1299 position is hindered by 
the side chains of residues within the C-terminal portions of the S6 segments that 
are predicted to splay outward upon depolarization (Lu et al., 2002; Long et al., 
2005a; Soler-Llavina et al., 2006; Long et al., 2007; Labro et al., 2008; Muroi et 
al., 2010).  Third, an additional reason for the differences in crosslinking may be 
due to the movement of the S4 voltage-sensing segments at the two holding 
potentials.  Because the C1299 substitution is near the N-terminal portion of the 
D3 / S4-S5, the proximity (within ~5 Å) to the inactivation gate may be outside of 
the distance window for covalent modification with the MTS-1-MTS spacer upon 
strong depolarizations required for full channel activation and opening.  Evidence 
supporting this theory comes from gating charge and site-directed mutagenesis 
experiments investigating the contribution of charged residues within the voltage-
sensing (S4) segments to gating charge and channel activation and their 
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“outward” displacement from a buried to an exposed position at different 
potentials, thus increasing probability of channel opening (Hodgkin and Huxley, 
1952; Hirschberg et al., 1995; Bezanilla, 2000).  To further evaluate this 
possibility, an additional set of experiments using an MTS crosslinking reagent 
with a larger alkyl spacer to calibrate the distance could be tested.  Such 
exploratory experiments and hypotheses will be discussed in more detail in the 
Discussion section of this dissertation. 
When the V1300C_I1461C channels were probed for interaction at -120 
mV, there was no decrease in the current over the recording duration (Figure 
35C; black squares).  However, covalent crosslinking was observed using a -60 
mV holding potential (Figure 35C; red squares), but not at a -20 mV holding 
potential (Figure 35C; blue squares).  These results were interesting, in that, the 
Cys substitution at the 1300 position was not detectably modified in the presence 
of the MTSET reagent suggesting that the residue was either inaccessible or not 
critical for stabilizing an inactivated state.  But, upon closer inspection of the data 
the results are in line with interaction between the C1299 and C1461 substituted 
residues.  Since the limiting factor of the MTS-1-MTS reagent is the spacer, 
which determines the crosslinking distance, interaction with Cys residues within 
the ~5 Å or less distance, would be expected to crosslink.  Therefore, because 
the C1300 substitution is one position downstream of the C1299, predicted to be 
within the same turn of the α-helix a crosslinking reaction is not surprising.  Thus, 
the accessibility of the C1300 substitution would not be predicted to be the 
limiting factor for the results observed in Figures 33 and 34.  However, the 
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contribution of this residue to the overall stability of transition to an inactivated 
state appears to be minor, as shown in Figures 33 and 34 for the Cys substitution 
and Figure 9 for the Phe substitution.  To support these findings, previous 
experiments have also demonstrated unique roles for the amino acids based 
residue location and the respective side chain in terms of gating and pore 
stabilization (Lu et al., 2002; Long et al., 2005a; Soler-Llavina et al., 2006; Long 
et al., 2007; Labro et al., 2008; Muroi et al., 2010). 
Control experiments at a holding potential of -60 mV were also performed 
to test the changes in current in response to the diluents (DMSO vehicle control) 
for the MTS-1-MTS compound (Figure 35D) and in the absence of any added 
reagent, for the WT and V1299C_I1461C channels, to the electrode solution over 
the same timecourse (Figures 35E and F).  The experiments primarily focused on 
the -60 mV holding potential because intramolecular interactions in the presence 
of the MTS crosslinking reagent at this holding potential were predominant 
compared to -120 and -20 mV.  In all of the control experiments no reduction in 
current amplitude was observed suggesting that the changes in current with the 
MTS-1-MTS reagent were due to the ability to crosslink engineered Cys residues 
within a distance of ~5 Å or less. 
  
 188 
5. Proposed models for state-dependent D3 / S4-S5 and D3-D4 
interactions during transition to an inactivated state based on MTS 
experiments 
The accessibility and crosslinking studies described in this section begin 
to shed light on the role of the D3 / S4-S5 linker during inactivation.  
Electrophysiological studies examining the role of this linker in VGSC gating have 
suggested this cytosolic linker is important for inactivation (Smith and Goldin, 
1997; Popa et al., 2004; Jarecki et al., 2008), acting as a putative “docking” site 
for the inactivation gate motif, and pore stabilization / electromechanical coupling 
(Muroi et al., 2010) during transition to an ion-conducting state.  However, based 
on the predicted α-helical structure of this linker, different residues comprising the 
D3 / S4-S5 may be involved in distinct features of gating based on their 
accessibility during depolarization, side-chain properties, and location within the 
linker.  Studies described within this dissertation indicate that the two Val 
residues mutated in PEPD at the 1298 and 1299 positions in Nav1.7 are, in a 
similar manner to the Ile at the 1461 position within the putative inactivation gate 
motif, important for stabilizing transition to an inactivated state (Figure 5).  
Furthermore, residues, when substituted to a Cys at the same position, are 
accessible at holding potentials where a large population of channels reside in a 
closed state (-120 mV) but not at depolarized potentials (-60 and -20 mV) when 
the channels are starting to transition to an inactivated state (Figure 36).  
Additionally, the adjacent Cys substituted residue at the 1300 position, did not 
appear to destabilize inactivation when compared to WT and the other Cys 
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substituted channels (Figure 36).  Interestingly, upon examination of the ability 
for the Cys substituted channel to crosslink during depolarization, Cys substituted 
residues within the D3 / S4-S5 and the D3-D4 inactivation gate motif appeared to 
covalently link (Figure 37).  This covalent linking was not observed at 
hyperpolarized holding potentials (-120 mV) when a large population of the 
channels are closed, or at more depolarized holding potentials (-20 mV) when 
channels have opened and are inactivated from the open state.  Together, these 
results strongly suggest that specific residues (V1298 and V1299) within the D3 / 
S4-S5 linker can interact with the putative inactivation gate motif during 
depolarization required to inactivate Nav1.7 channels, within ~5 Å, and may 
represent a “hotspot” region within the linker that upon mutation can have 
significant effects on the stability of the channel configuration and gating. 
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Figure 36.  Summary of effects on Nav1.7 channel gating with MTSET 
modification.  Depicted above are cartoon images of the D3 and D4 S4-S6 
segments.  The S4 segments, highlighted in yellow, are laden with positive (+) 
charges that are predicted to translocate upon depolarization.  The S6 pore 
forming segments, highlighted in blue, are predicted to splay outward upon 
depolarization and S4 gating charge displacement.  The putative inactivation 
gate motif (IFMT) highlighted in a pink oval, within the D3-D4 linker, is a mobile 
entity that can interact with intracellular “docking” sites upon depolarization to 
occlude Na+ flux.  The D3 and D4 / S4-S5 are colored in orange and the location 
of Cys substitutions within the D3 / S4-S5 is denoted with a green asterisk (*).  
Summarizing results denoted in pictorial format indicate that at hyperpolarized 
holding potentials (-120 mV) only the Cys substitutions at the 1299 and 1461 
positions, in the presence of MTSET, altered the stability of transition to an 
inactivated state indicating that modification of these residues (ET+) resulted in 
destabilized inactivation.  This was observed as an increase in the persistent Na+ 
current during the decay phase of a current trace.  Depolarized holding potentials 
(-60 and -20 mV) did not dramatically affect the population of channels 
transitioning to an inactivated state. 
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Figure 37.  Cartoon summary of Nav1.7 D3 / S4-S5 crosslinking effects with 
the putative inactivation gate motif located in D3-D4.  Structural and color 
scheme is the same as described for Figure 36 above.  Cys substituted residues 
within the D3 / S4-S5 and putative inactivation gate motif were not covalently 
crosslinked at a holding potential of -120 mV, however upon depolarizing the 
holding potential to -60 mV, covalent crosslinking was observed for the Cys 
substituted constructs in the presence of MTS-1-MTS noted by a decrease in 
current amplitude over the recording timecourse.  There was no change in 
current amplitude observed at a holding potential of -20 mV. 
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IV. DISCUSSION 
A. Dissertation research overview 
This dissertation primarily focused on the structural and functional roles of 
the neuronal VGSC isoform Nav1.7 during transition to an inactivated state.  
Using whole-cell voltage-clamp electrophysiology I was able to examine the 
functional impact of structural alteration to regions critical for inactivation to 
determine (1) the significance that inherited point mutations, implicated in a 
painful disorder, have on stability of inactivation, (2) how alternative splicing can 
affect gating properties of painful mutant channels, (3) the modulating role 
resurgent sodium currents have in inherited channelopathies, and (4) the 
interactions that may be important in transition to an inactivated state within a 
theoretical “hotspot” region of Nav1.7.  To evaluate the significance single-point 
missense mutations have on gating, the effects of several Nav1.7-PEPD 
mutations on voltage-dependent properties were characterized.  Results 
demonstrated that two PEPD mutations within the D3 / S4-S5 linker significantly 
altered transition to an inactivated state in a similar manner to a mutation within 
the D3-D4 putative inactivation gate (Jarecki et al., 2008).  These effects were 
residue and location specific suggesting a spatial orientation within the D3 / S4-
S5 that may allow for interactions critical for stabilizing an inactivated state 
resulting in a normal AP response to a given stimulus.  Indeed, additional 
experiments indicated an importance for the S4-S5 PEPD mutations in AP firing 
properties, in that, PEPD mutations can render neurons hyperexcitable, thus 
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yielding an abnormal response to a given stimulus (Dib-Hajj et al., 2008).  
Because the location of pain, response to therapeutics, and age-onset is distinct 
for PEPD compared to an additional disorder (IEM), caused by Nav1.7 mutations, 
the effects of alternative Nav1.7 splicing on the impact of PEPD and IEM was 
investigated.  Results from these experiments indicated that the functional impact 
of PEPD was affected by alternative splicing, whereas IEM was not (Jarecki et 
al., 2009).  This effect was predicted to be caused by a unique charge 
substitution difference between the splice variants that would shift the activation 
window and additively increase the probability for PEPD mutant channels to 
reside in an open state.  We further examined the potential modulatory role of 
resurgent sodium currents in voltage-gated sodium channelopathies that result 
from slowing of inactivation, as this may be another factor for the distinct age-
onset and location of pain perceived in PEPD.  Our results demonstrate that 
inherited mutations in several channelopathies can increase resurgent sodium 
currents which are predicted to impact neuronal and muscle AP firing properties 
(Jarecki et al., 2010).  Finally, because the structural interactions required for 
stabilizing transition to an inactivated state appear to be highly regulated, as 
evidenced from all of the previous experiments described above, direct 
interactions during inactivation were surveyed.  Results from these studies, 
guided by the locations of PEPD mutations within Nav1.7, indicate that specific 
residues within the D3 / S4-S5 are critical for stability of transition to an 
inactivated state and may serve as a putative “docking” site for the inactivation 
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gate motif.  Below is the detailed discussion of these results and how they impact 
our knowledge of Nav1.7 electrophysiology. 
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B. Paroxysmal extreme pain disorder (PEPD) mutations within the D3 and D4 / 
S4-S5 linkers of Nav1.7 cause moderate destabilization of fast inactivation 
1. Functional consequences of PEPD mutations 
Two molecular neuropathic pain syndromes, inherited erythromelalgia 
(IEM) and paroxysmal extreme pain disorder (PEPD) are caused by mutations in 
SCN9A gene encoding for Nav1.7, and the consequences of these mutations are 
distinct.  Patients with PEPD have paroxysmal episodes of intense burning pain 
localized in (but not limited to) the rectal, ocular, and jaw areas accompanied by 
autonomic changes such as skin flushing near the perceived site of pain 
(Fertleman et al., 2007).  IEM is characterized by episodes of burning pain 
triggered by warmth or exercise, along with erythema and mild swelling in the 
extremities, ears, and face (Drenth and Michiels, 1992; Drenth et al., 2001; 
Drenth et al., 2005; Novella et al., 2007).  A majority of the SCN9A mutations 
implicated in IEM are found within transmembrane segments and cytoplasmic 
linkers of D1 and D2 in Nav1.7.  D1 and D2 IEM mutant channels, expressed in 
hEK293 cells, cause a lowering of VGSC activation threshold, slowing of 
deactivation, and increased ramp current amplitudes between -60 and -40 mV 
(Dib-Hajj et al., 2007).  DRG neurons transfected with Nav1.7 channels 
containing IEM mutations increase neuronal excitability (Dib-Hajj et al., 2005; 
Rush et al., 2006) and computer simulations indicate the hyperpolarizing shift in 
activation is a major determinant of this hyperexcitability (Sheets et al., 2007). 
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In the first part of this dissertation, it was investigated whether single-point 
missense mutations in Nav1.7 D3 / S4-S5, implicated in paroxysmal extreme pain 
disorder (PEPD), alter voltage-dependent gating properties similar to PEPD 
mutations within the D3-D4 putative inactivation gate motif (IFMT).  Although it 
was originally proposed that all PEPD mutations might selectively cause marked 
deficits in fast inactivation (Fertleman et al., 2006), only three of the eight known 
PEPD mutations, identified in 11 families, had been functionally characterized.  
Furthermore, the initial functional characterization, while intriguing, was not 
comprehensive.  For example, PEPD mutations that overlap with a putative 
“docking” site for the VGSC inactivation gate (Smith and Goldin, 1997; Popa et 
al., 2004) within the D3 / S4-S5 linker were not evaluated.  Therefore, we 
examined the consequences of three PEPD mutations; the I1461T mutation 
studied by Fertleman et al. (2006) and two uncharacterized mutations identified 
within the cytosolic S4-S5 linker of D3, C-terminal to D3 / S4.  The initial 
hypothesis of this study was that PEPD mutations located in the D3 / S4-S5 
linker would differentially affect transition to an inactivated state compared with 
those found in the inactivation gate motif. 
We investigated whether two of the D3 / S4-S5 PEPD mutations (Figure 3) 
had similar effects on voltage-dependent gating properties of Nav1.7 channels 
utilizing whole-cell voltage-clamp electrophysiological techniques.  Both D3 / S4-
S5 PEPD mutations (V1298F and V1299F) significantly shifted the V1/2 of steady-
state inactivation by ~20 mV in the depolarizing direction compared to WT 
(Figure 5).  This was nearly identical to the effect of the I1461T mutation on 
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steady-state fast inactivation we observed (Figure 5).  However, our data differs 
from that of Fertleman et al. (2006), which indicated the I1461T mutation 
impaired fast inactivation to a much greater extent than we observed.  In 
Fertleman et al., it was shown that ~40% of the I1461T current failed to inactivate 
during a “steady-state inactivation protocol”.  Conversely, we observed nearly 
complete steady-state inactivation with the PEPD mutants (Figure 5C).  One 
reason for the differences observed in “steady-state inactivation” is that the 
protocol used in Fertleman et al. employed 60 ms inactivating pre-pulses, which, 
as can be seen in Figure 4A, is inadequate to obtain steady-state conditions.  
Nav1.7 channels exhibit slow kinetics for the development of closed-state 
inactivation (Cummins et al., 1998) and therefore 500 ms conditioning pulses are 
needed to ensure steady-state conditions over the full-range of potentials tested.  
Our data is consistent with Fertleman et al., in that mutations implicated in PEPD 
disrupt the voltage-sensitivity of the fast-inactivated state, resulting in a 
decreased fraction of channels transitioning to a non-conducting state at 
potentials between -90 and -20 mV.  However, because our data shows that 
PEPD mutations do not substantially increase the non-inactivating component 
under true steady-state inactivating conditions (with both fluoride containing and 
non-fluoride containing electrode solutions), this indicates the impairment of fast 
inactivation by PEPD mutations can be more moderate than previously 
suggested. 
Our data also show that the D3 / S4-S5 PEPD mutations, as well as the 
I1461T mutation, increase the inactivation time constants (τh) compared to WT at 
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potentials positive to -10 mV.  This indicates rate transitions for inactivation of 
mutant channels become less voltage-dependent at potentials positive to -10 mV 
thus, providing further evidence the PEPD mutations destabilize the inactivated 
configuration.  Upon inspection of the mutant I/V traces at -10 mV, we observed 
a small persistent component (6% of peak) with the three PEPD mutant traces 
compared to WT (Figure 5E)  By contrast, Fertleman et al. reported that short 
depolarizing pulses elicited relatively large persistent components (~40% of 
peak) for I1461T currents.  A mutation that induces non-inactivating components 
that are 40% of the total current would be expected to have major consequences 
on the neuronal excitability of every cell exhibiting that mutation and would, 
therefore, be predicted to cause more widespread pain than is typically observed 
in many individuals with PEPD, as Nav1.7 channels are highly expressed 
throughout the PNS.  Our data, demonstrating the impairment of inactivation 
caused by the V1298F, V1299F, and I1461T PEPD mutations can be more 
moderate than previously indicated for the I1461T mutation, help explain why 
PEPD mutations do not cause pain throughout the body. 
We further evaluated the effects the PEPD mutations had on the stability 
of the inactivated state by testing channel development and recovery from open-
state inactivation (OSI) and closed-state inactivation (CSI).  All three PEPD 
mutations increased the recovery rates for CSI and OSI.  Surprisingly, the 
V1298F and V1299F mutations within the D3 / S4-S5 linker increased the rate of 
development of CSI, whereas the I1461T mutation within the putative inactivation 
gate did not.  Although the rate for development of CSI at -60 mV was increased, 
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the fraction of channels undergoing CSI at -60 mV was greatly reduced for the 
three PEPD mutant channels, compared to WT channels, which likely reflects 
disruption of strong binding of the inactivation gate by the PEPD mutations. 
Since it has been demonstrated that variability of CSI kinetics between 
different VGSC subtypes can influence Iramp amplitudes (Cummins et al., 1998) 
we examined currents elicited by a slow (0.27 mV/ms) depolarizing ramp 
stimulus.  We observed a significant increase in the Iramp for all three PEPD 
mutant channels at potentials positive to -20 mV when compared to WT, which is 
likely due to the decreased rate of OSI at these potentials.  While both IEM and 
PEPD mutations are likely to increase ramp current amplitudes, the voltage-
dependence of the ramp currents observed with the PEPD mutant channels are 
distinct from the ramp currents observed with several of the Nav1.7 IEM mutant 
channels, which exhibit increased ramp current amplitudes at negative potentials 
but not at potentials near -10 mV compared to WT channels (Cummins et al., 
2004).  Voltage ramp protocols are useful to assay subthreshold currents near 
RMP.  Thus, ramp current properties may yield insight into changes that may 
significantly influence excitability.  As such, the PEPD mutations may 
differentially alter action potential (AP) properties when compared to the IEM 
mutations because PEPD mutations primarily slow transition to an inactivated 
state.  The PEPD mutations are likely to contribute to broadening of the AP 
duration, enhanced repetitive or burst firing and decreased AP threshold, but 
probably do not depolarize the resting membrane potential (RMP) in the same 
manner as IEM mutations (Dib-Hajj et al., 2005; Rush et al., 2006).  We also 
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show that PEPD mutations can alter the voltage-dependence of slow inactivation 
of Nav1.7.  The impairment of slow inactivation that we observe at potentials 
between -90 and -60 mV with all three of the PEPD mutations examined in this 
study is also likely to increase Nav1.7 channel availability near resting potential 
and therefore contribute to enhanced excitability of sensory neurons.  In a 
parallel study, determining the effects of a novel mutation (M1627K) from a 
previously unreported family with PEPD, we showed that this mutation, located in 
the D4 / S4-S5 linker of Nav1.7 displays similar voltage-dependent gating 
characteristics to those we reported for the S4-S5 of D3.  Additionally, using 
current clamp, we show that M1627K PEPD mutant channels lower threshold for 
single APs and increase number of APs in response to graded stimuli in small 
DRG neurons, most of which are nociceptors.  The lowered AP threshold and 
increased repetitive firing are two hallmarks of nociceptor hyperexcitability and 
are likely to contribute to neuropathic pain in PEPD.  It is interesting to note that 
several of the PEPD mutations identified, to date, are primarily found in the D3 
and D4 / S4-S5 linkers and within the putative inactivation gate (Dib-Hajj et al., 
2007).  These regions have been hypothesized to be critical for stabilizing the 
transition to an inactivated state, however, direct evidence supporting this 
statement is lacking. 
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2. Structural role of the Nav1.7 D3 / S4-S5 cytosolic linker in channel 
gating 
Specific regions within each of the four domains (D1-D4) of VGSCs are 
thought to have distinct, but integrated roles in channel gating and 
conformational stability in response to changes in membrane potential (Noda et 
al., 1984; Stuhmer et al., 1989; West et al., 1992; Cha et al., 1999; Hille, 2001; 
Chanda and Bezanilla, 2002; Chanda et al., 2004).  Significant advances in 
understanding the structural interactions involved in voltage-sensitive channel 
gating have been demonstrated through the determination of the structure of 
potassium channels using X-ray crystallography (Doyle et al., 1998; Long et al., 
2005b, a; Long et al., 2007) and computer-based homology modeling using the 
potassium channel template (Lipkind and Fozzard, 2000).  The modeled crystal 
structure of the Kv1.2 channel shows the α-helical S4-S5 segments crossing over 
hydrophobic regions of the S6-segments.  It has been proposed that the distal 
portion of the S6-segments need to pivot or splay during the activating transition 
to the ion-conducting state and that the voltage-dependent outward displacement 
of the S4 segments is coupled to channel opening via hydrophobic interactions of 
the S4-S5 and S6-segments.  A crystal structure has not been obtained for 
mammalian VGSCs.  While homology modeling of VGSCs based on potassium 
channel structures provides some insight, study of disease-associated and 
laboratory-designed mutations has significantly enhanced our knowledge of the 
secondary structure and critical features involved in gating of VGSCs (Hille, 
2001).  Studies have indicated that residues within the D3 / S4-S5 linker can (1) 
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act as a part of the unique “docking” site for the VGSC putative inactivation gate 
via direct interactions and / or (2) indirectly stabilize the fast-inactivated 
configuration via cooperative interactions with specific residues located in the D4 
/ S4-S5 cytosolic linker as the inactivation gate (IFMT) docks at a site within the 
channel pore (Smith and Goldin, 1997; Popa et al., 2004).  Our data demonstrate 
that V1298 and V1299 are important to help stabilize the fast-inactivated states 
of Nav1.7.  Our data on the adjacent and identical mutation V1300F within D3 / 
S4-S5 of Nav1.7 indicate that orientation and / or position-specific interactions are 
also important.  In contrast to V1298F and V1299F, the V1300F mutation had 
very small effects on inactivation, shifting the V1/2 of steady-state inactivation by 4 
mV in the hyperpolarizing direction and decreased the percentage of peak 
current elicited during a slow ramp depolarization compared to WT channels.  
The V1300F mutation had a more pronounced effect on activation, shifting the 
V1/2 of channel conductance by ~10 mV in the depolarizing direction and 
decreasing the voltage-dependent time constants for deactivation.  The distinct 
effects of adjacent, identical mutations are consistent with the hypothesis that the 
D3 and D4 / S4-S5 linkers of VGSCs retain an alpha-helical secondary structure 
(Filatov et al., 1998).  These studies are important because they suggest that 
mutation within the D3 and D4 / S4-S5 linkers may, in an isoform-specific 
manner, predictably disrupt critical stabilizing interactions that decrease the 
overall affinity of gating reactions, which may offer insight on structural 
requirements for gating.  Thus, our studies confirm an important structural and 
functional role for D3 / S4-S5 of Nav1.7 during stabilization of the inactivated 
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states, such that mutation of residues critical during transition decreases the 
voltage-dependent probability of channels residing in this configuration and 
indicate the extreme precision with which the interactions critical for gating 
orchestrate opening and closing of these channels in response to changes in 
membrane potential. 
Overall, these experiments show that D3 / S4-S5 mutations identified in 
patients with the inherited molecular neuropathy PEPD result in destabilization of 
the fast and slow-inactivated states of Nav1.7, thus, contributing to depolarizing 
shifts in the steady-state inactivation profiles and enhancing ramp currents.  It is 
worthwhile to note that at least 11 additional D3 / S4-S5 VGSC mutations have 
been associated with inherited disorders of excitability, including epilepsy (Heron 
et al., 2002; Berkovic et al., 2004; Meisler and Kearney, 2005), ataxia (Kohrman 
et al., 1996), long QT syndrome type 3 (LQT3) (Wang et al., 1996; Smits et al., 
2005), Brugada syndrome (Casini et al., 2007), myotonia  (Yang et al., 1994; 
Richmond et al., 1997; Bouhours et al., 2005), and hypokalemic paralysis 
(Sugiura et al., 2003), indicating this region may be a “hotspot” for disruptive 
mutation.  These disorders are a result of single-point mutations occurring in a 
highly conserved region of various VGSC isoforms.  Interestingly, some of these 
disease-related mutations predominately alter the voltage-dependence of 
channel conductance.  Although many of these mutations slow the rate of 
inactivation, none substantially increase the percentage of non-inactivating 
current.  Here, our studies show that, contrary to prior reports, PEPD mutations 
do not necessarily cause marked loss of fast inactivation.  The moderate 
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decrease in the stability of the fast-inactivated configuration we observe might 
help explain why the pain associated with PEPD mutations in Nav1.7 is typically 
not associated with all nociceptive neurons expressing Nav1.7.  However, several 
issues regarding the age-onset, therapeutic efficacy, pain triggers, and location 
of pain perception still remain unresolved for patients with PEPD and IEM, both 
of which result from single-point missense mutations in Nav1.7.  It is interesting to 
note that modulating factors that affect VGSC gating properties such as cellular 
redox balance (Kassmann et al., 2008) and temperature (Bouhours et al., 2004; 
Foulkes and Wood, 2007; Han et al., 2007; Zimmermann et al., 2007), along with 
cellular background (Leffler et al., 2002; Rush et al., 2006; Yiangou et al., 2007) 
and alternative splicing (Raymond et al., 2004) could affect some of the noted 
differential factors for patients with IEM versus PEPD.  It remains to be seen if 
there is one answer for the differences or if it involves a myriad of molecular 
components, however, further investigation into these mechanisms could provide 
valuable insight into developing more specific pain therapeutics. 
C. Alternative splicing of Nav1.7 exon 5A increases the impact of the painful 
PEPD mutant channel I1461T 
1. Effects of alternative splicing on Nav1.7 disease mutations 
The potential reasons for the differences noted between IEM and PEPD 
inspired the design of the second part of this dissertation.  As mentioned above, 
notable differences such as age-onset, therapeutic efficacy, triggers of painful 
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episodes, and location of perceived pain have been documented for patients with 
IEM and PEPD.  One of the intriguing possibilities for these differences is 
alternative splicing of Nav1.7.  Indeed, alternative splicing within exons 5 and 11 
of Nav1.7 has been shown to occur resulting in two separate pairs of splice 
variants (Raymond et al., 2004).  Variants within exon 5 have been termed 5A 
(“adult”) and 5N (“neonatal”), although the logic is not clear because the 
expression patterns are not well-correlated with age.  Residue differences are 
noted within the exon 5 coding region, which is located within an area of D1 / S3-
S4.  Variants from exon 11 splicing are defined as 11S (“short”) and 11L (“long”), 
where the short form lacks an 11 amino acid stretch excluded from the D1-D2 
loop.  In particular, a recent study has shown that alternative splicing of Nav1.7 
channels can affect the biophysical properties (Chatelier et al., 2008).  
Interestingly, the exon 5 variants, which differ by two amino acids (L201V, 
N206D) in the D1 / S3-S4 linker, differentially affect the amplitude of currents 
generated in response to a slow depolarizing ramp stimulus.  IEM and PEPD 
mutations also alter Nav1.7 ramp current properties and this is thought to 
contribute to the chronic pain induced by these mutations.  Therefore, it was 
hypothesized that alternative splicing of Nav1.7 could impact the functional 
consequences of IEM (I136V) and PEPD (I1461T) mutations. 
The second overall goal of this dissertation was to determine if exon 5 
splicing impacts the biophysical properties of IEM and / or PEPD using a single-
point missense mutation associated with each painful disorder.  We present 
evidence that the 5A alternative splice variant of Nav1.7 alters the biophysical 
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properties of a disease mutation implicated in PEPD (I1461T) but not IEM 
(I136V).  Since a majority of the IEM mutations primarily alter the voltage-
dependent activation and deactivation properties (Dib-Hajj et al., 2007) the 
relatively small shifts induced by the 5A splice variant on voltage-dependent 
activation may be masked.  The I136V mutation alone shifted the midpoint of 
activation by approximately -8 mV compared to WT, which is much larger than 
the shift observed for the WT-5A compared to WT-5N splice variants.  Our 
results suggest that IEM mutations are not additively affected by the 5A splicing.  
These results are in agreement with those from Han et al. (2009) showing that 
the voltage-dependent properties of another “late-onset” IEM mutation (Q10R) 
are also not affected by alternative splicing.  However, our results for the PEPD 
(I1461T) splice variants are intriguing because they indicate that the impact of 
PEPD mutations and exon 5 changes are additive.  Mutations associated with 
PEPD generally affect the voltage-dependent transition to an inactivated state 
and thus, destabilize an inactivated channel configuration allowing an increasing 
fraction of channels to remain available for activation and opening (Fertleman et 
al., 2006; Dib-Hajj et al., 2008; Jarecki et al., 2008).  Many of the characterized 
PEPD mutations shift the voltage-dependent inactivation properties to more 
depolarized potentials and yield incomplete development of closed-inactivation 
and accelerated recovery from inactivation compared to wild-type (Jarecki et al., 
2008).  Conversely, our results demonstrate that the 5A splice variant of WT 
channels moderately hyperpolarizes the midpoint of activation and increases 
ramp current, which are in agreement with Chatelier et al. (2008).  Since the 
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stability of the inactivated conformation is decreased by the I1461T mutation, the 
effects of the 5A alternative splicing for the I1461T channels would be predicted 
to amplify the overlap between channels opening versus inactivating (window 
current) and increase the probability of channel opening in an additive manner. 
Indeed, when the ability of channels to generate subthreshold ramp currents was 
assayed the I1461T 5A variant significantly increased the peak current and 
shifted the ramp current threshold to more hyperpolarized potentials compared to 
the 5N variant.  The changes observed in ramp current for the I1461T 5A variant 
could be caused by a lowered energy barrier for the channels to activate relative 
to deactivation, and a slowed and incomplete development of a closed-
inactivated state thus favoring ion flux.  It is worthwhile to note that the voltage-
dependent properties of the ramp current for the I1461T 5A variant, even when 
compared to the wild-type 5A variant, resemble a melding of those observed for 
IEM mutations (Cummins et al., 2004; Dib-Hajj et al., 2005; Cheng et al., 2008) 
and PEPD mutations (Dib-Hajj et al., 2008; Jarecki et al., 2008) in Nav1.7 
channels.  These effects were similar to those observed for a novel mutation that 
caused patient symptoms associated with both disorders (Estacion et al., 2008).  
The overlapping functional effects for these separate painful mutations are 
particularly interesting because patients diagnosed with PEPD have reported 
differential age-onset of pain compared to IEM patients (Fertleman et al., 2007).  
Therefore, it is appealing to consider that temporal and tissue specific increases 
in relative expression of the 5A variant could result in a transition to a state where 
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patients with disease mutations in Nav1.7 experience more frequent and diverse 
attacks. 
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2. Mechanistic implications from amino acid differences between 
Nav1.7 exon 5 splice variants 
The coding region of exon 5 includes a portion of the Nav1.7 gene that 
extends from the D1 / S3 segment to the C-terminal end of the positively charged 
D1 / S4 (Raymond et al., 2004).  The residue differences between the 5N and the 
5A variants are localized to the extracellular portion of the D1 / S3 and the D1 / 
S3-S4 cytosolic linker.  Interestingly, the residue difference in the cytosolic linker 
of the 5A variant contains a polar, negatively charged (acidic) residue (Asp206) 
compared to the 5N variant which retains a polar, non-charged Asn at the 206 
position at physiological pH.  This acidic residue substitution could contribute an 
additional negative charge to the electrostatic field surrounding the D1 / S4 
(Asamoah et al., 2003; Sigg and Bezanilla, 2003).  Additionally, the Asp206 may 
form electrostatic interactions with N-terminal residues in the mobile D1 / S4 
charge translocator, which is laden with positive residues (Cha and Bezanilla, 
1998; Sorensen et al., 2000).  In fact, alternative splicing in this region of Nav1.5 
has been explored (Onkal et al., 2008), wherein a positively charged residue 
(Lys) has been substituted for a negative residue (Asp) between variants.  
Results from Onkal and colleagues suggest that this reversal of residue charge 
impacts the voltage-sensitivity and kinetics of channel activation, such that the 
positively charged splicing substitution within D1 / S3-S4 depolarized the 
activation midpoint and slope factor, and slowed the time to peak, all of which 
were reversed upon switching the charged residue substitution.  Since movement 
 210 
of the D1 / S4 is critical during the early fast component of gating charge 
translocation and channel activation (Cha et al., 1999; Chanda and Bezanilla, 
2002), a negative charge on an extracellular linker within proximity to accessible 
positively charged D1 / S4 residues could accelerate the movement of this 
segment during depolarization.  Indeed, several studies have shown that the 
upper portion of charged residues within the S4 is accessible in the extracellular 
space during depolarization (Yang and Horn, 1995; Larsson et al., 1996; Starace 
and Bezanilla, 2001; Ruta et al., 2005).  Thus, small changes such as increased 
electrostatic interactions that may lower the energy barrier for activation for the 
S4 segments would be predicted to enhance their gating movement, reduce 
deactivation, and increase the probability to generate subthreshold currents at 
more hyperpolarized potentials.  The other amino acid change that results from 
the alternative splicing involves a more conserved substitution (Leu to Val at 
position 201), but as conserved substitutions can have important consequences 
(i.e., I136V causes chronic pain); we cannot rule out a role for this amino acid 
change in altered channel gating. Furthermore, we cannot overlook the possibility 
that the combination of the two substituted residues that differ in the 5N versus 
the 5A variants decreases the stability of the channel population in the closed 
state relative to the open state.  And finally, it is worthwhile to consider the 
possibility that particular VGSC auxiliary subunits, expressed in nociceptive 
neurons, may differentially augment channel properties in response to regulation 
of alternative splicing events. 
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3. Global effects of alternative splicing 
Alternative splicing affects the properties of a variety of sodium channels 
(Sarao et al., 1991; Dietrich et al., 1998; Tan et al., 2002; Raymond et al., 2004; 
Fraser et al., 2005; Liu et al., 2008; Onkal et al., 2008), calcium channels (Liao et 
al., 2004; Shen et al., 2006; Altier et al., 2007; Liao et al., 2007; Shcheglovitov et 
al., 2008; Tang et al., 2008; Adams et al., 2009), and potassium channels (Bassi 
et al., 2005; Aydar and Palmer, 2006; Xu et al., 2007).  In particular, Nav1.1-3, 5 
and 6, in addition to Nav1.7, have alternative splicing within exon 5 that involves 
a change in the charge of one residue (Raymond et al., 2004).  Interestingly, of 
the Nav isoforms with exon 5 splicing, disease-associated (gain-of-function) 
mutations have also been identified in Nav1.1 and 1.2 (epilepsy) (Catterall et al., 
2008; Lossin, 2009) and 1.5 (LQTS) (Koopmann et al., 2006) and, as with the 
PEPD mutations, some of these mutations primarily impair inactivation.  
Therefore, based on our data with the I1461T PEPD mutation, we predict that the 
changes induced by splicing likely have a functional impact on other disease 
mutations and this could be useful in understanding the underlying molecular 
mechanisms inactivation gating.  It is likely that expression patterns of splice 
variants in human populations are altered under pathological conditions 
(Raymond et al., 2004; Fraser et al., 2005; Altier et al., 2007) and may result in 
unique differences in response to pharmacological agents (Tan et al., 2002).  
Although the interactions and effects may be complex, physiological regulation of 
the splice variants may prove useful in better understanding disparities in 
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pathophysiology related to patient age or genetic background.  Understanding 
how alternative splicing alters intramolecular interactions during channel gating 
could lead to the development of novel pharmacological strategies.  However, 
alternative splicing of Nav1.7 may be just one piece of the puzzle which may 
account for differences in symptoms between patients with IEM and PEPD.  
Unraveling further structural and molecular details that account for differences in 
localization of pain and therapeutic efficacy may further enhance our knowledge 
of pain signaling and understanding of how dysfunction in one component of the 
process lower the threshold and / or response to non-noxious stimuli. 
D. Inherited mutations implicated in neuronal and muscle channelopathies can 
increase resurgent sodium currents in DRG neurons 
We also hypothesized that an increased contribution of inward current that 
flows at repolarizing potentials when channels should reside in an inactivated / 
non-conducting state.  The amplitude of this unique type of current, termed 
resurgent current, is increased upon artificial slowing of sodium channel 
inactivation using toxin application (Grieco and Raman, 2004).  Therefore, 
inherited Nav1.7 mutations implicated in PEPD would be predicted to increase 
resurgent sodium currents.  We hypothesize that increased resurgent currents 
may be a novel reason for the difference between patients with PEPD, whose 
pain is associated with Nav1.7 mutations that affect inactivation properties, 
compared to IEM, whose pain is associated with Nav1.7 mutations that affect 
activation properties. Together, increases in resurgent sodium currents may help 
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explain the spectrum of severity of voltage-gated sodium channelopathies 
associated with mutations that alter channel inactivation and cellular excitability. 
Our data show for the first time that (1) Nav1.4, Nav1.5 and Nav1.7 
channels have the capability to generate resurgent currents and (2) the relative 
amplitudes of resurgent sodium current observed with the disease mutations that 
impair inactivation are approximately of the same magnitude of the resurgent 
currents generated by Nav1.6 under control conditions in cerebellar Purkinje 
neurons and DRG neurons (Raman et al., 1997; Cummins et al., 2005).  An 
extensive series of studies on cerebellar Purkinje neurons indicates that 
resurgent currents have a major impact on excitability, contributing to 
spontaneous firing and accelerating the rate of repetitive firing of APs (Raman 
and Bean, 1997; Raman et al., 1997; Raman and Bean, 1999b, 2001; Khaliq et 
al., 2003).  As a consequence, it is predicted that the resurgent currents 
associated with the inherited neuronal and muscle channelopathies could 
significantly impact AP firing in neurons and muscle and contribute to disease 
pathophysiology.  Indeed, our computer models of a DRG neuron and cardiac 
myocyte indicate that resurgent currents could significantly exacerbate the 
effects of the disease mutations on cellular excitability (Jarecki et al., 2010). 
Our data provide further evidence that the sodium channel isoforms differ 
in their proclivity to produce resurgent sodium currents.  We show that, under 
normal conditions, Nav1.6 is more inclined to generate resurgent currents than 
Nav1.4, Nav1.5 or Nav1.7.  Furthermore, the identical mutation produced a 
greater increase of resurgent currents in Nav1.6 than in Nav1.7.  Although studies 
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of Nav1.6 knock-out mice strongly indicate that Nav1.6 is the predominant 
generator of resurgent currents in cerebellar Purkinje and DRG neurons (Raman 
et al., 1997; Cummins et al., 2005), resurgent currents have been detected in 
Purkinje and other CNS neurons from Nav1.6 knock-out mice (Do and Bean, 
2004).  Nav1.2 channels produce resurgent currents when expressed in DRG 
neurons, albeit in only two of 25 transfected cells (Rush et al., 2005).  Although it 
is not known if Nav1.1 and Nav1.3 channels produce resurgent currents, 
mutations that slow the rate of inactivation have been identified in these isoforms 
in patients with epilepsy (Lossin et al., 2002; Holland et al., 2008).  Therefore, it 
is conceivable that resurgent currents could also contribute to the 
pathophysiology of some inherited epilepsies. 
In our study we show that a mutation that occurring in the voltage-sensing 
segment 4 of the fourth domain as well as mutations in the IFMT inactivation 
motif can induce enhanced resurgent currents, suggesting that any mutation that 
slows the rate of open channel fast inactivation might be able to induce resurgent 
currents. 
To verify this hypothesis and expand this study, I further tested the ability 
of an additional Nav1.7-PEPD mutation (V1299F) located in the D3 / S4-S5 linker 
to generate resurgent currents.  This particular mutation was chosen for a few 
reasons.  First, this Nav1.7-PEPD mutation is located outside of the putative 
inactivation gate motif (IFMT) but within an intracellular linker region important for 
interactions critical for stabilizing transition to an inactivated state, as 
demonstrated within this dissertation.  Second, based on the characterization 
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data shown in this dissertation, the V1299F PEPD mutation has differential 
effects on the kinetics of development of and recovery from inactivation 
compared to the inactivation gate mutation I1461T.  As shown in Figure 38, 
transiently transfected rat DRG neurons, expressing the Nav1.7r-V1299F PEPD 
mutant channels shift the inactivation profile rightward (Figure 38A) and can 
produce resurgent currents (Figure 38B) within a voltage-dependent window 
(Figure 38C) in a similar manner to the Nav1.7r-I1461T inactivation gate 
mutation.  However, my preliminary data suggests that the amplitude of 
resurgent currents is increased with the D3 / S4-S5 PEPD mutation (V1299F) 
compared to wild-type Nav1.7r and inactivation gate mutant (I1461T) channels.  
These data may indicate that although the PEPD mutations, which all appear to 
disrupt inactivation, have the potential to generate resurgent currents, the 
location and the residue substitution may determine the relative amplitude of 
resurgent current. 
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Figure 38.  A D3 / S4-S5 PEPD mutation (V1299F) shifts steady-state 
inactivation and increases resurgent current amplitude compared to 
Nav1.7r wild-type and I1461T channels in transfected DRG neurons.  (A) 
Comparison of steady-state inactivation for wild-type Nav1.7r and Nav1.7r-
V1299F channels.  Representative trace (B) and voltage-dependence (C) of 
resurgent currents elicited for the Nav1.7r-V1299F channel.  The voltage-
dependent plot shown was collected from the data in the representative trace 
illustrated in (B).  The gray shading in (C) indicates the voltage window where 
peak resurgent current amplitude is typically observed.  (D) Bar graph 
comparison of percentage of resurgent current amplitude for wild-type Nav1.7r (5 
of 21 cells), Nav1.7r-I1461T (20 of 30 cells), and Nav1.7r-V1299F (5 of 10 cells) 
PEPD mutant channels.  The lines above each bar are color-coded to denote 
significance between the channels for generation of resurgent currents.  Protocol 
used to generate the data for this graph is described in the Methods section of 
this dissertation. 
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important role in determining the amplitude of resurgent currents elicited.  
Collectively, these data may suggest a molecular / structural basis as to why 
some of the patients with PEPD respond to certain therapeutic agents better than 
others.  One intriguing way to correlate amino acid substitutions (structure) to 
changes in resurgent current amplitude (function) could be via utilization of Cys 
substitutions.  For example, if one was to compare the side chain volume and the 
effects on activation and inactivation properties, a relatively minor Cys 
substitution appears to be innocuous to steady-state channel properties 
compared to a more bulky Phe substitution, as seen in PEPD (Figure 39).  Thus, 
using a series of MTS reagents that add charge (MTSET, MTSEA, MTSES), 
aromatic bulk (MTSBn), or photoactivatable moieties to an accessible engineered 
Cys residue may be a useful way of bridging changes in amino acid properties to 
voltage-dependent characteristics of resurgent currents to changes in an AP 
profile.  Additionally, one may be able to “titrate” the effects using a series of site-
directed mutagenesis techniques that involve substituting amino acids with 
varying side chain properties or inserting unnatural amino acids that are modified 
to test effects of chemical structure on current properties and correlate the 
replacements to changes in resurgent current characteristics and AP properties. 
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Figure 39.  Side chain volume of amino acid substitutions made within the 
Nav1.7 D3 / S4-S5 linker at a location critical for stabilizing inactivation 
which is mutated in PEPD.  Comparison of amino acid side chain volume 
substitutions and resulting changes in V1/2 activation (A) and inactivation (B).  
The substitutions occur at the same location (1299 position) replacing a native 
Val to a Phe, as seen in PEPD, or Cys, which was used in this dissertation to 
probe interactions during transition to an inactivated state.  The bulky Phe 
substitution had small, but significant effects on the activation profile, and more 
dramatic alterations to the voltage required to inactivate 50% of the channels, 
compared to WT Nav1.7 and V1299C channels.  These data were determined 
using transiently transfected hEK293 cells with activation and inactivation 
protocols described in the Methods section.  * denotes statistical significance. 
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However, it is important to note that the rate of inactivation cannot be the 
only determinant of resurgent current production.  Nav1.8 currents are slower to 
inactivate than Nav1.7r-I1461T channels.  Despite this, in cultured rat DRG 
neurons treated with TTX that produced large endogenous Nav1.8 currents (but 
no recombinant currents) resurgent currents were not observed (Jarecki et al., 
2010).  Thus, other factors must also contribute to the inclination of specific 
VGSC isoforms to generate resurgent currents. 
The data presented in the resurgent currents Results section, in 
conjunction with a previous study (Cummins et al., 2005), clearly show that DRG 
neurons have the appropriate cellular environment for production of resurgent 
currents.  By contrast, adult DRG sensory neurons do not express Nav1.4 and 
Nav1.5 and it is not known if cardiac and skeletal muscle cells have the 
appropriate cellular environment for the production of resurgent currents.  Data 
from cerebellar Purkinje neurons indicate that the auxiliary sodium channel β4-
subunit may be the putative blocking factor crucial to generation of resurgent 
currents with Nav1.6 channels (Grieco et al., 2005).  Previous work has 
demonstrated that DRG neurons, cardiac and skeletal muscle all express high 
levels of β4 (Yu et al., 2003).  However, while the β4-subunit may be necessary, 
it does not appear to be sufficient.  Phosphorylation of the sodium channel, the 
β4-subunit, or possibly an unidentified protein also seems to be required (Grieco 
et al., 2002), at least in cerebellar Purkinje neurons.  This indicates changes in 
kinase and phosphatase activity are likely to impact the generation of resurgent 
currents.  Therefore, even if the conditions in normal cardiac and skeletal muscle 
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are not appropriate for generation of resurgent currents, under specific, possibly 
pathological, conditions these cells might express the appropriate accessory 
subunits and kinases.  Since our optimized expression system utilized adult DRG 
neurons where Nav1.4 and Nav1.5 are not normally expressed, it would be of 
great interest to determine if Nav1.4 and Nav1.5 wild-type and mutant channels 
produce resurgent sodium currents in skeletal and cardiac muscle, respectively, 
under either normal or pathophysiological conditions. 
It is important to note that not all of the DRG neurons expressing 
recombinant channels capable of generating resurgent currents produced 
detectable resurgent currents.  This further indicates that the cellular environment 
is a crucial determinant of resurgent current production.  Regional differences in 
the properties of sensory afferents that impact resurgent current generation might 
contribute to the phenotypical association of pain with particular body regions in 
PEPD.  Over 40 cells with peak transient current amplitudes greater than 20 nA 
were recorded from that did not have detectable resurgent currents.  Notably, the 
relative amplitude of resurgent currents is poorly correlated with peak transient 
current amplitude (Jarecki et al., 2010).  At this time we do not know how DRG 
neurons that do and do not produce resurgent currents differ in terms of β-
subunit expression and / or kinase activity.  Our optimized DRG expression 
system could be very useful in identifying cellular factors that modulate resurgent 
currents. 
Our data clearly show that resurgent sodium currents are likely to play a 
role in the functional consequences of inherited neuronal and muscle 
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channelopathies.  In addition our data, in conjunction with the previous study 
indicating that beta-pompilidotoxin can artificially induce resurgent currents in 
cerebellar Purkinje neurons (Grieco et al., 2005), indicate that any manipulation 
which slows or destabilizes inactivation has the potential to induce resurgent 
currents.  Many post-translational modifications have been reported to slow the 
rate of inactivation or increase the amplitude of persistent sodium currents, 
including hypoxia (Hammarstrom and Gage, 2002), phosphorylation (Numann et 
al., 1991), altered calcium signaling (Herzog et al., 2003a), G-protein activation 
(Ma et al., 1997) and oxidation (Kassmann et al., 2008).  We propose that these 
alterations could also result in abnormal resurgent current generation.  The 
induction of resurgent sodium currents likely contributes to the more extreme 
electrophysiological changes and disease sequelae that can be associated with 
both inherited and acquired disorders of neuronal and muscle excitability 
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E. Residues located within the D3 / S4-S5 of Nav1.7 directly stabilize an 
inactivated configuration 
A multitude of scanning mutagenesis studies localized to the S4-S5 
segments of D3 and D4 in VGSCs suggest that these cytosolic linkers serve as 
putative “docking” sites for the mobile inactivation gate and that the biochemical 
properties of specific residues within the linkers can specifically stabilize an 
inactivated channel configuration (Lerche et al., 1997; Smith and Goldin, 1997; 
Filatov et al., 1998; McPhee et al., 1998; Popa et al., 2004).  Additionally, 
inherited single point mutations in the D3 and D4 / S4-S5 that are implicated in 
several muscle and neuronal voltage-gated sodium channelopathies can alter 
transition to an inactivated state, which is postulated to contribute to the 
phenotype of the disease (Cannon, 2006; Koopmann et al., 2006; Catterall et al., 
2008).  However, the evidence for direct interactions with the VGSC inactivation 
gate motif and the means by which residues within the D3 and D4 / S4-S5 
segments stabilize an inactivated configuration are unclear.  The potential for 
interactions with the S4-S5 linkers, which lie outside of the pore and the 
inactivation gate, has proven to be a controversial issue as the VGSC 
inactivation gate has been proposed to interact and “dock” with residues inside 
the aqueous channel pore. 
Interestingly, mutation of residues (V1298, V1299, and M1627) within the 
D3 and D4 / S4-S5 linker are implicated in a painful disorder termed PEPD 
(Fertleman et al., 2006).  Results from this dissertation demonstrate that a 
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doublet of native Val residues within the D3 / S4-S5 linker of Nav1.7 at the 1298 
and 1299 positions and the native D4 / S4-S5 Met residue are critical for 
stabilizing an inactivated state and that upon mutation, can increase neuronal 
excitability (Dib-Hajj et al., 2008; Jarecki et al., 2008).  Destabilized inactivation is 
predicted to be due to either direct alterations to a putative “docking” site for the 
inactivation gate outside of the aqueous channel pore, or alterations that 
indirectly decrease the stability of an inactivated configuration where the 
inactivation gate motif “docks” to sites within the channel pore.  Therefore, I 
sought to determine if residues within the D3 / S4-S5 linker of Nav1.7 can directly 
interact with the inactivation gate motif and serve as a putative “docking” site 
during transition to an inactivated state.  Results from these studies reveal 
several layers of evidence that suggest the D3 / S4-S5 linker of Nav1.7 can 
provide an accessible interface, dependent on membrane potential, to which the 
inactivation gate motif can “dock”. 
First, the specific location and orientation as well as the biochemical 
properties of the side chain of the substituted amino acid within the D3 / S4-S5 
linker of Nav1.7 are important for stabilizing interactions required during 
inactivation.  Substitution of the native V1298 and V1299 to Cys residues does 
not affect steady-state gating or kinetic properties, whereas the V1300C 
substitution reduced the voltage-sensitive response to depolarization, thus 
shifting the activation and inactivation potentials rightward.  However, substitution 
to bulky (Phe) or charged (Asp) residues dramatically affects transition to an 
inactivated state at the 1298 and 1299 residue positions.  These data suggest 
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that mild side chain substitutions (i.e. ValCys) do not significantly disrupt the 
van der Waals interactions that stabilize inactivation at the 1298 and 1299 
positions, however, bulky groups that may add steric hindrance (i.e. ValPhe), 
or charged groups (i.e. ValAsp) that may alter neighboring electrostatic 
interactions can affect the stability of transition to an inactivated state.  
Furthermore, because substitution of bulky or charged residues at the 1298 and 
1299 positions alter transition to an inactivated state, the native residues would 
be predicted to lie within an accessible region of the alpha helical D3 / S4-S5 
linker (Filatov et al., 1998) that could interact with residues that stabilize 
inactivation.  Indeed, upon homology model predictions performed by me, 
utilizing the Kv1.2 crystal structure, the native Val residues at the 1298 and 1299 
positions appear to face away from the lipid membrane towards the cytosol on a 
single turn within the alpha helix suggesting they may be accessible for 
intramolecular interactions that stabilize inactivation. 
Second, the Cys substitutions at the 1299 position, but not the 1300 
position within the D3 / S4-S5 linker, were modifiable and disrupted transition to 
an inactivated state in the presence of MTSET similar to a Cys substitution at the 
1461 position within the D3-D4 Nav1.7 inactivation gate motif.  It is important to 
note that modification was only seen at holding potentials (-120 mV) where a 
large fraction of the channels were captured in a closed state before test 
potentials were applied, and not at more depolarized potentials (-60 and -20 mV).  
These data indicate that before triggering the movement of the mobile 
components responsible for gating and altered channel configuration via 
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membrane depolarization, residues (C1299 and C1461) within regions of the 
VGSC critical for inactivation are accessible to MTSET modification.  The MTSET 
modification of these residues disrupts transition to an inactivated state and 
increases the persistent component.  However, upon depolarization, the same 
residues (C1299 and C1461) become inaccessible and are unable to be 
modified.  This may suggest that the packing orientation of residues changes or 
that interacting residue pairs are now at distances that allow for formation of 
stabilizing intramolecular interactions that prevent cysteine modification.  
However, because the residues of both the D3 / S4-S5 (C1299) and D3-D4 
inactivation gate (C1461) are located within cytosolic regions predicted to interact 
with one another during transition to an inactivated state, I hypothesized that 
these two residues could be covalently crosslinked, thus “locking” the channel in 
a specific conformation when the accessible Cys residues are in a predicted 
distance from one another in a similar manner to studies “locking” mobile 
components of hERG (Ferrer et al., 2006), HCN (Prole and Yellen, 2006; Bell et 
al., 2008), both of which trapped interactions between the S4-S5 linkers and the 
C-terminal portion of the S6, and the components responsible for the “ratcheting” 
S4 gating charge movement in a bacterial voltage-gated sodium channels 
(DeCaen et al., 2008).  I postulated that this interaction may occur at 
intermediate potentials (i.e., -60 mV) that are more hyperpolarized than those 
required to transition the channel into a conducting (open) configuration.  These 
intermediate potentials allow for the mobile S4 segments to “initiate” and 
translocate positive charges from a buried position to one that was more exposed 
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on the extracellular surface.  At these intermediate potentials, inactivation can 
occur, and is termed closed-state inactivation.  I hypothesized that, at the 
intermediate potentials, before channel opening, but during S4 activation, the 
mobile inactivation gate motif can “dock” and interact with residues outside of the 
mouth of the channel pore, such as the V1299 residue within the D3 / S4-S5 
linker. 
Third, upon intracellular application of a crosslinking reagent (MTS-1-
MTS), substituted Cys residues at the 1299 position in the D3 / S4-S5 linker and 
the 1461 position in the D3-D4 inactivation gate motif of Nav1.7 were covalently 
crosslinked at a holding potential of -60 mV, but not at -120 or -20 mV.  This 
crosslinker covalently modifies nearby Cys residues within a predictable distance 
based on the alkyl spacer in between the bifunctional reactive moieties (~5 Å).  
The covalent modification with the MTS-1-MTS reagent thus, effectively “locked” 
a fraction of the channels in a non-conducting state mimicking inactivation.  
These results indicate that the D3 / S4-S5 can interact with the mobile 
inactivation gate within ~5 Å during transition to a closed-inactivated state.  It is 
important to note that this interaction could suggest that the inactivation gate 
motif (IFMT) may not need to snugly bind within the aqueous mouth of the 
channel pore at these potentials to inactivate closed (or partially activated) 
channels. 
An additional interpretation may be that the Cys substitution of the Ile 
within the inactivation gate motif may interact with residues outside of the mouth 
of the pore within a three-dimensional space.  These data are intriguing because 
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the covalent “locking” interactions were not observed at -120 mV and -20 mV.  
Thus, it could be hypothesized that at -120 mV, when a large fraction of the 
channels are in a closed state, movement of the inactivation gate towards a 
“docking” site with which it has an affinity towards, has not been triggered, and 
therefore the distance is outside of the window of the 5 Å caliper used in this 
study.  The limited range of the MTS crosslinker may also be a reason for why 
the channels were not “locked” at -20 mV.  At a holding potential of -20 mV, a 
majority of the S4 segments have translocated their charges across the plasma 
membrane, which is electromechanically coupled to pore opening.  The tethered 
interface for this coupling reaction is hypothesized to be the S4-S5 segments.  
Therefore, as the S4 segments move “outward” upon depolarization this is 
transmitted to the S4-S5 segments which would be predicted to move in the 
same three-dimensional direction as the S4 segments.  This “outward” 
movement may put the substituted residues outside of the MTS-1-MTS 5 Å 
distance for crosslinking.  Alternatively, the inactivation gate motif may interact 
with residues within the channel pore at this holding potential, which would not 
allow for direct interactions with residues in the S4-S5 segments at more 
depolarized potentials. 
Together, these results could suggest two separate “docking” sites for the 
inactivation gate motif, one outside of the pore at the S4-S5 interface, and one 
within the mouth of the aqueous pore.  However, the limitations of the reagents 
used in this study and the electrophysiological techniques render this hypothesis 
solely speculative at this point.  With this in mind, there are alternative 
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approaches that I propose to answer these questions in more detail.  First, to 
address the limited window of reactive crosslinking, one could use a variety of 
MTS crosslinking reagents with longer alkyl spacers that would probe for 
interactions up to ~20 Å.  Similar experimental strategies taking advantage of the 
biochemical properties of site-engineered Cys residues and / or synthesized 
reagents that act like molecular “tape measures” have been used (Blaustein et 
al., 2000; Laine et al., 2003; Prole and Yellen, 2006; DeCaen et al., 2008; Bali et 
al., 2009).  Additionally, experiments utilizing charged residue pairs with 
predictable electrostatic interaction limitations have shed light on intramolecular 
interactions of voltage-sensitive channels (Seoh et al., 1996; Smith and Goldin, 
1997; Ferrer et al., 2006; Muroi et al., 2010).  Furthermore, computer-based 
homology modeling (Sunami et al., 2004) have been resourcefully used to 
calculate approximate regional distances of different intramolecular components 
of ion channels.  In the context of future experiments, the MTS crosslinkers 
would allow examination and calibration of the distance of interactions between 
residues in the S4-S5 segments and the inactivation gate motif at a range of 
potentials as the channel dynamically transits through gating states.  In the 
absence of a fully solved crystal structure for the VGSC these types of studies, 
could provide insight into the approximate distance and potential interactions 
required to stabilize an inactivated configuration.  Second, to address the issues 
related to a theoretical second “docking” site within the aqueous pore, a Cys 
residue within a region of the aqueous pore, focusing on the C-terminal portions 
of the S6 segments, where the inactivation gate motif may interact.  Studies have 
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shown there are that residues lining the S6 segments are located in the aqueous 
portion of the channel pore (Lipkind and Fozzard, 2000).  Interestingly, two 
studies in two different VGSC isoforms (Nav1.4 and 1.7) have shown that there 
are two conserved Phe residues within the C-terminal portion of the D3 / S6 
segment critical for gating (Lampert et al., 2008; Muroi et al., 2010).  The 
importance of the Phe residue during channel opening suggests it may be useful 
when probing for interactions that stabilize an inactivated channel configuration.  
If the sidechain of the Phe residue is indeed confined to the aqueous pore, 
substituting this residue with a Cys and probing for covalent interactions with the 
inactivation gate motif would be useful.  If the Phe sidechain is facing outside of 
the aqueous pore, but accessible for interactions with the D3 / S4-S5 linker, the 
side-chain accessibility could provide useful evidence of indirect interactions of 
the S4-S5 segments that stabilize a splayed open configuration of the channel 
pore, where within the pore lies a “docking” site for the inactivation gate motif.  
Therefore, engineering a Cys residue within the inactivation gate, the S6 
segment and the S4-S5 linker could yield insight into interactions that stabilize 
particular transitions to an inactivated state.  Taken together, these additional 
studies proposed could provide useful information of the channel configuration 
during inactivation and may yield information about potential regions of the 
VGSC that could be targeted by therapeutic agents to stabilize inactivation. 
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F. Summation and future directions 
Results from this dissertation demonstrate that (1) PEPD mutations 
significantly shift the voltage-dependent properties of Nav1.7 channels, 
destabilize an inactivated state in a residue specific manner, and render 
nociceptive neurons hyperexcitable; (2) alternative splicing can functionally 
impact PEPD; (3) channelopathies, resulting from slowed inactivation in neuronal 
and muscle VGSC isoforms, increase an unusual sodium conductance that flows 
during repolarization; and (4) specific residues located in distinct regions of 
Nav1.7 serve as docking sites to stabilize inactivation at different membrane 
potentials.  Overall, this dissertation addresses key questions regarding the 
molecular mechanics required during inactivation and the biophysical 
consequences of Nav1.7 mutations implicated in painful disorders.  The results of 
this dissertation are important for a more detailed understanding of pain 
perception and validate the applicability of studying Nav1.7 for discovery of 
therapeutic targets for treatment of pain. 
Nav1.7 channels, highly expressed in peripheral and sympathetic nervous 
systems, are essential in nociception as evidenced by single point missense 
mutations causing a spectrum of pain syndromes (Drenth et al., 2001; Fertleman 
et al., 2006; Dib-Hajj et al., 2007), and nonsense mutations resulting in human 
insensitivity to pain (Cox et al., 2006).  Therefore, further examination of the 
potential role these channels may have in diseases whose symptoms are 
associated with some type of pain, such as cancer, may become increasingly 
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important in the years to come.  Because humans constantly evolve and adapt to 
their surroundings, the critical role of particular VGSCs isoforms in tuning the 
response to various stimuli will ultimately provide a wealth of information about 
how we understand the inner workings of human physiology and disease in the 
many years to come. 
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4. Indiana Clinical and Translational Sciences Institute (CTSI) Fellowship, 
(12 month funding period), August 2009. 
 
5. Graduate Student Organization Education Enhancement Grant (EEG) 
Award Recipient, Spring and Fall 2008. 
 
6. National Society for Neuroscience (SFN) Ph.D. Graduate Student Travel 
Grant Award Recipient, November 2008. 
 
7. Best Graduate Student Poster, Society for Neuroscience (SFN), 
Indianapolis Chapter, November 2008. 
 
8. Best Graduate Student Poster, First Place Award, Society for 
Neuroscience (SFN), Indianapolis Chapter, November 2007. 
 
9. Andrew S. Cebula Scholarship Recipient, (12 month scholarship), August 
2005. 
 
10. Butler University “Top 100 Students” Nominee, August 2002. 
 
11. Butler University Heritage Award and Academic Scholarship, (4 year 
scholarship), August 1999. 
 
RESEARCH EXPERIENCE 
 
1. Indiana University School of Medicine, Indianapolis, IN, April 2006 – 
February 2010. 
a) Department of Pharmacology and Toxicology – Ph.D. Thesis 
Project. 
b) Gating of the Sensory Neuronal Voltage-gated Sodium Channel 
Nav1.7: Analysis of the role of D3 and D4 / S4-S5 Linkers in 
Transition to an Inactivated State. 
c) Mentor:  Theodore R. Cummins, Ph.D. 
 
2. Indiana University School of Medicine, Indianapolis, IN, December 2005 – 
April 2006. 
a) Department of Pharmacology and Toxicology – Research Rotation. 
b) Determine the cellular mechanisms mediating the release of 
neurotransmitters from pain-sensing (nociceptive) sensory neurons. 
c) Mentor:  Michael R. Vasko, Ph.D. 
 
3. Indiana University School of Medicine, Indianapolis, IN, August 2005 – 
December 2005. 
a) Department of Pharmacology and Toxicology – Research Rotation. 
b) Investigated mechanisms by which environmental agents and 
therapeutic drugs elicit liver cancer. 
c) Mentor:  Lisa M. Kamendulis, Ph.D. 
 
4. Indiana University School of Medicine, Indianapolis, IN, May 2005 – 
December 2005. 
a) Department of Pharmacology and Toxicology – Work Study. 
b) Focused on subcloning a voltage-gated sodium channel (VGSC) 
isoforms into an eGFP vector and evaluating the differential 
pharmacological sensitivity of two VGSC isoforms to local 
anesthetics using electrophysiological techniques of two VGSC 
isoforms. 
c) Advisor:  Theodore R. Cummins, Ph.D. 
 
5. Purdue University, West Lafayette, IN, May 2003 – June 2005. 
a) Organic Chemistry Department – Research Chemist. 
b) Utilized various synthetic steps to extract, separate, isolate, and 
purify compounds to develop general procedures for undergraduate 
organic chemistry students. 
c) Advisor:  Kurt Keyes 
 
6. Butler University, Indianapolis, IN, June 2002 – June 2003. 
a) Liberal Arts and Sciences, Department of Chemistry – Research 
Student. 
b) Synthetic methods and aspects in organic, organometallic, and 
polymer chemistry. Primary research focused on the synthetic 
design of novel C2-bridged indenyl metallocenes. 
c) Mentor:  John J. Esteb, Ph.D. 
 
PROFESSIONAL ACTIVITIES 
 
1. National Biophysical Society (BPS) Member, 2008 – present. 
 
2. National Society for Neuroscience (SFN) Member, 2007 – present. 
 
3. Local Society for Neuroscience (SFN) Student Member, Indianapolis 
Chapter, 2007 – 2010. 
 
4. Chemistry Mentor and Tutor, Butler University, Indianapolis, IN, 2002 – 
2003. 
 
5. Member of ACS Chemistry Club, Butler University, Indianapolis, IN, 2001 
– 2003. 
 
6. Licensed Pharmacy Intern, Butler University, Indianapolis, IN, 2001. 
 
7. Pharmacy Mentor, Butler University, Indianapolis, IN, 2000 – 2001. 
